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Systemic lupus erythematosus (SLE) is an autoimmune disease affecting 
multiple organ systems with potentially serious health outcomes. Furthermore, as a 
chronic disease that has an early age of onset, it poses a considerable humanistic and 
economic burden on patients and society. Health-related quality of life (HRQoL) is 
an indicator of humanistic burden measured for important applications including 
healthcare decision- and policy-making. As HRQoL is a complex construct, HRQoL 
instrument development involves multiple phases and has many requirements. An 
instrument is also required to be relevant to each disease and target population, as 
cross-cultural differences in HRQoL exist. Similarly, the economic burden of a 
disease is population-specific owing to healthcare system differences and broader 
epidemiological, social and economic factors specific to each country.  
 
 The first general theme of this thesis was uncovering characteristics of the 
HRQoL and economic burden of a disease- and country-specific patient population – 
SLE patients in Singapore. Through a qualitative focus group methodology, areas of 
HRQoL that were relevant and important to this population were identified by 
patients, four of which are unaddressed by extant instruments. Although an ideal 
HRQoL instrument was unavailable, a quantitative assessment of HRQoL was 
performed using extant HRQoL instruments in a cross-sectional survey study. With a 
similar study design combined with an analysis of costs from hospital databases, the 
economic burden of SLE was described in a cost of illness study. Together, the latter 
two studies found that the HRQoL and economic burden, in particular direct cost, 
were relatively low in our study sample relative to other SLE populations. However, 
x 
 
a large proportion of direct costs are likely borne by patients and HRQoL is likely to 
be worse among non-Chinese patients.  
 
 The second broad theme of this thesis was original research into the 
methodology of developing HRQoL instruments. Concerning a method used to 
establish content validity of instruments, patient focus groups were evaluated for the 
known negative effects of group interaction. As recommendations do not exist to 
guide such analysis, a set of methods were developed from an existing sociological 
model of patient focus groups to analyze interaction effects. These methods and 
results of an empirical focus group evaluation demonstrate that such analysis is 
feasible and valuable. Concerning the development of a new computerized adaptive 
testing (CAT) test form, a SLE-specific fatigue bank was developed from the generic 
PROMIS fatigue bank in an exploratory study. Although this attempt was 
unsuccessful as assumptions failed to hold for item response theory modeling, study 
results suggested that fatigue in SLE patients may be conceptually different from the 
general population, highlighting the need to further evaluate the method of 
developing disease-specific banks from generic banks.  
 
 To summarize, this thesis presents new knowledge on the subject of HRQoL 
and economic burden of SLE patients in Singapore that can guide decision-making 
and further research. For the international community, this thesis also presents new 
understanding about the methods for developing HRQoL instruments in the novel 
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1.1 Outcomes and outcomes research 
 
1.1.1 Outcomes research 
 
Outcomes research is the study of end results of health care practices and 
interventions with the aim of assessing the quality and effectiveness of health care. 
(Agency for Healthcare Research and Quality, 2000; National Library of Medicine) 
The end results evaluated in outcomes research are diverse and include effectiveness, 
cost, quality-of-life, quality of care, appropriateness, access of interventions and 
patient satisfaction. (Jefford, Stockler, & Tattersall, 2003) The reasons for conducting 
outcomes research are also diverse. These reasons include generating evidence for 
decision-making, monitoring quality of health care, understanding health services 
accessibility and formulating practice guidelines. (Lee, Earle, & Weeks, 2000) For 
each purpose, selecting appropriate outcomes to assess in research activities is 
essential. (Berger, Bingefors, Hedblom, Pashos, & Torrance, 2003; Bootman, 
Townsend, & McGhan, 1996) For example, though patient satisfaction is a useful 
indicator for the monitoring of quality of healthcare services provided, evidence 
supporting the correlation between greater patient satisfaction and improved health 
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When the purpose of conducting outcomes research is to compare the overall 
value between alternative healthcare interventions, the economic, clinical and 
humanistic outcomes (ECHO) model (Kozma, Reeder, & Schulz, 1993) is a 
commonly used framework that proposes the relevant outcomes to assess. (Berger et 
al., 2003; Epstein & Sherwood, 1996; Gunter, 1999) In this model, relevant medical 
care outcomes can be classified along three dimensions. Clinical outcomes are 
medical events that occur as a result of disease or treatment. These outcomes have 
been the focus of earlier research of medical interventions. Economic outcomes are 
the direct, indirect, and intangible costs associated with the disease or treatment and 
its alternatives. Humanistic outcomes are patient self-assessment of the impact of 
disease or treatment on their lives and well-being.  
 
As the outcomes to be assessed are specified prior to performing the 
evaluation, this ensures a balanced and comprehensive assessment that incorporates a 
range of outcomes that are important to the various stakeholders. (Bootman et al., 
1996; Gunter, 1999) The ECHO model was introduced in 1993 as a planning model 
for pharmacoeconomic research. Pharmacoeconomics is “the scientific discipline that 
evaluates the clinical, economic and humanistic aspects of pharmaceutical products, 
services, and programs, as well as other health care interventions to provide health 
care decision makers, providers and patients with valuable information for optimal 
outcomes and the allocation of health care resources”. (Berger et al., 2003) It is a 
collection of descriptive and analytic techniques used to assess the overall value of 
pharmaceutical interventions. (Arnold, 2009)  
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1.1.2 Patient reported outcomes (PROs) 
 
One simple way of categorizing the numerous types of outcomes measured in 
outcomes research is to classify these outcomes by their data source. (Acquadro et al., 
2003) In such a classification framework, patient-reported outcomes (PROs) are 
outcomes reported directly by patients, as opposed to caregiver-reported outcomes, 
clinician-reported outcomes or physiological outcomes. The rationale behind such a 
classification framework is that each data source provides a unique and valuable 
perspective in the assessment of outcomes. (Acquadro et al., 2003; Berger et al., 
2003)   
 
1.1.2.1 Constructs measured by PROs 
 
  “Patient-reported outcomes” is an umbrella term that comprises many 
different constructs. Constructs refer to measured variables that are abstract and latent 
in nature, rather than concrete and observable. (Nunnally & Bernstein, 1994) The 
various types of PRO constructs measured include symptoms, treatment satisfaction, 
functional status, psychological well-being, health-related quality of life and treatment 
adherence. (Acquadro et al., 2003). Symptoms reported by patients have traditionally 
been important in disease assessment and clinical decision-making, especially in 
conditions that rely largely on patient’s report of symptoms, such as insomnia. 
(Acquadro et al., 2003) In contrast, other PRO constructs that incorporate the patient’s 
values and preference have seldom been used in earlier evaluations, as they were 
perceived to be subjective and unreliable. (Clancy & Eisenberg, 1998) However, 
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interest in these perspectives has grown, due to an emphasis on patient-centered care, 
defined as “health care that is closely congruent with and responsive to patients' 
wants, needs, and preferences.” (Kupfer & Bond, 2012; Laine & Davidoff, 1996) This 
was also supported by the advancement of measurement methods, which have enabled 
the measurement of these increasingly complex constructs of health that integrate 
clinical and biological factors into broader social factors. (Meyer & Clayton, 2009)  
 
1.1.2.2 Humanistic outcomes  
 
Within the context of pharmacoeconomic evaluation, PROs are relevant as humanistic 
outcomes specified in the ECHO model. As these outcomes are the patient’s self-
assessment of the disease and treatment impact on their lives and well-being, the 
patient is the ideal source for reporting such outcomes. In some cases, such as among 
the very young or severely ill, patient report is not possible and proxy report is 
necessary. However, not all PRO constructs are equally appropriate as humanistic 
outcomes.
 1
   For example, a straightforward report of symptoms, while useful for 
clinical assessment of the disease, lacks the patient’s self assessment of its impact on 
daily life. Furthermore, some PRO concepts measured may not be of the patient’s 
primary concern. (McKenna, 2011) Patient satisfaction, as described earlier, is an 
example of an outcome that is more relevant to stakeholders monitoring the quality of 
                                                 
 
1
 It may be noted that earlier classifications of humanistic outcomes were less strict and included many 
of the different PRO constructs described above.  (Epstein & Sherwood, 1996) However, in more 
recent publications, the distinctions between these terms have been clarified. (Acquadro et al., 2003; 
McKenna, 2011)   
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care, than to the patient who is likely to be concerned with other health outcomes. 
(Kupfer & Bond, 2012) As patient satisfaction is a measure concerning the treatment 
process, such assessment is limited to the healthcare experience and excludes other 
aspects of illness and daily life. Patient satisfaction depends on the healthcare services 
provided, such as acceptability of drugs, professionalism of healthcare workers and 
also the patient’s expectations of healthcare services. It is therefore more relevant to 
stakeholders because such factors are within the purview of providers and 
stakeholders. On the other hand, constructs that are of primary interest to patients, 
such as health-related quality of life, are influenced by many other factors that are 
beyond the treatment process.  
 
1.1.2.3 Health-related quality of life   
 
Health-related quality of life (HRQoL) is a specific PRO construct that is 
relevant to the definition of humanistic outcomes.
 
A brief definition of HRQoL is the 
“patient’s evaluation of the impact of a health condition on daily life”. The distinctive 
feature of this PRO construct is that the domains assessed are of primary importance 
to the patient, as it concerns the patient’s daily life. (Acquadro et al., 2003) A more 
detailed definition of HRQoL specifies that it encompasses three distinct areas of 
health, namely the physical, psychological and social domains of health. These areas 
are also influenced by a person’s experiences, beliefs, expectations, and perceptions. 
(Testa & Simonson, 1996) The construct of HRQoL and its relationship to a few other 
PRO constructs can be understood with a conceptual model of HRQoL proposed by 
Wilson and Cleary. (I. B. Wilson & Cleary, 1995) This model defines causal links 
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between clinical variables, individual factors and environmental factors in influencing 
the overall assessment of HRQoL.  The causal links between five levels of health 
constructs were specified in this model: biological and physiological factors, 
symptoms, functioning, general health perceptions and overall quality of life. These 
constructs are arranged in order of increasing complexity, from the inclusion of only 
biological factors, to integrate psychological and broader social factors. Thus, these 
constructs are also increasingly difficult to measure. (Meyer & Clayton, 2009) 
 
1.1.3 Economic outcomes  
 
The need to evaluate economic outcomes alongside clinical and humanistic 
outcomes arose due to medical care cost escalation, the rise of accountable care 
organizations (ACOs) and increasing demand for accountability. (Gunter, 1999; 
Kozma et al., 1993) Economic evaluation of alternative therapies generates the 
evidence required for decision-making in the allocation of scarce resources. Economic 
outcomes are the end results of economic evaluations that compare these costs to 
consequences of medical treatment alternatives.  
 
1.1.3.1 Economic costs  
 
Economic costs that arise due to illness and disease include direct medical, direct 
nonmedical and indirect costs. (Hodgson & Meiners, 1982) Direct costs include 
medical care expenditures, such as for diagnosis, treatment and rehabilitation of the 
disease. Direct costs also include other health care expenditures, transportation to 
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health care services, and illness-related expenditures, such as for household help, aids 
and devices and home modification that are needed due to one’s illness. Indirect costs 
refer to output losses due to lost productivity as a result of morbidity or mortality. 
Typically, economic outcomes are expressed as ration of cost to consequences in full 
economic evaluations. (Berger et al., 2003) Depending on the nature of the 
consequence assessed, there are four types of full economic evaluations: cost-benefit, 
cost-effectiveness, cost-utility and cost-minimization analyses. (Drummond, 2005) 
 
1.1.3.2 Full economic evaluations 
 
 In a cost-benefit analysis, both costs and health outcomes are characterized in 
monetary terms and economic outcomes can be presented as benefit-cost ratios or net 
monetary benefits. In a cost-effectiveness analysis, the consequence is a health 
outcome that is naturalistic (e.g. life-year saved) or a disease-specific unit. A cost-
utility analysis can be considered a type of cost-effectiveness analysis, where the 
health outcome measure used is a composite value of well-being, such as a quality-
adjusted life year (QALY). (Drummond, 2005; M. C. Tan et al., 2006) Finally, a cost-
minimization analysis compares only costs between alternatives as the health 
outcomes of interest are assumed to be similar. Cost-minimization analyses are 
considered to be full economic evaluations only if health outcomes have been 
demonstrated to be equivalent in clinical research. (Drummond, 2005)  
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1.1.3.3  Cost of illness analysis – a partial economic evaluation 
 
A cost of illness study (COI) is a partial economic evaluation that estimates 
costs arising due to a disease without comparing it with outcomes. (Tarricone, 2006) 
COIs are conducted to estimate the economic impact of an illness, to identify the main 
cost drivers among the various cost components, and to describe and explain the 
variability of costs, such as across patient demographic or illness characteristics, or 
characteristics of healthcare providers. (Tarricone, 2006). In turn, such information 
provided by COI studies can be used in the justification of intervention programs, 
assistance in allocation of research dollars on specific diseases, providing basis for 
policy and planning, and forming an economic framework for program evaluation. 
(Rice, 2000)  
 
1.1.4 Other uses of patient-reported and economic outcomes  
 
1.1.4.1 Indicators of disease burden 
 
Economic costs and HRQoL can also be evaluated together as indicators of the 
burden of disease on society. The burden of disease can be defined as the “quantified 
social and economic impact at the population level.” (Preedy & Watson, 2010) From 
a macro perspective, such as a public health perspective, the principal reason for 
estimating disease burden is to assess priorities and for decision-making for the 
allocation of scarce resources toward healthcare. (Hyder, Rotllant, & Morrow, 1998; 
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Murray, Lopez, & Jamison, 1994) The social indicators for disease burden typically 
consist of premature mortality and reduced HRQoL. (Preedy et al., 2010) The 
economic impact refers to the economic costs that arise due to illness and can be 
estimated with COI studies. When conducted from a societal perspective, the cost 
estimate represents the overall economic burden of an illness to society. In reality, 
these costs are borne by different people and at different levels of organization within 
society. These groups and levels are individuals (people with the disease), households 
(including family members of patients), the healthcare system, 
business/industry/employers, and the government. (Chisholm, Stanciole, Edejer, & 
Evans, 2010; Larg & Moss, 2011)  
 
1.1.4.2 Other uses of PROs  
 
 Although many PRO measures were originally developed to assess treatment 
effectiveness, (Dawson, Doll, Fitzpatrick, Jenkinson, & Carr, 2010)  they are now also 
used in many other areas of outcomes research. (Snyder & Brundage, 2010) At the 
population level, PROs are used for surveillance and policy, such as in national audits 
and qualification for disease registers. (Lipscomb, Donaldson, & Hiatt, 2004), They 
are also used as quality indicators for healthcare delivery in clinical governance and 
quality assurance, as well as in improving individual patient outcomes (Dawson et al., 
2010; Howell & Liu, 2012; Rogers & Carrothers, 2012) Similarly, HRQoL is used as 
an outcome in population surveillance studies, decision-making between alternative 
therapies, assessment of disease impact, and at a micro-level of direct patient–
clinician decision-making. (Karakiewicz, Briganti, Chun, & Valiquette, 2006).  




1.2 Measuring PROs 
 
1.2.1 Overview of PRO measurement  
 
 In spite of the importance of patient perspectives in health care decision-
making, there is some hesitation to include PROs as a key source of information, due 
to challenges in the measurement and interpretation of PROs. (Snyder & Brundage, 
2010) The underlying challenge is that many PRO constructs are subjective 
phenomena that cannot be measured directly, unlike physiological outcomes such as 
body weight and blood pressure. (McDowell, 2006) Development of PRO measures is 
a multi-step process. (McDowell, 2006) The first task is to identify and define the 
construct that is to be measured. As described earlier, a wide range of PRO constructs 
can be measured. For example, HRQoL was defined as the patient’s evaluation of the 
impact of a health condition on daily life and comprises the physical, psychological, 
and social domains of health. The second and third steps of PRO measurement are to 
select appropriate indicators that represent the concept in the target population, and to 
assign numerical scores to these indicators for quantification respectively. These steps 
are elaborated in the subsequent sections.  
 
1.2.2 Content validity of a PRO measure  
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Selection of the appropriate indicators for the measurement of a construct is 
central to content validity of the instrument developed. (McDowell, 2006) With 
respect to PRO measures, content validity is the extent to which the concepts of 
interest are comprehensively represented by the items in the questionnaire. (Guyatt, 
Feeny, & Patrick, 1993) As PROs are measured to reflect patient perspectives, the 
items and domains of such instruments should be important to the target population 
and comprehensive with respect to patient concerns. (Patrick et al., 2011) As such, 
one requirement for the establishment of content validity of a PRO instrument is 
direct qualitative input from an adequate sample of the target population during the 
instrument development process. (Patrick et al., 2011)  
 
1.2.2.1 The importance of patient input  
 
The development of PRO instruments can also be informed through literature 
review and clinical and expert input. (Peter M Fayers & Machin, 2007) In fact, earlier 
guidelines did not specifically require patient input, (Terwee et al., 2007) and many 
earlier PRO instruments were developed without patient input. (Frei et al., 2011)  
However, it is now recognized that patient input is important in identifying key 
domains that are relevant from the patient point-of-view, (DeWalt, Rothrock, Yount, 
& Stone, 2007; Turner-Bowker, Saris-Baglama, Derosa, Paulsen, & Bransfield, 2009) 
and that patients offer a unique perspective from health care providers. In HRQoL 
research, patients have identified additional domains of HRQoL and conceptualized 
HRQoL differently from their healthcare providers. (Bounthavong & Law, 2008; 
Hansel, Wu, Chang, & Diette, 2004)  It is also recognized that HRQoL can be 
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evaluated differently by patients from different cultures. (Angel, 2006; M Bullinger, 
Anderson, Cella, & Aaronson, 1993) In comparative qualitative studies, culture-
specific differences have been identified in the conceptualization and in the important 
areas of HRQoL. (Ho, Twinn, & Cheng, 2010; Oates et al., 2004; Tam Ashing, 
Padilla, Tejero, & Kagawa-Singer, 2003; Wong-Kim, Sun, Merighi, & Chow, 2005)  
 
1.2.3 Scaling PRO measures  
 
Before quantitative analysis can be performed on PROs, numerical estimates 
for indicators of the PRO constructs have to be derived. Ordinal response scales are 
commonly used in PRO measures, in which responses are ordered in terms of 
magnitude. Such responses may be adjectives, e.g. “mild”, “moderate” or “severe”, or 
a direct rating on a numerical scale, e.g. from a scale of 0 to 10. However, ratings on 
such scales have no intrinsic meaning. Therefore, in order to improve the numerical 
characteristics of such scales for quantitative analysis, scaling procedures are used. 
(McDowell, 2006) 
 
1.2.3.1 Scaling techniques  
 
In PRO measurement, scaling methods can be broadly be classified into 
methods based on psychometric methods or econometric methods. Psychometric 
techniques generate profile-based measures, which describe individual experience and 
are concerned with current health status. These measures record patient report of 
symptoms, behaviors, abilities or perceptions and therefore also include incorporate 
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the patient’s feelings, opinions and attitudes. (Marquis, Arnould, Acquadro, & 
Roberts, 2006; McDowell, 2006) Econometric methods generate preference-based 
measures which can be used to estimate utilities. Utilities represent the strength of 
preference for different health outcomes when faced with uncertainty, such as the 
possibility of a future gain. (Marquis et al., 2006; McDowell, 2006) Utilities can be 
used to calculate quality-adjusted life years (QALYs) which can be incorporated in 
cost-utility economic analyses. Majority of PRO measures are based on psychometric 
scaling techniques, which include the classical test theory (CTT) and the newer item 
response theory (IRT). (Acquadro et al., 2003; Marquis et al., 2006) 
 
1.2.3.2 Psychometric-based measurement theories  
 
Traditional PRO measures are constructed based on the CTT. Since then, the 
limitations of CTT in health outcomes measurement have been recognized and other 
desirable properties of health outcome measurement tools have emerged. (Chang & 
Reeve, 2005) Precise measures with lower respondent burden are desirable in study 
populations such as the elderly and the ill and useful in clinical trials for the 
evaluation of interventions because fewer patients are required. (Reeve, 2003) Also, 
as a large number of PRO instruments have been developed, methods to standardize 
concepts and metrics to allow comparisons of instruments and respondents are 
desirable. (Reeve, Hays, Chang, & Perfetto, 2007) Item response theory (IRT), a 
newer measurement theory relative to the CTT, is anticipated to be able to produce 
instruments with stronger psychometric properties and be able to meet these needs for 
health outcome assessment. (Fries, Bruce, Bjorner, & Rose, 2006; Reeve, 2003)   




Classical test theory  
 
With CTT, observed responses to items or scales are partitioned into two 
components, the true score and error score. The true score is the actual level of the 
concept that is the goal of measurement and error is the imprecision of measurement. 
(McDowell, 2006) In CTT, the true score is linked to overall test scores, rather than to 
individual item scores. In estimating the true score, using CTT does not differentiate 
between the influence of respondent’s ability and the item characteristics. (Hays, 
Morales, & Reise, 2000) CTT scores are also test-dependent, as the respondent’s 
ability is reflected by estimated true scores on the test score scales, which limits 
comparability across different test forms. Also, across all levels of measurement (e.g. 
from mild fatigue to severe fatigue), a single reliability estimate is produced with 
CTT, though it is known that reliability varies across the levels of measurement. 
(Hays et al., 2000) 
 
Item Response Theory  
 
In contrast, the essential feature of IRT that enables its important applications 
is that respondent ability can be estimated separately from the characteristics of the 
items. IRT, a psychometric technique which has been widely used in educational 
testing, places each item measuring a latent trait on a common ruler, according to the 
probability of a positive response. (Hambleton, 2000) Regardless of the sample of the 
respondents that an item is administered to, its item parameters should be the same, a 
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property known as item parameter invariance. (Embretson & Reise, 2000) This 
property gives IRT the many useful applications that meet the needs of health 
outcome measurement.  
 
First, the effects of differential item functioning (DIF) across groups can be 
evaluated, such as in the investigation of cross-cultural differences of item 
performance. Second, different instruments that measure the same domain can be 
linked on a common metric so that study results can be combined or compared. Third, 
shorter questionnaires with reduced respondent burden can be created. (Reeve & 
Fayers, 2005) While IRT can also be used to analyze items and scales to construct 
traditional static instruments with increased precision, a promising application of IRT 
is the ability to develop computerized adaptive testing (CAT) forms. (Kopec et al., 
2006) A CAT test form administers a set of items that is tailored for each individual 
based on one’s estimated trait level. With CAT forms, fewer items are administered to 
each respondent, item pools covering a wider range of difficulty can be administered 
and trait levels can be estimated with increased precision. (Fries et al., 2006) 
 
1.2.3.3 Item Banks and the Patient-Reported Outcomes Measurement Information 
System (PROMIS)  
 
An item bank is a collection of questions (items) that are calibrated with IRT 
that develop, define and quantify a common theme. Therefore, the item bank provides 
an operational definition of the trait that it measures. (Chang & Reeve, 2005)With a 
calibrated item bank, the set of questions that can best assess the level of a trait can be 
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selected for each individual with CAT forms. Therefore, the item bank is the basis of 
CAT development. In 2004, the Patient-Reported Outcomes Measurement 
Information System (PROMIS), a National Institutes of Health initiative of the United 
States (US), undertook the construction and validation of common accessible item 
banks to measure key symptoms and health concepts applicable to a range of chronic 
conditions. (Cella et al., 2007) PROMIS item banks are developed with rigorous 
qualitative and quantitative methodologies (Cella et al., 2007; DeWalt et al., 2007; 
PROMIS® Validity Standards Committee, 2012; Bryce B Reeve et al., 2007; 
Rothrock, Kaiser, & Cella, 2011) and 11 of these banks have been tested and 
calibrated in the US population. (Cella et al., 2010) Both CAT forms and short forms 
of PROMIS measures have also been evaluated. (Bajaj et al., 2011; Fries, Krishnan, 
Rose, Lingala, & Bruce, 2011; D. Khanna et al., 2012) In these studies, PROMIS item 
banks and measures were found to be reliable and precise measures of generic 
symptoms and functional reports when compared to traditional, legacy instruments. 
 
1.3 Humanistic and economic outcomes in Systemic Lupus Erythematosus (SLE)  
 
1.3.1 Systemic Lupus Erythematosus (SLE) – the disease 
 
Systemic Lupus Erythematosus is a multi-system, autoimmune disease with 
variable clinical manifestations, disease course and prognosis. It is a chronic disease 
which may be life-threatening when major organs are affected. More commonly, it 
results in chronic poor health. (D'Cruz, Khamashta, & Hughes, 2007) The onset of 
disease occurs most commonly in women during their reproductive years, with a 
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female to male ratio of 9:1. (Pons-Estel, Alarcon, Scofield, Reinlib, & Cooper, 2009) 
Apart from gender, there are also ethnicity differences in the occurrence of SLE. 
Incidence and prevalence rates of SLE are about two to three times higher in people 
of African or Asian descent as compared to Caucasian populations. (Pons-Estel et al., 
2009) The HRQoL of SLE patients is lower than the general population and 
comparable to severe illnesses such as AIDS, Sjogren’s syndrome and rheumatoid 
arthritis. (McElhone, Abbott, & Teh, 2006)  
 
 SLE has a significant impact on young women because it affects many women 
during their reproductive years. During this period, child-bearing decisions can be 
influenced by many SLE-related factors, including the increased risk of a disease flare 
during pregnancy, adverse maternal outcomes (such as hypertension and pre-
eclampsia), adverse fetal outcomes (such as premature delivery and low birth weight), 
and the contraindication of certain drugs used to treat lupus during pregnancy. Thus, 
family plans of a young woman with lupus may be delayed or modified. The multi-
faceted impact of SLE also affects patients’ career prospects during the critical early 
years of career development. SLE can limit physical function and activity, result in 
fatigue, cognitive impairment, and even undesirable changes in appearances, which 
can reduce day to day productivity. In addition, the unpredictability of SLE flares and 
possible occurrence of serious manifestations that require hospitalizations and long 
leaves of absence may hinder career prospects.   
 
1.3.2 Humanistic outcomes in SLE patients  
 
Chapter 1. Introduction   Ow, YL Mandy 
25 
 
HRQoL is an important indicator of disease burden and outcome measure in 
the evaluation of alternative interventions for SLE sufferers. As a chronic illness with 
an early onset and improving survival rates, premature morbidity does not adequately 
describe the burden of disease. (D'Cruz et al., 2007; Urowitz, Gladman, Tom, Ibañez, 
& Farewell, 2008) HRQoL also represents a different dimension from the clinical 
outcomes of SLE disease activity and severity. (Jolly & Utset, 2004; McElhone et al., 
2006; V Strand et al., 2000) When clinical trials are conducted among SLE patients, 
it is recommended that HRQoL is to be assessed as a minimum standard, alongside 
other endpoints of disease activity, disease damage and adverse events. (V Strand et 
al., 2000) 
 
 In SLE, HRQoL is a unique dimension as it does not correlate strongly with 
disease indicators of SLE activity and SLE damage. (D. D. Gladman, Urowitz, Ong, 
Gough, & MacKinnon, 1996; V Strand et al., 1999) The latter are measured with SLE 
disease indices, such as the Systemic Lupus Erythematosus Disease Activity Index 
(SLEDAI) and the Systemic Lupus International Collaborating Clinics/American 
College of Rheumatology Damage Index (SLICC/ACR-DI). (Bombardier, Gladman, 
Urowitz, Caron, & Chang, 1992; D D Gladman et al., 1997) As opposed to these 
clinical indices that are completed by a physician, (Ramsey-Goldman & Isenberg, 
2003) HRQoL reflects the patient’s perspective on the impact of the disease and 
interventions on the patient’s daily life and well being. Discordance has been shown 
between physician and patient ratings of SLE disease activity and global health in 
SLE. (Leong et al., 2010; V Strand et al., 2000) Overall concordance for disease 
activity was only 51% and patients' perception of illness severity was consistently 
related to psychosocial stresses and poorly related to physician rated SLE symptoms. 
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(V Strand et al., 2000) Therefore, HRQoL assessment alongside clinical outcomes 
would provide a more complete assessment of outcomes in SLE patients. (Smolen et 
al., 1999) 
 




The generic Medical Outcomes Survey (MOS) Short-Form-36 (SF-36) is the 
measure that has been most often used to assess HRQoL in SLE patients. (McElhone 
et al., 2006; Pons-Estel et al., 2009; V. Strand & Chu, 2011) Other generic measures, 
such as the European QoL scale (EQ-5D) and the World Health Organization Quality 
of Life scale (WHOQOL-Bref) have also been used. (S. Khanna, Pal, Pandey, & 
Handa, 2004; Luo et al., 2003; K C Tse, Tang, Lio, Lam, & Chan, 2006; Wang, 
Mayo, & Fortin, 2001) Instruments originally developed for other rheumatic 
conditions have also been applied in SLE. For this purpose, the Stanford Health 
Assessment Questionnaire (HAQ) and the Arthritis Impact Measurement Scale 
(AIMS), originally developed for arthritis patients, have been validated and used in 
SLE patients. (Fries, Spitz, Kraines, & Holman, 1980; Meenan, Gertman, Mason, & 
Dunaif, 1982)Although the SF-36 has the advantages of comparability across 
populations and diseases, and the ability to derive utility scores for economic 
analyses, it may not cover all domains relevant to SLE patients. (V. Strand & Chu, 
2011)  Due to its generic nature, domains relevant to a specific disease population, 
such as self-image, sleep and sexual health in SLE patients are omitted.  (McElhone et 
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al., 2007) In general, disease-specific instruments are likely to be more sensitive to 
change, and therefore have been recommended alongside generic instruments for 
evaluating treatments in trials. (V. Strand & Chu, 2011; Testa & Simonson, 1996) 
 
 SLE-specific measures  
 
Relative to the generic instruments, SLE-specific HRQoL measures are a more 
recent development. Since 2005, five disease-specific HRQoL measures have been 
developed for SLE populations. The first SLE-specific measure, the Systemic Lupus 
Erythematosus-specific Quality-of-Life (SLEQOL) was developed in Singapore and 
found to be more responsive to change than the SF-36. (Leong et al., 2005) However, 
an acknowledged limitation of the SLEQOL was the lack of patient input in 
generating items for the questionnaire. The LupusQoL©, was originally developed 
and validated in the United Kingdom (UK), (McElhone et al., 2007) and has been 
validated for use in the US population. (Jolly et al., 2009) Also developed and 
validated in the UK, the L-QoL was developed based on a needs- based QoL model 
and the statistical Rasch model. (L. C. Doward et al., 2009) The Simple Measure of 
the Impact of Lupus Erythematosus in Youngsters (SMILEY), is a SLE-specific 
measure developed for pediatric SLE patients. (Moorthy et al., 2007) The newest 
instrument, Lupus-PRO, was developed in the US and includes four domains 
reflecting “non-HRQoL” domains (desires/goals, coping, social support, and medical 
care) alongside ten HRQoL domains. (Jolly et al., 2012) An additional instrument, the 
SLE Symptom Checklist (SSC), (C Grootscholten et al., 2003) contains a list of SLE-
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related symptoms but is not considered to be a true HRQoL measure. (C.-S. Yee, K. 
McElhone, L.-S. Teh, & C. Gordon, 2009)  
 
1.3.3 Economic outcomes in SLE patients 
 
Among the different types of full economic evaluations outlined in Section 
1.1.3.2, very few full economic evaluations have been conducted in SLE patients. 
Mycophenolate mofetil, an immunosuppressant drug, was evaluated in cost 
comparison and cost-effectiveness studies, in which it was compared to conventional 
therapy in a sub-group of SLE patients with lupus nephritis. (K. C. Tse, Tang, Lam, 
Yap, & Chan, 2009; E. C. Wilson, Jayne, Dellow, & Fordham, 2007). Also, genotype-
based dosing of azathioprine was evaluated against conventional dosing in a cost-
effectiveness study using a decision model of a hypothetical cohort of SLE patients 
and rheumatoid arthritis patients. (Oh, Anis, & Bae, 2004) 
 
There are three possible reasons why so few full economic evaluations have 
been performed in SLE patients. (Panopalis & Clarke, 2006)  First, few drug therapies 
have been approved for the treatment of SLE. Only corticosteroids, 
hydroxychloroquine and low dose aspirin have been approved by the US Federal 
Drug Administration (FDA) for treatment of SLE, and no new treatment had been 
approved from 1955 to 2011. (Mitka, 2011) Second, relative to other diseases such as 
rheumatoid arthritis, medication costs in SLE do not take up a large percentage of 
direct costs. (Panopalis & Clarke, 2006)   Third, the large variability in disease 
manifestations and the unpredictable disease course make the evaluation of therapies 
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difficult, and are usually restricted to sub-groups with specific manifestations, such as 
lupus nephritis.  (Panopalis & Clarke, 2006) However, it is expected that drug costs 
will rise as new biologic drugs are developed for specific targets of the immune 
system. Thus, economic implications of these new drug inclusions will become more 
important. (Panopalis & Clarke, 2006) Belimumab, a monoclonal antibody biologic 
agent, was approved by the US FDA in 2011. Although the economic outcomes of 
Belimumab have not been assessed, there are already concerns about its cost, 
estimated to be US$35,000 per year. Without available pharmacoeconomic data, the 
discussion about the expected economic impact of Belimumab has been based on 
estimates derived from COI studies conducted in SLE patients. (Boyce & Fusco, 
2012) 
 
1.3.3.1 Cost-of-Illness in SLE patients 
 
Relative to the paucity of full-economic evaluations, several COI studies have 
been conducted in SLE populations.  Both direct and indirect costs have been assessed 
and found to be substantial in several countries, namely  the US, (Brunner, Sherrard, 
& Klein-Gitelman, 2006; Carls et al., 2009; Clarke et al., 2004; Gironimi et al., 1996; 
Nichol, Shi, Knight, Wallace, & Weisman, 2004; Panopalis et al., 2007; Panopalis et 
al., 2008) UK, (Clarke et al., 2004; Panopalis et al., 2007; Sutcliffe, Clarke, Taylor, 
Frost, & Isenberg, 2001) Germany, (Huscher et al., 2006) Canada, (Clarke et al., 
1993; Clarke et al., 2004; Gironimi et al., 1996; Panopalis et al., 2007) and Hong 
Kong. (Zhu, Tam, Lee, Lee, & Li, 2009) Despite numerous studies, costs in SLE are 
still not well-characterized.  (Lau & Mak, 2009; K. a. Slawsky, A. W. Fernandes, L. 
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Fusfeld, S. Manzi, & T. F. Goss, 2011b; Zhu, Tam, & Li, 2011) This is due to the 
large variations in cost estimates reported across studies, attributed in part to 
methodological differences.  Also, there are large inter-individual differences within 
studies, attributed to the variable manifestation of SLE in its patients. (Slawsky et al., 
2011b) Furthermore, across countries, unique epidemiologic patterns, patient needs, 
available resources and healthcare systems can further accentuate healthcare 
utilization and cost differences. (Lau & Mak, 2009; Mak, 2010) Broader economic 
factors can also influence indirect cost, such as unemployment rates, which may 
influence the rates of employment losses in a disease population 
 
1.3.4 Humanistic and economic outcomes of SLE patients in Singapore  
 
 
The prevalence rate of SLE in Singapore, estimated based on a hospital cohort, 
is 40 per 100,000. (Edwards, 2001) This rate is comparable internationally and with 
countries in the Asia-Pacific region. (Jakes et al., 2012; Osio-Salido & Manapat-
Reyes, 2010) To date, no full economic evaluations on therapeutic agents for the 
treatment of SLE patients have been conducted in Singapore. The COI in this 
population has also not been estimated. Similarly, the burden of SLE in terms of its 
social or humanistic impact has not been estimated in Singapore. However, several 
HRQoL instruments have already been validated for use among SLE patients, namely 
the generic MOS SF-36 and the EQ-5D. (Luo et al., 2003; Thumboo et al., 1997; 
Thumboo et al., 1999) and the SLE-specific SLEQOL, which was actually developed 
in Singapore. (Leong et al., 2005)  
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1.4 Research questions  
 
 As PROs have increasingly important applications in healthcare decision-
making, policy and other outcomes research activities, instruments with good 
measurement properties are needed. Among SLE patients, it is particularly important 
that HRQoL is measured as it is an important end point in clinical trials involving 
SLE patients. Therefore, the first general research question addressed in this thesis is 
“How can better measures of HRQoL for SLE patients be developed, particularly for 
SLE patients in Singapore?” Two specific research questions are addressed in this 
thesis: 
 
1. Which areas of HRQoL are important and relevant to SLE patients in 
Singapore, and are these areas addressed by extant instruments? Due to 
cross-cultural differences in HRQoL, identifying the range of issues that 
are relevant to the target population is essential for establishing the content 
validity of an instrument developed for a specific population. 
 
2.  Is it possible to develop a SLE-specific item bank, by using PROMIS 
items together with other items that are relevant to the SLE population, so 
that new PRO instruments such as CAT test forms can be developed? As 
PROMIS item banks are generic banks meant for use across chronic 
conditions, and are developed with a rigorous methodology, the potential 
to use these banks in a specific disease population can be evaluated.  
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In addressing research question 1 above, patient focus groups were conducted 
among SLE patients in Singapore (see Chapter 2). During this study, an important 
knowledge gap regarding the use of patient focus groups was identified and raised 
another research question. A well-known limitation of using patient focus groups to 
access the patient perspective is that the content of group discussion is inevitably 
influenced by effects of group interaction. (Carey & Smith, 1994; Hollander, 2004; 
Kitzinger, 1994; Smith, 1999; Webb & Kevern, 2001; Willis, Green, Daly, 
Williamson, & Bandyopadhyay, 2009) Despite this, very few patient focus groups 
studies conducted in health research have analyzed and reported these effects. (Moen, 
Antonov, Nilsson, & Ring, 2010; Rothwell, 2010; Stevens, 1996; Williams & Ayres, 
2007) In these studies, the main danger of omitting interaction analysis was found to 
be the failure to recognize the contexts from which focus group data emerge, resulting 
in inappropriate or incomplete analysis of data. Examples of contexts previously 
observed and identified to be important to interpreting focus group data were the 
presence of peer pressure among adolescent participants, (Rothwell, 2010) a relative 
lack of dissonant opinion during discussion, (Williams & Ayres, 2007) and the 
context of a particularly hostile focus group climate. (Moen et al., 2010)  Interaction 
analysis was also found to be useful in determining validity of focus group findings. 
(Moen et al., 2010) However, little guidance has been provided as to how these 
effects should be analyzed, and none has been specific to patient focus groups 
conducted for HRQoL research.  (Duggleby, 2005; Rothwell, 2010; Stevens, 1996) 
Therefore, the third research question addressed in this thesis is: 
 
3. How can patient focus groups conducted for the development of HRQoL 
measures be analyzed for the effects of group interaction?  




Extant instruments for measuring HRQoL in SLE patients are currently 
available for use. While developing improved PRO instruments is important, 
understanding the current burden of SLE in Singapore is also important. Primarily, 
areas of heavy disease burden are potential areas where disease burden can be 
reduced, and is therefore the starting point for healthcare providers and planners in 
selecting strategies to reduce this burden.  The overall burden of disease can be 
described in terms of the social or humanistic burden and the economic burden. Thus, 
the fourth and fifth specific research questions addressed in this thesis are:  
 
4. As an indicator of the social or humanistic burden of SLE, what is the 
HRQoL of SLE patients in Singapore, as measured with extant HRQoL 
instruments?  
5. As an indicator of economic burden, what is the cost of illness among SLE 
patients in Singapore?  
 
1.4.1 Organization of thesis 
 
 The study presented in Chapter 2 is a focus group study conducted to identify 
areas of HRQoL that are important and relevant to SLE patients in Singapore. This 
chapter is also the foundation for Chapters 3, 4 and 5. The concepts discussed by SLE 
patients in these focus groups were compared against items from the PROMIS banks, 
as an initial gauge of whether PROMIS banks are relevant and could be used to 
develop a SLE-specific item bank, a study presented in Chapter 3. The focus group 
Chapter 1. Introduction   Ow, YL Mandy 
34 
 
study was also the empirical study material used in the evaluation of group interaction 
effects, which is presented in Chapter 4. In Chapter 5, HRQoL of SLE patients in 
Singapore was assessed with extant instruments. However, while interpreting these 
results, it must be borne in mind that some areas of HRQoL may not be addressed by 
extant instruments, and that these unaddressed areas were identified through the focus 
group study in Chapter 2. Finally, Chapter 6 is a study of the economic burden of SLE 
in SLE patients in Singapore. Together, Chapters 5 and 6 describe the social or 
humanistic burden and economic burden of SLE in Singapore.  
 
1.4.2 Overview of data collection and sources  
 
 The studies presented in the thesis used data collected with three main 
methods or sources, namely a patient focus group study, cross-sectional surveys and 
hospital administrative and finance databases. Table 1.1 presents an overview of the 
data collection methods and sources, recruitment sources for participants and overlap 
across studies, and how the collected data were analyzed for each study presented in 
this thesis. Briefly, patient focus group transcripts were analyzed in Chapter 2 for the 
themes discussed, and analyzed as empirical data in Chapter 4 for group interaction 
effects. The cross-sectional survey was divided into two parts as each part had a 
slightly different inclusion and exclusion criteria. The main difference is that 
participants of the item bank study in Chapter 3 had to be English literate and 
participants of the economic burden study in Chapter 6 had to be diagnosed with SLE 
for a minimum of 12 months preceding the survey to report annual costs. Patients who 
fulfilled criteria of both studies could take part in both. HRQoL data, measured with 
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extant instruments, was collected from both parts of the survey and were analyzed for 
the HRQoL study in Chapter 5. The third data source, hospital administrative and 
finance databases were used to augment the cost estimates presented in Chapter 6. 











Patient recruitment source and 






Major types of data 
collected  
How data were analyzed Chapter No. and Short Title 
Focus 
groups 
1. Lupus Association (n=10) 
2. SGH outpatients (n=19), of 
which 17 took part in 








focus group voice 
recordings 
Transcripts analyzed for 
themes (content) 
Ch. 2 Domains of HRQoL 
important & relevant to SLE 
patients in Singapore 
Transcripts analyzed as 
empirical data for group 
interaction effects 
Ch. 4 Distilling the patient 
perspective from patient focus 





(Part 1 & 
2) 
SGH outpatients and inpatients 
who completed both Part 1 & Part 
2 of surveys  (n=113) 
Fulfill both 
survey Part 1  
& 2 criteria  
(1) Background data 
(2) HRQoL 
questionnaires 
HRQoL scores computed and 
compared between 
instruments  for patients who 
completed all questionnaires 
Ch. 5 The HRQoL among 
SLE patients in Singapore 
Part 1 
Part 1 only (n=9); 





(3) Responses to items 
from  new SLE-
specific fatigue bank 
Evaluation of psychometric 
properties of items 
Ch. 3 Evaluating the use of 
PROMIS items in an item 
bank developed to measure 
fatigue in SLE patients 
Part 2 
Part 2 only (n=21) ; 
Total (n=134) 
Diagnosed 
with SLE not 
less than 12 
months ago 
(1), (2) &  
(4) Cost  questionnaire  
Estimate total annual cost of 
illness 
Ch 6. The economic burden 







Same patients  from survey Part 2 
(n=134) 
1 year hospital charges 
and utilization from 
finance database 
Substitute survey estimates of 
medical costs at SGH 
Database sample 
All SLE patients in SGH RHI 
database, includes all SGH 
patients recruited above (n=374) 
N/A Up to 5 years of 
hospital charges per 
patient from 2006-
2011 
Augment survey estimates of 
medical costs as SGH 
*SGH: Singapore General Hospital; RHI: Department of Rheumatology & Immunology, SGH 
#
Lists only criteria that are unique from other studies. The complete inclusion/exclusion criteria list is found in individual chapters.  
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CHAPTER 2 Domains of health-related quality of life 
important and relevant to multi-ethnic English-
speaking Systemic Lupus Erythematosus 
patients in Singapore - a focus group study 
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2.1 Introduction  
 
Systemic lupus erythematosus (SLE) is an autoimmune disease with variable 
clinical manifestations and an unpredictable, fluctuating disease course. (D'Cruz et al., 
2007) Health-related quality of life (HRQoL) among SLE patients is reduced as SLE 
has an impact on the physical, social and psychological aspects of life. (B 
Bauernfeind et al., 2009; McElhone et al., 2006; D. Robinson et al., 2010; T A Stamm 
et al., 2007) A challenge in outcome assessment among SLE patients is therefore in 
identifying domains that are relevant and important because of the heterogeneous 
manifestations of SLE. (Aringer et al., 2006)  
 
Extant SLE-specific HRQoL measures address additional domains relevant to 
SLE patients that are not addressed in generic measures, such as the Medical 
Outcomes Survey Short Form 36 (SF-36). (McElhone et al., 2006; C.-S. Yee et al., 
2009)  These domains include fatigue, sleep disturbances, sexual functioning and 
body image. (C. S. Yee, K. McElhone, L. S. Teh, & C. Gordon, 2009) Four SLE-
specific patient-reported outcome (PRO) measures are available for use in adult SLE 
patients: the SLEQOL, (Leong et al., 2005) the LupusQoL©, (McElhone et al., 
2007)the L-QoL, (L. C. Doward et al., 2009) and the SLE Symptom Checklist (SSC), 
(C. Grootscholten et al., 2003) which contains a list of symptoms and is not 
considered to be a true HRQoL measure. (C. S. Yee et al., 2009)  
 
To understand the impact of SLE on patients, culture-specific patient 
perspectives are also important. (Berzon, Hays, & Shumaker, 1993; T. A. Stamm et 
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al., 2007) Input from SLE patients in Western countries has been sought in recent 
qualitative studies. (Archenholtz, Burckhardt, & Segesten, 1999; B. Bauernfeind et 
al., 2009; L. C. Doward et al., 2009; Karasz & Ouellette, 1995; McElhone et al., 2007; 
Mendelson, 2006; D. Robinson, Jr. et al., 2010; T. A. Stamm et al., 2007) These 
include studies for the development of SLE-specific HRQoL instruments, the 
LupusQoL© and the L-QoL, (L C Doward et al., 2009; McElhone et al., 2007) and 
for the development of the International Classification of Function, Disability and 
Health (ICF) Core Sets for SLE. (B. Bauernfeind et al., 2009; T. A. Stamm et al., 
2007) With an exception, the Systemic Lupus Erythematosus-specific Quality-of-Life 
(SLEQOL) was developed in Singapore. (Leong et al., 2005) However, contents of 
the SLEQOL were derived from rheumatologists and nurse clinicians, without a 
formal qualitative study involving patient input. The developers of SLEQOL have 
acknowledged the lack of a formal qualitative study as an important limitation of the 
study.  
 
Though well-validated, both extant generic and SLE-specific measures suffer 
from the limitations of “one size fits all” instruments because the same items are 
administered to all patients. (Chakravarty, Bjorner, & Fries, 2007) A newer approach 
involving item response theory (IRT) has demonstrated advantages for clinical 
outcome assessment. (Fries et al., 2006) IRT is a family of measurement models that 
places each item measuring a latent trait on a common metric, according to the 
probability of a positive response. (Hambleton, 2000)  An important application of 
IRT is the use of computerized adaptive testing (CAT), whereby selective 
administration of items tailored to the individual’s ability level contributes to 
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increased precision yet lower respondent burden. (Kopec et al., 2006) Items are also 
selected from pools covering a wider range of difficulty. (Fries et al., 2006)  
 
The PROMIS (Patient-Reported Outcomes Measurement Information 
System), a National Institutes of Health initiative, has begun construction of item 
banks to measure key symptoms and health concepts applicable to a range of chronic 
conditions. (Cella et al., 2007) This effort was undertaken to standardize and promote 
a common measurement system for PROs across clinical research. (Cella et al., 2007) 
Five domains were selected as initial areas for PROMIS item bank construction: (1) 
Physical functioning, (2) Fatigue, (3) Pain, (4) Emotional Distress, and (5) Social 
Role Participation. (Cella et al., 2007)  Items from these five domains are available 
online in the form of PROMIS Version 1.0 Item Banks. (PROMIS, 2009)  
 
The first two objectives of this study were (1) to identify HRQoL domains of 
importance to SLE patients in Singapore and (2) to identify content gaps in existing 
SLE-specific HRQoL measures. Because of culture-specific differences in HRQoL, 
(M Bullinger et al., 1993) it is unknown whether domains identified by Western 
patients are also important to Asian patients. Additional domains important to Asian 
patients may also need to be elucidated. Hence, Asian patient perspectives are 
required for development of an instrument relevant for the use in Asian SLE patients. 
The third study objective was (3) to determine whether PROMIS item banks could 
serve as a core set of questions for the assessment of HRQoL among SLE patients. As 
PROMIS item banks are meant to be relevant across chronic diseases, existing banks 
could potentially be used for HRQoL assessment among SLE patients. If PROMIS 
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item banks can serve as a core set of items, this would avoid replication in the 
construction of item banks.  
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In this Institutional Review Board-approved study, SLE patients were 
recruited from an outpatient clinic at the Singapore General Hospital (SGH) and from 
a patient support group, the Lupus Association (Singapore). Inclusion criteria for the 
study were (1) a diagnosis of SLE made by a Rheumatologist, (2) aged 21 to 65 years, 
(3) able to read and understand English, (4) able to speak coherently and provide 
written informed consent and (5) able to travel to the interview venue without 
assistance. Due to the relatively low prevalence of SLE, a small patient number 
contributed to an a priori decision to stratify participants only by gender, as it was 
anticipated that sensitive issues may be discussed. However, participants were 
selected for each session based on their availability and characteristics, such as age 
and ethnicity, to be as homogenous as possible. Unless data from ongoing focus 
groups suggested important differences between ethnic groups, stratification by 
ethnicity was not compulsory.
2
  Recruitment was ongoing and focus group sessions 




                                                 
 
2
 Two general focus groups (mixed ethnicity and mixed age), two all-Chinese groups, one all-non-
Chinese group (comprising three Malays and one Indian), and one all-Chinese, under 45 years group 
were conducted. From the non-Chinese group conducted, as well as from the mixed focus groups, the 
study team did not identify significant differences in the topics discussed based on ethnic groups. 
Therefore, there was no decision to stratify groups by ethnicity.  
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We aimed to recruit four to seven participants for each session, as the ideal 
focus group composition is four to 12 participants, with the optimal number 
dependent on the aim of the research study. (Tang & Davis, 1995) Interaction 
between focus group members and the moderator can generate in-depth and more 
diverse information than other methods, such as surveys or individual interviews. 
(Parsons & Greenwood, 2000) More importantly, the discussion may proceed with 
relatively little input from the moderator, (Kitzinger, 1994)generating more patient-
related content. Based on the phenomenological approach to study the experience of 
SLE patients through the eyes of the participants, (Lasch et al., 2010) the interview 
guide was designed to be open-ended. It proceeded from the most general to specific 
questions, minimizing the influence of moderator probes. Across all sessions, a 60-
minute discussion on SLE-related impact on HRQoL was led by a moderator (Ow 
YLM) and facilitated by a note-taker (Lim YT or Sow WT). The first question for 
discussion was, “In general, how has having SLE affected your health-related quality 
of life?”. Subsequent questions focused the discussion on the three broad domains of 
physical, mental and social well-being, according to the World Health Organization’s 
(WHO) definition of health as a state of physical, mental and social well-being. 
(WHO) After a definition of “health-related quality of life” was provided to 
participants,
3
 they were also invited to express their opinions on the definition. During 
the rest of the discussion, the term “health-related quality of life” was used 
interchangeably with “life” and “daily life”.  
                                                 
 
3
 The following extract from the moderator script illustrates how health-related quality of life was 
introduced and described to participants in the focus groups: “Today, we want to find out how lupus 
has affected your health-related quality of life. By health-related quality of life, we refer to your 
physical, emotional and social functioning and well-being. Of course, you may have a different opinion 
about what health-related quality of life mean to you and we want to hear about it.” 




As we were unable to recruit sufficient male participants to form a focus group 
(due largely to the female preponderance in SLE, and partly to the varied work 
schedule of the patients), semi-structured, individual interviews were conducted by a 
male interviewer (Huang KQ) based on the discussion guide. Following the 
discussion, participants were asked to rate seven areas of life as “highly”, 
“somewhat”, or “not at all” important and relevant to them. These areas were pre-
selected based on a review of domains addressed by existing SLE-specific 
instruments and the PROMIS item banks. All focus groups, interviews and 
subsequent data analysis were conducted successfully in English. Participants also 
completed a questionnaire on background information and were presented with a 




Focus group and interview discussions were voice-recorded, transcribed 
verbatim and analyzed using thematic analysis. The open-ended discussion guide and 
data-driven analytic methods adopted in this study are based on elements of the 
grounded theory, to encourage development of conceptual frameworks that are 
derived from participant input, rather than existing concepts.
4
 (Lasch et al., 2010)  In 
thematic analysis, segments of texts describing similar manifestations are grouped 
                                                 
 
4
 A data-driven analytic approach in qualitative research emphasizes that the ideas or themes arising 
from study data drives or outlines the analysis before any analysis takes place. In contrast, a theory-
driven approach investigates specific existing ideas or hypotheses. Specific to HRQoL research, an 
example of a theory-driven approach analysis approach would be to analyze and compare study data 
with existing domain frameworks of HRQoL. 
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into themes. (Pope & Mays, 2006) Two independent analysts, trained graduate 
students who were unfamiliar with existing frameworks of HRQoL, read the 
transcripts reflectively to identify relevant categories and assign codes to text 
segments, in a process known as open coding. (Ryan & Bernard, 2003) Open coding 
is a data-driven process that identifies themes from data directly, rather than using 
ideas from existing literature or frameworks. (Gibbs, 2007)  
 
A codebook comprising five fields (code title, definition, examples, guidelines 
for use, and relationship to other codes) was created as analysts coded sub-sets of 
transcripts in an unspecified number of rounds. This iterative process of independent 
coding and consensus meetings continued until investigators were satisfied that the 
codes could be consistently applied. The codes were then independently applied to all 
transcripts and coding discrepancies were resolved at a final consensus meeting. 
Further analysis was facilitated by axial coding using Atlas.ti, a qualitative analysis 
software. (ATLAS.ti Scientific Software Development GmbH, 2009) Axial coding is 
the process of confirming what has been established and developing it to a more 
abstract level. (Marks & Yardley, 2004) The final output of thematic analysis was a 
list of themes descriptive of HRQoL domains and their constituent sub-themes, which 
elaborated on the scope of the domains as discussed by study participants.  
 
Mapping of themes and sub-themes to SLE-specific instruments and PROMIS v1.0 
Item Banks 
 
Existing SLE-specific instruments were identified through the PROQOLID 
database and a systematic literature search using PubMed with the terms “systemic 
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lupus erythematosus” AND “quality of life". Four instruments were identified from 
the search and items from the SLEQOL, the LupusQoL© and the SLE Symptom 
Checklist (SSC) were compared with sub-themes identified from the focus groups 
because developers of these instruments did not object to us doing so. (C. 
Grootscholten et al., 2003; Leong et al., 2005; McElhone et al., 2007) The SLEQOL 
and the LupusQoL© are SLE-specific HRQoL measures. (Leong et al., 2005; 
McElhone et al., 2007) The SSC is a checklist of symptoms covering physical 
symptoms and one item on mood changes. (C. Grootscholten et al., 2003) Items from 
11 of the 12 PROMIS Version 1.0 Item Banks (excluding Global Health) were also 
compared with focus group sub-themes. These 11 banks covered the five domains 
selected as the initial areas for PROMIS item bank construction (physical functioning, 
fatigue, pain, emotional distress, social role participation). (PROMIS, 2009)  A 
content gap was identified when sub-themes and domains elicited from focus groups 
were not addressed by any item from these existing sources.  
 
A flowchart and table illustrating the processes of open coding, axial coding 
and mapping to existing items is presented in   Figure 2.1 and illustrated using a sub-
theme of the fatigue domain as an example.  
 






 Figure 2.1. Flowchart of the coding and mapping process (illustrated with an example sub-theme) 
 
 
      
E.g. Similar cases within 
the fatigue domain 
“I used to work throughout 
the whole day but now I 
can’t, like half a day and I 
need to rest.” 
“I help out in the church, 
I’m also very tired after a 
few hours.” 
“I feel very tired, compared 
to last time… It’s not like 
last time, when I reach 
home I can still do the 
housework.” 
E.g. PROMIS items that 
map to the subtheme 
How often were you too 
tired to do errands? 
How often were you too 
tired to do your 
household chores? 
How often did your 
fatigue limit you at work 
(include work at home)? 
E.g. A sub-theme 
within the “fatigue” 
domain 
 
Fatigue limits the 
work I can do 
All cases within a 
domain are examined. 
Similar cases are 
grouped together. 
A more specific, 
descriptive name is 
given to each sub-
group, known as “sub-
themes”. 
Individual PROMIS 
items are mapped to 
each sub-theme.   
Open codes are 
independently assigned 
by two analysts. Open 
codes generally 
correspond to resultant 
domain names. 





Focus group participants 
 
 27 female SLE participants aged 23 to 62 years participated in six focus 
groups conducted from August 2009 to March 2010.
5
 Four sessions comprised four to 
five participants and the other sessions comprised two participants (due to 
unanticipated non-attendance at very short notice) and seven participants each. 
Saturation of topics occurred at the fifth session, with no new topics emerging at the 
sixth session. In addition, two male SLE participants, aged 32 and 39, participated in 
individual interviews. The majority of participants were Chinese (72%), the others 
being Malay (14%) or Indian (10%). (Table 2.1)  The median age was 45 years 
(interquartile range of 33 to 53 years) and the median disease duration was 14 years 
(interquartile range of 8 to 21 years). Most participants were working (59%) or 
homemakers (24%). Education levels of participants were well-varied among degree-
holders (34%), post-secondary (31%), secondary education (21%) and below (14%).   
 
  
                                                 
 
5
 47 subjects gave written consent for the focus groups and were enrolled in this study. The 27 
participants who completed the study were selected primarily based on availability, as well as with 
considerations of stratification by age and ethnicity. As a minimum number of five participants was 
required before a scheduled focus group was convened, 17 subjects enrolled did not participate as we 
could not schedule sessions compatible with their availability. Three other subjects withdrew because 
they could not find time to participate in the study. 
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Table 2.1 Participant Characteristics (n=29) 
Characteristic Number (%) 
Age (year)  
Median 45 







   Chinese 21(72) 
   Malay 4(14) 
   Indian 3(10) 
   Other 1(3) 








Unemployed (able to work) 1(3) 
Unemployed (unable to work) 1(3) 
Other 2(7) 
Education  
University degree 10(34) 
Diploma 4(14) 
GCE “A” Levels 5(17) 
GCE “N” or “O” Levels  6(21) 
Incomplete secondary schooling and below 4(14) 
Years since diagnosis of SLE  
Under 5 years 8(28) 
5 years to under 10 years 2(7) 
10 years to under 20 years 10(34) 
More than 20 years 9(31) 
* 
Females participated in six focus group sessions. Males participated 







 A total of 40 open codes was created, categorised as codes (i) descriptive of an 
impact on HRQoL (27 codes), (ii) not descriptive of an impact on HRQoL (7 codes), 
or (iii) broad category codes which subsumed other codes (6 codes). Broad category 
codes were “physical symptoms”, “physiological changes”, “activities”, “social life”, 
“emotional state” and “others”. Codes not descriptive of an impact on HRQoL, such 
as “coping with SLE”, were created to facilitate understanding of the impact of SLE 
on HRQoL and their relationships with other themes. (Table 2.2) Open codes 
descriptive of a HRQoL impact were further refined into 21 domains comprising 92 






Table 2.2 Open codes descriptive of an impact on health-related quality of life 
(HRQoL) that were not resultant domains after axial coding 
Open code Reason for unsuitability as a 
domain  
Final disposition of open code 
and cases 
Tremors List of symptoms without 
further description of an 
impact on health-related 
quality of life (HRQoL) 
Open codes re-classified as sub-
themes of a newly created 







Depression Unclear whether participants 
referred to clinically-
diagnosed depression or 
feelings of sadness 
Open code removed; cases were 
subsumed under the domain 
“sad” 
Mood swing Rapid changes in mood  
described by participants 
referred to either getting 
angry or sad easily 
Open code removed; cases were 
subsumed under the domains 
“sad” or “anger” as appropriate  
Physical 
activities 
“Physical activities”, defined 
in the codebook as the 
“limitation in activities 
requiring appreciable physical 
exertion as a result of physical 
impairments due to SLE”, 
extensively co-occurred with 
other domains concerned with 
activities.  
Open code removed; cases were 
re-classified as sub-themes of 
having difficulty or being unable 
to perform activities in other 
domains, namely “activities of 
daily living”, “leisure activities”, 
“social activities” or “work” 
(E.g. a segment of text 
describing physical limitations in 
performing household chores 
was re-classified exclusively into 
the sub-theme of “I have 
difficulty performing household 






Domains of HRQoL identified 
 
The most-specific concepts (themes) identified were referred to as “sub-
themes” in this study. Domains identified comprise sub-themes that represent the 
content of the domain. Similar domains were grouped into form domain 
groups.Domains identified by participants were classified into five domain groups: 
physical symptoms, activities, social life, emotional state and other. As PROMIS v1.0 
Item Banks address only selected domains, results of sub-theme mapping to existing 
items are presented in separate tables (Table 2.3 and Table 2.4). Table 2.43 lists only 
domains addressed by PROMIS banks. Table 2.4 lists domains that are unaddressed 
by PROMIS banks. 
 
Domains addressed by PROMIS v1.0 banks 
 
 Domains grouped under “physical symptoms” (fatigue, pain and sleep 
disturbance) and “emotional state” (anger, sad, lonely, fear and worry) were generally 
addressed by the LupusQoL©, SLEQOL and relevant PROMIS banks. (Table 2.3) 
Items from the PROMIS banks covered the most number of sub-themes within these 
domains. Domains within “activities” were activities of daily living (ADL), leisure 
activities and social activities. ADL is addressed by the SLEQOL, LupusQoL© and 
items from the PROMIS Physical Function bank. Unaddressed sub-themes of leisure 
and social activities were related to restrictions that SLE patients face in their choice 
of activities and destinations, rather than being unable to perform them. This was 
reportedly attributable to the need for minimizing disease flare triggers through 
avoiding the sun and vigorous activities.  From the family domain, only the sub-theme 
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of “ability to carry out duties to family members” was covered by the PROMIS 
Satisfaction with Participation in Social Roles Bank. “Willingness to start a family” 
describes the impact of SLE on participants’ decisions regarding marriage and having 
children, owing to concerns of disease unpredictability and being a burden to the 
family. Concerns with childbearing difficulties and finding a partner accepting of 
one’s medical condition were subsumed under the sub-theme “ability to start or 
expand my family”. The domain, “self-esteem” is covered by the LupusQoL©, 
SLEQOL and by the PROMIS Depression Bank.  Many sub-themes emerged within 
the work domain, reflecting the profound impact of SLE on a patient’s work life. The 




Table 2.3 Domains and sub themes important to SLE patients in Singapore and 
Extent of coverage by existing SLE-specific instruments and PROMIS Version 
1.0 Item Banks*
 





SLEQOL SSC PROMIS 
PHYSICAL SYMPTOMS     
FATIGUE  + + FAT 
I feel tired +   FAT 
Fatigue limits the work I can do    FAT 
Fatigue limits the activities I participate in    FAT 
I need to have early nights +    
I feel like I can't get out of bed    SLI 
I had problems concentrating + + + SLI 
Others perceive that I am lazy because of my 
fatigue 
    
PAIN     
I feel pain     
My pain was so bad I would do anything to end 
it 
    
Pain affects my mobility +   PBE 
Pain limits the work I can do    PIN 
Pain limits the activities I can participate in  +   PIN 
Pain makes me feel depressed    PIN 
Pain has set me back in life    PIN 
SLEEP DISTURBANCE +   SLP 
I have difficulty falling asleep    SLP 
I cannot get a sound sleep    SLP 
I have interrupted sleep    SLP 
I do not feel the need to sleep at bedtime     
I sleep at odd hours     
Poor sleep affects my ability to work in the day    SLI 
I feel frustrated about not being able to sleep     
ACTIVITIES     
ACTIVITIES OF DAILY LIVING (ADL)     
I have difficulty moving around the house +   PF 
I have difficulty feeding myself    PF 
I have difficulty dressing myself    PF 
I have difficulty with basic, everyday tasks + +  PF 
I have difficulty performing household chores +   PF 
I am dependent on others for my daily activities +    
LEISURE ACTIVITIES (NON-ADL)    DSA 
I am unable to do things I would like to for 
leisure 
   DSA 
I refrain from certain leisure activities      
I refrain from going to sunny places for leisure  +   
I restrict myself in the choice of holiday 
destinations 
    
SOCIAL ACTIVITIES  +  DSA 
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Table 2.3 Domains and sub themes important to SLE patients in Singapore and 
Extent of coverage by existing SLE-specific instruments and PROMIS Version 
1.0 Item Banks*
 





SLEQOL SSC PROMIS 
I am unable to take part in social activities I want 
to  
    
I refrain from participating in certain social 
activities  
    
I would rather not participate in social activities    DEP 
SOCIAL LIFE     
FAMILY     
My willingness to start a family has been 
affected 
    
My ability to start or expand my family has been 
affected 
    
My ability to carry out duties to family members 
has been affected 
   SR 
EMOTIONAL STATE     
ANGER     
I feel angry +   ANG 
I nitpick on things     
I have a bad temper    ANG 
I am frustrated +   ANG 
I get irritated    ANG 
SAD     
I feel sad + +  DEP 
I feel guilty    DEP 
I feel helpless    DEP 
I feel hopeless    DEP 
I feel hurt by others     
I feel like I don’t want to live     DEP 
LONELY     
I feel lonely    DEP 
I feel that no one understands me     
FEAR     
I feel fearful  +  ANX 
WORRY      
I feel worried + +  ANX 
I feel stressed    ANX 
OTHER     
SELF ESTEEM     
I feel humiliated     
I have a low self-esteem + +  DEP 
WORK  +  SR 
I am unable to perform the full range of duties or 
activities  
   SR 
I am unable to do as much work as before    SR 
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Table 2.3 Domains and sub themes important to SLE patients in Singapore and 
Extent of coverage by existing SLE-specific instruments and PROMIS Version 
1.0 Item Banks*
 





SLEQOL SSC PROMIS 
I refrain from doing too much work because I 
am afraid of stressing my body out 
    
I have less motivation at my job     
My job prospects are poor because of my illness     
Taking time off work/ school has affected my 
work negatively 
 +  SR 
I do not perform as well at work  +  SR 
I earn less money because I am unable to do as 
much work as before 
 +   
My employer has a negative impression of me 
because of my illness 
    
*
 ‘+’ denotes the sub-theme/domain is covered by items from existing SLE-specific 
measures (LupusQoL©, SLEQOL, SSC). Sub-themes/domains covered by PROMIS 
v1.0 banks are denoted by abbreviations of the PROMIS bank name: ANG=Anger; 
ANX=Anxiety; DEP=Depression; FAT=Fatigue; PBE=Pain – Behaviour; PIN=Pain 
– Interference; PF=Physical Function; DSA=Satisfaction with Discretionary Social 
Activities; SR=Satisfaction with Social Roles; SLP=Sleep Disturbance; SLI=Sleep-
related Impairment.  
α 
Concepts in bold, capital letters are broad category codes, concepts in capital letters 





Domains not addressed by PROMIS v1.0 banks 
 
 Sub-themes of symptoms not covered by PROMIS banks included tremor, 
weakness, pain at specific locations, decreased interest in sex and changes in 
appearance. (Table 2.4) With the exception of tremors, all symptoms were included in 
at least one existing SLE-specific measure. “Burden to others” and “self-image” were 
covered by the LupusQoL© and SLEQOL, and the LupusQoL© contained an item on 
“dependence”. Other domains, namely relationships, stigma and discrimination and 
freedom, were generally not covered by existing instruments. Sample quotations 
illustrating each sub-theme from these domains are presented in Table 2.5a. Sub-
themes of “stigma and discrimination” include being avoided or shunned, being 
excluded from activities, and receiving unkind or insensitive remarks from others. 
These relate to changes in one’s appearance and misconceptions about the disease 
(such as lupus being contagious, or being a sexually transmitted disease). Participants 
also expressed a dislike for being treated differently because of one’s illness. Finally, 
“freedom” comprised sub-themes that described restrictions in activities and places, 
not being able to do things freely, diminished enjoyment of life, and a slowed pace of 
life. Feelings of restrictions, diminished enjoyment and a sentiment of being held back 





Table 2.4 Domains and sub themes important to SLE patients in Singapore and 
Extent of coverage by existing SLE-specific instruments only (i.e. not covered by 
PROMIS Version 1.0 Item Banks)* 
 Concepts derived from the focus groups 
α
 Lupus QoL© SLEQOL SSC 
PHYSICAL SYMPTOMS    
OTHER SYMPTOMS     
Tremors    
Weakness   + 
Pain – specific locations  + + 
Decreased interest in sex + +  
Changes in appearance
6
   + 
SOCIAL LIFE    
RELATIONSHIPS  +  
I have less social contact with the outside world    
I prefer to keep things from others    
I feel that people don't understand my condition    
My relationships are strained     
OTHER    
BURDEN TO OTHERS    
I feel that I am a burden to others + +  
I am afraid that others will perceive me as a 
burden 
   
DEPENDENCE    
I am dependent on others for my activities of 
daily living (ADL)  
+   
I am afraid that no one will provide care when 
dependent 
   
I do not wish to be dependent on others    
STIGMA & DISCRIMINATION    
People avoid or shun me    
Family or friends exclude me from their 
activities 
   
People make unkind or insensitive remarks about 
me 
 +  
People treat me differently because I have a 
disease 
   
SELF-IMAGE    
I look unattractive +   
I get bothered by comments about appearance    
I am frustrated by my appearance changes    
My appearance makes me avoid social situations +   
                                                 
 
6
 Concepts within the domain “Other symptoms” describe symptoms. Although items from the 
LupusQoL© and SLEQOL address domains of self-image/body-image, these items do not elicit report 
of symptoms. Thus, relevant items were mapped onto the self-image/body-image domains and not 
“Other symptoms”.  
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Table 2.4 Domains and sub themes important to SLE patients in Singapore and 
Extent of coverage by existing SLE-specific instruments only (i.e. not covered by 
PROMIS Version 1.0 Item Banks)* 
 Concepts derived from the focus groups 
α
 Lupus QoL© SLEQOL SSC 
I am more image-conscious  +  
FREEDOM    
There are many restrictions on the things I can 
do 
   
There are many restrictions on the places I can 
go 
   
I cannot do things freely    
Having to be cautious affects my enjoyment of 
life 
   
Lupus holds me back in life +   
*
 ‘+’ denotes the sub-theme/domain is covered by items from existing SLE-specific 
measures (LupusQoL©, SLEQOL, SSC).  
α 
Concepts in bold, capital letters are broad category codes, concepts in capital letters 




Domains of HRQoL identified by male participants 
 
 Similar to female participants, male participants (n=2) reported symptoms, 
impact on emotional states, activities and work. Two main differences were identified 
in the accounts of male participants. First, they reported additional challenges of lupus 
in coping with the physically demanding and outdoor nature of their work. Second, 
male participants often related an impact to how it affected one’s work, income and 
ability to provide for the family, as illustrated with three quotes from male 





Table 2.5 Sample quotations from focus group discussions 
Sub-themes 
Sample quotation  
(age, gender, ethnicity) 
2.5a. Sub-themes from domains not addressed by existing SLE-specific 
instruments and PROMIS Version 1.0 Item Banks 
RELATIONSHIPS 
I have less social contact 
with the outside world 
“The one year plus I was in hospital… my closest friends, 
I still keep in touch, but the rest I just cut off. Like now, I 
don’t really go out and meet them. I don’t like to go out 
in public.” 
(23, female, Malay) 
I prefer to keep things 
from others 
“I’ll stop seeing some of my friends... I don’t want them 
to look at my ugly side and I don’t like to explain much.”   
(33, female, Chinese) 
I feel that people don’t 
understand my 
condition 
“You want to ask for help but you cannot every now and 
then ask somebody to help you. People think you are so 
petty, a little bit of pain [and you ask for help] – because 
they don’t know what is lupus.” 
(48, female, Malay) 
My relationships are 
strained 
“In a way, it has also affected my marriage… That’s the 
period where men have physical needs and I totally 
neglected that area of his life because at the point, it was 
just self-pity, anger and the grieving process.” 
(59, female, Chinese) 
STIGMA & DISCRIMINATION 
People avoid or shun me “My face will be puffy and very red. If I wait for a lift, I 
find that my neighbours all avoid me, they don’t want to 
go in the same lift as me.” 
(62, female, Chinese) 
Family or friends exclude 
me from their activities 
“They think this is contagious. Even my family, my sister-
in-law, said “You take your food separately”. 
(55, female, Chinese) 
People make unkind or 
insensitive remarks 
about me 
“You will have aunties that go, “Wow, why is your face 
like that?” I know they mean well but for someone who 
feels rotten by herself, what kind of stupid comment is 
that?”  
(31, female, Chinese) 
People treat me 
differently because I 
have a disease 
“My colleagues or friends, who know I have lupus, they 
will see me in a different light, they see as very fragile... I 
don’t like any special treatment.”  
(39, female, Chinese)  
FREEDOM 
There are many 
restrictions on the 
things I can do 
“[I feel] angry because I’m not able to do things because 
of the disease. I used to do a lot, you know, there are a 
lot of restrictions. 
(53, female, Chinese) 
There are many 
restrictions on the 
places I can go 
“When I plan for places to go, I will surely think of 
whether there are medical facilities easily available… 
and sunlight and all these things, there are a lot of 
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Table 2.5 Sample quotations from focus group discussions 
Sub-themes 
Sample quotation  
(age, gender, ethnicity) 
restrictions, so have to plan.”  
(33, female, Chinese) 
I cannot do things freely “A lot of things, activities are being put to a stop. You 
have to pause a while and think, “Can I go or not?” … 
[others] can just go freely. 
(59, female, Chinese)  
Having to be cautious 
affects my enjoyment 
of life 
“You can’t enjoy as much as before. You think a lot, like, 
“if too long under the sun, will I get affected again?” It’s 
like you will be worried and you can’t really enjoy as 
much as before.” 
(30, female, Chinese) 
Lupus holds me back in 
life 
“Since I’ve got lupus, I’ve got to slow down. Because as 
you move too hard or too harsh, your body starts to feel 
the pain. And then you start to have a butterfly rash, 
that’s for me...  I have to cool down my activities daily, 
and my work force.” 
(48, female, Malay) 
2.5b. Male participants describing and relating the various impact of SLE to 
work 
Sub-themes 
Sample quotation  
(age, gender, ethnicity) 
Changes in appearance “Rash only causes a lot of inconvenience because I still 
need to face the public at work. Sometimes they will 
ask, “Do you have a skin problem?’”.  
(39, male, Chinese) 
I feel fearful “I fear that when the flares and attacks come, these 
cause a lot of medical fees and money to be spent. I also 
take a long leave from work, so sometimes I have a fear 
I will have to give up my job. From there, it affects my 
family because there’s no income.” 
(39, male, Chinese) 
Taking time off 
work/school has affected 
my work negatively 
“As long as it’s not a flare that I have to stay in the 
hospital for quite a long time, like two years back… 
[and] rest for 2 to 3 months at home, that will affect the 
job. That’s the only stress but if the company is good, 
they will keep you.” 




Rating of importance and relevance on select areas of life 
  
 Of the seven areas of life identified from existing SLE-specific instruments or 
PROMIS Version 1.0 Item Banks, fatigue was rated as “highly important” (62%) and 
“highly relevant” (69%) by the largest proportion of respondents (Table 2.6). Two 
other areas of physical health, namely “physical function” and “pain & other 
symptoms” were next most frequently rated as highly important and relevant. 
Comparatively, burden to others and self-image, areas of life addressed by the 
SLEQOL and the LupusQoL© but not PROMIS Version 1.0 banks, were rated 
“highly relevant” as frequently as physical function (34%).   
 
 




Number rated as 
“highly important” 
(%) 
Number rated as 
“highly relevant” 
(%) 
Fatigue 18 (62) 20 (69) 
Physical function 17 (59) 10 (34) 
Pain & other symptoms 16 (55) 14 (48) 
Burden to others
 
13 (45) 10 (34) 
Self-image 10 (34) 10 (34) 
Emotional health 12 (41) 9 (31) 
Social & occupational activities 7 (24) 6 (21) 
* 
Areas of life were selected for rating based on a review of domains included in 






This qualitative study identified domains of HRQoL relevant and important to 
multi-ethnic Asian SLE patients in Singapore using a data-driven analytic 
methodology. Content gaps from existing SLE-specific instruments were identified 
and the relevance of PROMIS Version 1.0 Item Banks to SLE patients was assessed. 
Many domains of HRQoL captured by the existing disease-specific HRQoL 
instruments were found to be also relevant to the current study’s participants, with the 
exception of items on (a) specific symptoms from the SSC and SLEQOL, (b) 
inconvenience of daily medication and clinic visits, (c) increased consumption of 
alcohol or tobacco from the SLEQOL, and (d) items related to the inability to plan 
due to the unpredictability of lupus from the LupusQoL©. Areas of physical health, 
particularly fatigue, were rated most frequently to be highly important and relevant to 
SLE patients.  
 
Domains unaddressed by existing SLE-specific measures were family, 
relationships, stigma and discrimination and freedom. Similar sub-themes of 
relationships could be identified from previous qualitative studies and are likely to be 
specific to SLE patients, including concerns about social isolation resulting from 
being misunderstood, (D. Robinson, Jr. et al., 2010) and concerns about the image 
portrayed to others. (L. C. Doward et al., 2009) Although themes regarding body-
image, (McElhone, Abbott, Gray, Williams, & Teh, 2010) attractiveness, (L. C. 
Doward et al., 2009) and facial manifestations (D. Robinson, Jr. et al., 2010) were 
identified, stigma and discrimination was not conceptualized as a theme or domain in 
previous studies. The loss of freedom arising from the need to restrict one’s activities 
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was also not reported as a theme. Certain sub-themes from the family and stigma and 
discrimination domains could be more relevant in the Asian socio-cultural context. A 
participant who has lived in a Western country compares the public stigma 
experienced in both contexts, “Of course they will stare at you, especially in Asia… I 
mean, [in the Western country] they’ll have the courtesy, at least, not to stare. Of 
course there are some people that would stare. But I’m just saying that I feel that 
most of it is in Asia.” The concerns with childbearing difficulties may also be 
accentuated in the Asian culture, due to the importance of perpetuating the family 
name in the Chinese culture. A Chinese participant described the stress experienced 
when plans for a baby were put on hold due to a disease flare “It worries me, and I 
kind of feel stressed because my husband is an only son, so it adds a certain stress to 
me.”  
 
Dependence, burden to others, self-image and symptoms (specific to SLE) are 
domains addressed by existing SLE-specific measures but not PROMIS v1.0 banks. 
Notably, at least one sub-theme from each domain is covered by either the 
LupusQoL© or the SLEQOL. Participants also rated burden and self-image to be 
“highly relevant” as frequently as physical function. Hence, until new measures are 
developed, using either instrument in combination with a generic measure provide 
additional HRQoL information relevant to SLE patients. Within the Asian population, 
the English and Chinese versions of the SLEQOL have been validated for use among 
SLE patients in Singapore. (Kong et al., 2007; Leong et al., 2005)  
 
Items from the existing PROMIS v1.0 banks generally addressed the 
corresponding domains well. Notably, the three areas of physical health rated most 
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frequently by participants as highly important and relevant (fatigue, pain and other 
symptoms, and physical function) were addressed by the PROMIS v1.0 banks.  
Hence, PROMIS v1.0 banks would serve as a useful core set of items for assessing 
HRQoL in SLE patients. However, new items need to be written for the identified 
gaps in some banks, owing to the peculiarities of SLE and its management. First, 
sleep disturbances experienced by SLE patients were often attributed to steroids, 
described by the unaddressed sub-theme, “I do not feel the need to sleep.” Second, 
items (from the PROMIS Satisfaction with Participation – Discretionary Social 
Activities Bank) with the stems, “I am satisfied with my current level of/ the amount 
of time I spend…” are more appropriate than items beginning with, “I am satisfied 
with my ability to…”. For SLE patients, activity limitation is not solely a result of 
physical inability to participate but also the need to refrain from certain activities, 
such as those involving exposure to the sun.  Third, family sub-themes pertaining to 
childbearing and willingness to start a family are unique to SLE due to the 
predominantly female population, onset at a childbearing age and fertility problems. 
Finally, the impact of SLE goes beyond the ability to work but include job prospects, 
limiting one’s workload and stress, poorer motivation and a negative impression to 
employers.  
 
 Certain study limitations may preclude an exhaustive coverage of topics for all 
sub-groups of SLE patients though it should be noted that as with much of qualitative 
research, focus group findings are not meant to be readily generalizable. Participants 
were recruited from outpatient sources, ambulatory and not stratified by disease 
characteristics, such as duration or specific organ involvement. Although periods of 
hospitalizations and severe illness were recounted in the sessions, additional domains 
 66 
 
might have been elicited among SLE inpatients or the more severely ill. Our attempts 
to recruit inpatients for individual interviews were unsuccessful as these patients were 
in an unsuitable state for participation. Secondly, , it is unknown whether topic 
saturation was achieved for male SLE patients as only two male patients were 
recruited.  
 
Thirdly, the views of non-English speaking residents were also not included, 
as only English-speaking participants were eligible for the study. However, 75% of 
the Singapore resident population aged 25 to 65 in 2010 is English-literate. (Ministry 
of Trade and Industry Singapore, 2000) Furthermore, SLE patients are generally 
younger and many are English-speaking. Hence, our study results would be 
generalizable to the majority of SLE patients in Singapore. This limitation would 
affect about 25% or less of the SLE patients in Singapore who are non-English 
speaking. Non-English speaking SLE patients may have identified additional or 
different domains, as they are potentially different from the current study sample, 
possibly having a lower socioeconomic status and being less influenced by the 
Western culture. These factors may influence the domains perceived to be relevant 
and important to HRQoL. This would be an important limitation to address if there 
was an intention to measure the HRQoL of non-English patients as well, for example 
in a clinical trial. Patient input from the target population would be necessary to 
establish content validity of the instrument.  
 
Another patient sub-group that could have been under-represented in this 
sample was younger patients. In this sample, participants’ age was well distributed 
across 31– 40 years, 41 – 50 years, and 51 – 65 years, with approximately 30% in 
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each age group. However, only 10% of patients were aged 21-30 years. The issues 
affecting young patients could be different, as they are more likely to be newly 
diagnosed, may have more active disease, have less time to adapt to the disease, and 
be affected in terms of career, education, or plans to start a family.  
Our study was conducted among patients in the Asian socio-cultural context. 
Domains affected by ethnic-specific values, such as the importance of perpetuating 
the family name, could be similar throughout an ethnic group located across countries. 
However, the stigma faced by SLE patients living in Asia is likely to be specific to 
this socio-cultural context. Although such an impact may not be relevant to other 
contexts, our findings contribute knowledge that findings from multi-ethnic SLE 
populations are not equivalent to patient perspectives directly obtained from each 
socio-cultural context. (D. Robinson, Jr. et al., 2010) Finally, PROMIS is an ongoing 
initiative with an evolving domain framework.  (Fries, Bruce, & Cella, 2005) Thus, 
some content gaps that were identified in the mapping process during our data 
analysis could be filled as new banks addressing these domains become available.  
 
The current, expanded PROMIS domain framework (available from May 
2012) encompasses many new domains as newly developed banks or banks in 
development that were not previously available as PROMIS v1.0 banks. (Patient 
Reported Outcomes Measurement Information System (PROMIS), 2012) The new 
self-efficacy bank potentially addresses sub-themes from the domains of dependence 
and/or burden to others, domains that were identified to be unaddressed by PROMIS 
v1.0 banks. Also, coverage of social health domains by the latest PROMIS framework 
is more comprehensive, as new banks address social isolation and aspects of 
relationships, which are relevant to domains of family and relationships identified in 
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the current study of SLE patients. (Rao et al., 2009) Beyond the generic PROMIS 
banks, banks developed by disease-specific item banking initiatives have also become 
available and are potentially relevant to domains identified in this study. The Neuro-
QoL, which focuses on HRQoL assessment in a variety of neurological disorders and 
settings, has developed an item bank to measure stigma. (Gershon et al., 2012) The 
cancer-specific extension of the PROMIS initiative has also developed several banks 
measuring sexual function, some of which may be potentially relevant to SLE patients 
as well. (Flynn et al., 2011) Thus, future comparisons of domain coverage, to 
minimize replication of bank development efforts,  should also consider extant 
disease-specific item banks for candidate items in addition to the generic PROMIS 








In conclusion, four additional domains have been identified as content gaps in 
existing-SLE specific measures, namely family, relationships, freedom, and stigma 
and discrimination.  Two of these domains, family and stigma and discrimination, 
may be accentuated in the Asian socio-cultural context. As stigma is a significant 
factor in many but not all diseases, disease-specific item banks such as our study and 
Neuro-QoL would provide additional value to PROMIS banks. As 40 sub-themes 
from 14 domains identified in this study as important and relevant to SLE patients 
were addressed by the PROMIS Version 1.0 Item Banks (Physical Function, Pain, 
Fatigue, Sleep Disturbance, Sleep-related Impairment, Anger, Anxiety and 
Depression), PROMIS item banks have tremendous potential to serve as a core set of 
items for HRQoL assessment in SLE patients.  Hence, a SLE-specific item bank may 
be developed by writing new items to fill the gaps in existing PROMIS item banks.  
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CHAPTER 3  Evaluating the use of PROMIS items in an 
item bank to measure fatigue among patients 
with Systemic Lupus Erythematosus 
 
 





As alluded to in the thesis introduction (Section 1.2.3.2), using item response 
theory (IRT) to develop patient-reported outcome (PRO) measures offers several 
advantages over the conventional classical test theory (CTT). One advantage is 
enabling computerized adaptive testing (CAT), a test form through which a set of 
items tailored for each individual is administered. However, in order to administer 
CAT forms, item banks first need to be developed. Item bank development is a 
substantial effort that extends over several phases. (Bjorner, Chang, Thissen, & 
Reeve, 2007) The major phases are the definition of domains or constructs to be 
measured, development of an item pool of candidate items, the evaluation of 
psychometric properties of items, and the eventual calibration of selected items. 
Finally, CAT simulations are also conducted if a CAT form is desired.   
 
 Although intended to measure generic symptoms across populations, the use 
of Patient-Reported Outcomes Measurement Information System (PROMIS) item 
banks for custom measurement in specific disease populations has also been 
researched. Psychometric properties of the full PROMIS Physical Function bank have 
been evaluated in an orthopedic population. (Hung, Clegg, Greene, & Saltzman, 
2011) The authors suggest that item parameters estimated in that study were relevant 
to orthopedic patients and could be a starting point for CAT development in the 
orthopedic patient population. Within the PROMIS network, variants of item banks 
have also been developed for specific patient sub-groups, including the cancer and 
HIV patient sub-populations. (Patient Reported Outcomes Measurement Information 
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System (PROMIS), 2012)  Six bank variants have been developed for the cancer sub-
population as of May 2012. In these PROMIS initiatives, developing bank variants 
from the original banks required additional steps. For the cancer-specific extensions, 
banks were refined for relevance to the cancer population through expert review of 
item content validity in oncology, and item evaluation and revision based on focus 
groups and cognitive interviews of patients with cancer. (Garcia et al., 2007) 
 
As PROMIS item banks have been developed with rigorous qualitative and 
quantitative methodologies, (Cella et al., 2007; DeWalt et al., 2007; PROMIS® 
Validity Standards Committee, 2012; Bryce B Reeve et al., 2007; Rothrock et al., 
2011) they are potential item pools that may be used to measure outcomes in specific 
disease populations. Therefore, the first objective of this study was to evaluate the 
psychometric properties of a full PROMIS bank when administered to a systemic 
lupus erythematosus (SLE) population in Singapore. If psychometric properties of 
these items are acceptable for data to be fit to an IRT model, i.e. IRT assumptions are 
met, item parameters can be estimated. Items in a bank that are calibrated can be 
selected for use in CAT forms, or in the construction of short-forms. The second study 
objective was to evaluate the psychometric properties of additional items adapted or 
written specifically for measuring fatigue in SLE.  
 
Among the 11 PROMIS item banks calibrated in the first test wave, the fatigue 
item bank was chosen for evaluation due to the importance and relevance of fatigue in 
SLE patients. Fatigue is the most prevalent symptom in SLE, present in up to 90% of 
the patients. At least 50% of SLE patients also considered fatigue to be the most 
disabling disease symptom. (Ad Hoc Committee on Systemic Lupus Erythematosus 
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Response Criteria for Fatigue, 2007) Qualitatively, SLE patients have described 
fatigue to be a central factor of the disease that controls life, (Pettersson, Moller, 
Svenungsson, Gunnarsson, & Welin Henriksson, 2010) negatively affects health-
related quality of life (HRQoL), (McElhone et al., 2010) and interferes with many 
aspects of family life. (Mendelson, 2006) Among SLE patients in Singapore, fatigue 
was rated as “highly relevant” and “highly important” by the largest number of focus 
group participants in the focus group study presented in Chapter 2 among seven pre-
identified domains of HRQoL (physical function, pain, fatigue, emotional health, 
social and occupational activities, self-image and burden to others).  
  





Generation of SLE-specific fatigue items (PLUS items) 
 
Items generated for the item pool (referred to as “PLUS” items for the rest of 
the chapter) to increase the bank’s relevance to SLE patients were adapted from 
existing SLE-specific HRQoL questionnaires or were newly written for this study. 
The details of the systematic literature search to identify existing instruments were 
presented in Chapter 2. Briefly, four instruments were identified from the search and 
items from the SLEQOL, the LupusQoL© and the SLE Symptom Checklist (SSC) 
were reviewed. (C Grootscholten et al., 2003; Leong et al., 2005; McElhone et al., 
2007) After constituent items were binned into domains, fatigue items that addressed 
a unique concept not described by any PROMIS fatigue item were selected for 
adaption. Items were adapted by revising the item context, stem, response options 
and time frame, so that final candidate items were similar in format to PROMIS 
items.  
 
New items were written to address concept gaps between focus group content 
and concepts measured by items from the PROMIS fatigue bank. The methods used 
to analyze focus group transcripts are reported in detail in Chapter 2. To identify the 
fatigue concepts measured by PROMIS items, both the content of individual 
PROMIS items and references cited in the PROMIS fatigue domain definition were 
reviewed. (Smets, Garssen, Bonke, & De Haes, 1995; Stein, Martin, Hann, & 
Jacobsen, 1998) Concept gaps with their supporting transcript segments were 
identified and organized by a researcher who moderated the focus groups and 
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analyzed the transcripts described in Chapter 2. From these suggested concepts and 
verbatim transcripts, new items were written by a psychometrician. These items were 
then reviewed and revised iteratively by the first researcher and a second researcher 
from the study team, without further input from SLE patients until the test items were 
administered and patients were asked for feedback to all items, as described in a 
subsequent section. The newly written items also had a format similar to PROMIS 
items.  
 
Study Sample  
 
In this Institutional Review Board (IRB)-approved study, SLE patients 
recruited were either outpatients at a rheumatology clinic or inpatients warded under 
the care of a rheumatologist at the Singapore General Hospital (SGH). Inclusion 
criteria for the study were (1) a diagnosis of SLE made by a rheumatologist, (2) aged 
21 to 65 years, (3) able to read and understand English, and (4) able to provide 
written informed consent. We aimed to recruit 120 participants for this study. 
Outpatients completed the test items at the clinic and inpatients completed the items 
in the wards. In addition to the test items, respondents also completed a background 
questionnaire, providing sociodemographic information, number of years with SLE 
and presence of co-morbid conditions. A token sum of $15 was presented for 
participation in the study due to the extended test length as numerous items were 
administered.  
 
Administration of test items 
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The default test mode was administration of items on a touch-screen computer, 
as a final CAT test form was intended. However, a paper-and-pen questionnaire 
option was also made available to respondents who requested for a paper format
 
or 
when the computer was unavailable. Three respondents requested for the paper 
format. One respondent had Parkinson’s disease and was not confident of using the 
touch-screen to input responses. Two respondents felt that completing the paper 
format would be “less tiring”. Ten other respondents completed paper versions of the 
questionnaires, as the computer was being used by another respondent completing the 
test items simultaneously. The full-bank testing approach was adopted in this study, 
i.e. respondents completed all PROMIS and PLUS items within the item pool, in 
order to allow the evaluation of the IRT assumption of unidimensionality of items.  
 
To minimize the effect of item order on responses, the order in which items 
were administered was randomized in blocks. Items using the same response options 
were grouped into blocks and the item order was randomized within blocks. This 
design was adopted because of respondent feedback during a pilot administration (5 
administrations) that constantly changing response options between consecutive 
items was confusing. The order of blocks was rotated in sequence among six 
different versions of questionnaires that varied in the order of items administered for 
a total of 127 items. Each of the six versions was programmed on the Microsoft 
Access platform for automatic administration in its unique item sequence. Also, eight 
items identified to be poorly understood by respondents were re-ordered to be 
administered as the last items of the test, so that the interviewer could ask for 
feedback for each item. These items were identified from respondent feedback in the 
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pilot administration of the items, as well as from feedback from the first ten 
respondents who took part in this study.  
 
As respondents completed test items, the interviewer noted whether assistance 
was required for respondents to complete the test items, such as when respondents 
asked for clarification on key terms or instructions. It was noted that three 
respondents did not understand the meaning of “fatigue” and clarified its meaning 
with the interviewer. After test items were completed, the interviewer asked each 
respondent for feedback on items using a standardized data collection form. 
Respondents were asked if any items were irrelevant, confusing or difficult to 
answer, and upsetting or annoying. They were also asked whether any important 
items were omitted, and for general and other comments on the test items. Items with 
reported cognitive difficulty would be removed from the pool of candidate items for 
further statistical evaluation, rather than modified to improve respondents’ 
understanding of items.    
 
Statistical evaluation  
 
The overall statistical evaluation plan was based on the published 
psychometric evaluation and calibration plan applicable to all PROMIS item banks,  
(Bryce B Reeve et al., 2007) and the specific analysis methods and strategy used to 
evaluate the PROMIS fatigue bank. (Lai et al., 2011)  Traditional descriptive 
statistics were reported and were used together with qualitative feedback to identify 
problem items before IRT assumptions were evaluated for the remaining items.  
Descriptive statistics included missing response rates, response frequency, response 
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mean and standard deviation, skewness and floor and ceiling effects. The analysis of 
PROMIS items was conducted first. Subsequently, PROMIS and PLUS items were 
analyzed together, to evaluate psychometric properties of the PLUS items. The drop 
in item coefficient alpha, item-total correlation, inter-item correlation coefficient 
(Spearman Rho) and Loevinger’s H coefficient for scalability were reported for each 
item. Loevinger’s H coefficient for scalability measures the extent to which items 
appear in the same relative order, with a value between 0.4 and 0.5 indicating a 
moderate scale and a value greater than 0.5 indicating a strong scale. (Mokken, 1971) 
Internal consistency reliability (coefficient alpha) and scalability (Loevinger’s H) 
were also reported for the scales.  
 
To evaluate the IRT assumption of unidimensionality, a single factor 
confirmatory factor analysis (CFA) using polychoric correlations was performed. If 
the CFA showed a poor fit, an exploratory factor analysis (EFA) would be conducted 
to determine the factor structure of the items. A bi-factor CFA model was also 
specified to determine whether the fatigue bank was sufficiently unidimensional, or if 
a bi-factor modeled for the conceptually distinct fatigue experience and fatigue 
impact items provided a better fit. This bi-factor model was specified as the PROMIS 
fatigue bank was initially developed as two separate banks that were later combined 
when sufficient unidimensionality of overall fatigue was demonstrated. (Lai et al., 
2011)  To evaluate the assumption of local independence, the residual correlation 
matrix of the single-factor CFA was examined, in which residual correlations greater 
than 0.2 would be flagged for possible local dependence (LD). In addition, the IRT-
based test of local dependence using the LD-X2 statistic was used as a diagnostic tool 
to detect LD item-pairs. (Chen & Thissen, 1997) If IRT assumptions were held, an 
Chapter 3.Developing a PROMIS-based SLE fatigue item bank Ow, YL Mandy 
80 
 
IRT model would be used to fit the data and item parameters would be estimated. 
Traditional item and scale statistics were analyzed with STATA Release 10, 
(StataCorp., 2007) factor analyses were conducted with MPlus Version 5.2,  (Muthén 
& Muthén, 2007) and IRT-based models and test statistics were run on IRTPRO 
Version 2.1. (Scientific Software International Inc, 2011) 
 







 109 outpatients aged 21 to 65 years were recruited from rheumatology clinics 
for this study. (Table 3.1) The mean respondent age was 41 years (SD: 10.7) and the 
mean SLE duration was 12 years (SD: 7.4). 91.7% of respondents were female and 
73.4% were Chinese. All except three respondents had at minimum completed 
secondary school education and about 40% had at least a degree qualification. 70% 
worked full- or part-time and 10% reported themselves as unemployed. 64% reported 
SLE as their sole medical condition. 96 respondents (88%) completed the test items 
on a touch-screen computer and 13 respondents (12%) completed the items on a paper 
questionnaire.  
 
9 inpatients under the care of a rheumatologist were also recruited and test 
items were completed in the ward. However, their responses were excluded from 
further analyses, due to a high missing response rate observed (12.5% missing 
responses for inpatients vs. 2.7% for outpatients) and qualitative feedback that 
multiple items were irrelevant to warded patients. As the recall period for all items 
was seven days, many items were not relevant to inpatients as they were hospitalized 
during this recall period. Examples of items found to be irrelevant assessed the impact 
of fatigue affecting one’s effectiveness at work/home, ability to do errands, household 
chores, work, or go out. Thus, items from the fatigue bank should not be used in the 
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assessment of inpatients without a further review of content validity to include this 
target population.  
 
Table 3.1 Participant Characteristics (n=109) 
Characteristic Number (%)* 
Age    
  Mean (sd) 41 (10.7) 
  Median  39 
  Range 21-65 
Years since SLE Diagnosis   
  Mean (sd) 12 (7.4) 
  Median  11 
  Range <1 - 38 
Sex   
  Male 9 (8.3) 
  Female 100 (91.7) 
Ethnicity   
  Chinese 80 (73.4) 
  Malay  18 (16.5) 
  Indian 7 (6.4) 
  Others 4 (3.7) 
Marital status   
  Single 37 (33.9) 
  Married 68 (62.4) 
  Separated/divorced/widowed 4 (3.7) 
Education   
  Incomplete secondary or below 3 (2.9) 
  N/O levels or ITE 32 (30.8) 
  A Levels / Polytechnic diploma 25 (24.0) 
  Degree 40 (38.5) 
  Post-Graduate 4 (3.8) 
Housing type   
  Public 1 or 2 room flat 1 (1.0) 
  Public 3 or 4 room flat 47 (45.2) 
  Public 5 room flat or larger 35 (33.7) 
  Private apartment / landed property 18 (17.3) 
Employment status 
   Working, full-time 62 (59.6) 
  Working, part-time 11 (10.6) 
  Retired / housewife / student 20 (19.2) 
  Not working, unemployed 10 (9.6) 
Number of co-morbidities   
  0 67 (64.4) 
  1 19 (18.3) 
  2 12 (11.5) 
  3 3 (2.9) 
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  4 2 (1.9) 
* Unless otherwise stated. 
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Qualitative feedback and descriptive statistics (all items) 
 
Due to the large number of items analyzed, all items and item-level statistics 
of the 95 PROMIS and 32 PLUS items are located in the Appendix. Table A1 lists all 
items and response options of the PROMIS and PLUS items. Table A2 displays the 
descriptive statistics of item responses to PROMIS and PLUS items. Table A3 displays 
item-level scale statistics of PROMIS items when PROMIS items were analyzed as a scale. 
Table A4 lists the newly written or adapted items (PLUS items) and the concepts introduced.  
 
Important findings are summarized in the subsequent sections. The relevant 
recall period for all items was seven days and five response categories were available 
for each item. Ten items were reverse-scored for consistency so that for all items, 
responses in category 1 represented lowest fatigue and category 5 represented highest 
fatigue across all items. Depending on the item stem and dimension measured, four 
response option scales were used. These were “Not at all/A little bit/Somewhat/Quite 
a bit/Very much” and “None/Mild/Moderate/Severe/Very severe” for items 
measuring degree or intensity, and “Never/Rarely/Sometimes/Often/Always” and 
“None/1 day/2-3 days/4-5 days/6-7 days” for items measuring frequency. (Table A1) 
 
The average frequency to response categories 1 to 5 across all items were 
35%, 36%, 20%, 7% and 2% respectively. (Table A2) Therefore, there were 
relatively fewer endorsements for higher levels of fatigue. Extreme skewness was not 
observed as no category was endorsed by more than 95% respondents in any item. 
The largest floor effect was observed with item AN14 “I need help doing my usual 
activities”, with 80.6% responding “Never”. The largest ceiling effect was observed 
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with FATIMP40 “How often did you have enough energy to exercise strenuously?” 
with 15.4% responding “Never”.  FATIMP40 is reverse-scored with “Never” 
representing the highest level of fatigue. 
 
 The overall missing response rate was low at 2.62%. Items with the highest 
missing rates (>5% missing) were also reportedly difficult to understand. From 
qualitative feedback obtained, the 12 items identified as cognitively difficult to 
understand are listed in Table 3.2. Eight items included words that respondents did 
not understand fully and four items had sentence structures that were confusing. Ten 
of these items were PROMIS items and were removed before IRT assumptions were 
evaluated for the set of PROMIS items.  
  








Items with poorly understood word(s) 
AN1 
I feel listless ("washed out") … 6 
FATEXP02 
How often did you feel run-down? 4 
FATEXP13 
How bushed were you on average? 30 
FATEXP16 
How often were you sluggish? 11 
FATEXP41 
How run-down did you feel on average? 4 
FATEXP45 
How sluggish were you on average? 11 
FATEXP52 
How wiped out were you on average? 9 
LUPQOL32  
How often did you feel worn out and sluggish? 10 
Items that are confusing 
 FATEXP21 
How fatigued were you when your fatigue was at its worst? 11 
FATEXP38 
How fatigued were you on the day you felt most fatigued? 9 
FATEXP50 
How fatigued were you on the day you felt least fatigued? 10 
FATSLE02  
On how many days did you feel that you have to rest before 
the day was over?  
4 
* Item number prefixes indicate the source of items. Original item numbers are 
retained for PROMIS items and are indicated with these prefixes: FATEXP- (fatigue 
experience), FATIMP- (fatigue impact), AN- / HI- (items from two legacy 
instruments). PLUS items are indicated with these prefixes: FATSLE- (newly 
written), LUPQOL- (adapted from LupusQoL©) 
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Evaluation of PROMIS items  
 
Traditional statistics  
 
After removal of ten PROMIS items for cognitive difficulty, item and scale 
statistics were evaluated for the remaining 85 PROMIS items. Internal consistency of 
the items was high (Cronbach’s alpha=0.988), though 15 items showed no drop in 
alpha when removed from the scale. (Table A3) The strong scalability of the items 
was indicated by a Loevinger’s H statistic of 0.57 for the scale. (Lai et al., 2011) 
However, four items showed weak scalability with an item H statistic of less than 0.4. 
Three of these items also had numerous item-rest correlations <0.4. These four items 
that displayed poor scalability were removed before IRT assumptions were evaluated 
for the remaining items. They were AN14 “I need help doing my usual activities…”, 
AN7 “I am able to do my usual activities…”,  FATEXP24 “How often did you have 
enough energy to enjoy the things you do for fun?” and FATIMP40 “How often did 




A single-factor model for the remaining 81 items was not supported in a 
confirmatory factor analysis. Model fit indices comparative fit index (CFI): 0.912 
(>0.95 for good fit), Tucker-Lewis index (TLI): 0.950 (>0.95 for good fit), and root 
mean squared error of approximation (RMSEA): 0.191 (<0.06 for good fit) did not 
meet the criteria for good fit proposed in the PROMIS psychometric evaluation plan. 
(Bryce B Reeve et al., 2007) Therefore, an exploratory factor analysis (EFA) was 
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conducted. Unidimensionality was supported by the EFA as the first factor accounted 





 factor was 10.8 (in excess of 4 to support unidimensionality) and from an 
examination of the scree plot.  A marginal improvement in fit indices over the single-
factor CFA was observed with the bi-factor model (CFI: 0.919, TLI:0.955, 
RMSEA:0.181).  
 
Local independence  
 
44 item-pairs were considered to be potentially local dependent as these item-
pairs had a residual correlation produced by the single factor CFA that was greater 
than 0.2. Using the IRT-based statistic LD-X2 as a diagnostic tool, 432 LD-pairs 
were detected. The LD-X2 is an approximately standardized statistic, computed by 
comparing the observed and expected frequencies in each of the two-way cross 
tabulations between responses to each item and each of the other items. (Chen & 
Thissen, 1997)A large LD-X2 value indicates violation of the local independence 
assumption. Values larger than 10 are considered large and values in the range of 5-
10 are ambiguous. (Scientific Software International)  
 
A further breakdown of LD item-pairs showed that majority of the item-pairs 
comprised items from within the same fatigue sub-concepts of fatigue experience and 
fatigue impact described. 160 Impact pairs, 99 Experience pairs and 83 Impact-
Experience pairs were detected with the LD-X2 statistic. For example, two Impact 
items, FATIMP48 “How often were you too tired to socialize with your friends?” 
and FATIMP04 “How often did your fatigue interfere with your social activities?” 
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were locally dependent.  In addition 38 Impact items and 42 Experience items were 
locally dependent on legacy items. Legacy items are items in PROMIS banks that are 
from widely used fixed measures in the field. Legacy items analyzed with the fatigue 
bank were taken from the FACIT-F and four items from the Medical Outcomes 
Study 36-Item Short Form Health Survey (SF-36) Vitality scale. (Lai et al., 2011) 
For example, a legacy item from the FACIT-F, AN4 “I have trouble starting things 
because I am tired...” and FATIMP27 “To what degree did you have trouble starting 
things because of your fatigue?” were locally dependent. To interpret the extensive 
local dependence detected, the basis of LD was evaluated within each sub-bank of 




 Items of the Impact sub-bank exhibited more extensive local dependence than 
items of the Experience sub-bank when they were analyzed separately. 102 pairs were 
detected within 55 items of the Impact sub-bank, with 48 items (87%) involved in at 
least one LD item-pair. (Table 3.3) The maximum number of LD-pairs for an Impact 
item was eight.  In contrast, only 15 LD item-pairs were detected from the Experience 
bank of 34 items. 21 items (62%) were involved in at least one LD item-pair and the 
maximum number of pairs for an item was three. The magnitude of the LD-X2 




                                                 
 
7
 An additional Legacy item, AN8 was removed as it showed poor scale statistics with both sub-bank 
of items 
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There are two types of local dependence. The first type, underlying local dependence 
(ULD) assumes that there is a separate trait that is common to each set of locally 
dependent items but is not common to the rest of the items in the test. (Chen & 
Thissen, 1997) This form of LD is also known as “trait dependence”, as a reflection 
that more than one trait is being measured, hence also a violation of 
unidimensionality. (Marais & Andrich, 2008) For example, LD clusters were detected 
among items within four sub-scales that measure different domains from the Shirom-
Melamed Burnout Questionnaire. (Lundgren-Nilsson, Jonsdottir, Pallant, & Ahlborg, 
2012)The second type of local dependence is surface LD, a specific type of LD that 
occurs when items are so similar in content that respondents cannot differentiate 
between them. (Chen & Thissen, 1997) Items that exhibited local dependence were 
evaluated for both types of LD.  
  








LD pair count per 
item 
No. of Impact items 
(%) 
No. of Experience items 
(%) 
No LD pairs 7 (12.7) 13 (38.26) 
1 pair per item 5 (9.1) 14 (41.2)) 
2 pairs per item 8 (14.5) 5 (14.7) 
3 pairs per item 4 (7.3) 2 (5.8) 
4 pairs per item 11 (20.0) - 
5 pairs per item 8 (14.5) - 
6 pairs per item 4 (7.3) - 
7 pairs per item 6 (10.9) - 
8 pairs per item 2 (3.6) - 
α
 55 Impact items and 34 Experience items 
 
 
Local dependence of fatigue items 
 
Many fatigue impact items had local dependence with at least three items (31 
of 55 items), and groups of items that shared similar LD pairs could be identified. For 
example, FATIMP30 “How often were you too tired to think clearly?” was locally 
dependent with 7 other items. Table 3.4 presents a mutually exclusive classification of 
all 55 Impact items, grouped according to similarity of LD item-pairs, if similarities 
could be found. Some groups comprised items that measured the same sub-domains 
of fatigue impact.
 
 All items had been classified into mutually exclusive sub-domains 
of fatigue impact assigned a priori, based on PROMIS domain definition and its cited 
references. Table 3.4a shows 11 of 13 items from the sub-domain “mental impact” 
and their LD item-pairs. Many items had multiple LD-pairs (three to seven pairs per 
item) and no item was locally dependent on items from other sub-domains, except 
with FATIMP25 “How often was it an effort to carry on a conversation because of 
your fatigue?” Two other mental impact items were free of local dependence.  Unlike 
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mental impact, items from the “social activities” sub-domain were also locally 
dependent on items from different sub-domains. Only 4 of 7 “social activities” items 
were grouped together for similar LD-pairs. (Table 3.4b) The remaining three items 
shared more similarity in LD-pairs to items from other sub-domains.  
 
 Seven of the 12 items from the sub-domain, “motivation to do things” shared 
similar LD-pairs and were locally dependent on items mostly from the same domain 
(Table 3.4c) These items measured the degree of concepts such as trouble starting 
things, finishing things and pushing oneself to get things done. Notably, these LD-
pairs were dissimilar to LD-pairs of items measuring frequency of the same concepts. 
Only one LD-pair was observed between an item that measured frequency and degree. 
Table 3.4d shows instead that the three frequency items were dependent with items 
measuring frequency of concepts from other sub-domains, such as effectiveness at 
work and home, doing errands, household chores and social activities. Two more 
items did not exhibit local dependence, even though equivalent concepts were 
measured in terms of degree. Even though items were not from the same sub-domain, 
frequency items grouped in Table 3.4d generally had a larger magnitude of LD-X2.  
 
 Two other groups of items shared similar LD-pairs but belonged to different 
sub-domains. (Table 3.4e) Possible explanations for the observed similarity are a 
higher difficulty level of items, and the sub-domain of physical impact measured. 
Lastly, Table 3.4f shows four items that did not have similar LD-pairs with other 
items and the 6 remaining items with one to two LD item-pairs.    
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 







3.4a (Group 1- Mental Impact, 11 Items) 
FATIMP30 
 





How often did your fatigue make it difficult to 
organize your thoughts when doing things at 




How often did your fatigue make it difficult to 















How often did your fatigue make you feel slowed 




How often was it an effort to carry on a 















How often did your fatigue make it difficult to 





How often were you too tired to think clearly? 17.9 MENTAL 
  
FATIMP06 
How often did your fatigue make you feel slowed 




To what degree did your fatigue make it difficult 




How often was it an effort to carry on a 




To what degree did your fatigue make you feel 









How often were you too tired to think clearly? 18.3 MENTAL 
  
FATIMP38 
To what degree did your fatigue make it difficult 









How often did your fatigue make you feel slowed 









To what degree did your fatigue make you feel 
slowed down in your thinking? 
12.7 MENTAL 
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 









How often did your fatigue make it difficult to 






How often did your fatigue make it difficult to 
organize your thoughts when doing things at 









How often were you too tired to think clearly? 20.5 MENTAL 
  
FATIMP02 
To what degree did your fatigue make you feel 









How often did your fatigue make you feel slowed 




How often were you too tired to think clearly? 14.4 MENTAL 
  
FATIMP11 










How often did your fatigue make you feel 



















To what degree did your fatigue make you feel 




How often was it an effort to carry on a 




How often were you too tired to think clearly? 15.1 MENTAL 
  
FATIMP26 










How hard was it for you to carry on a 




How often did your fatigue make it difficult to 
organize your thoughts when doing things at 





How often did your fatigue make it difficult to 










How often were you too tired to think clearly? 
23 MENTAL 
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 









To what degree did your fatigue make you feel 




To what degree did your fatigue make it difficult 



















How often did your fatigue make it difficult to 





How often did your fatigue make you feel slowed 









To what degree did your fatigue make you 









To what degree did your fatigue make it difficult 




To what degree did your fatigue make you feel 









To what degree did your fatigue make it 














To what degree did your fatigue make you feel 









To what degree did your fatigue make it 
difficult to organize your thoughts when doing 




To what degree did your fatigue make you feel 
less alert? 
- MENTAL 
3.4b (Group 2- Social Activities Impact, 4 Items) 
FATIMP56 
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 














How often did your fatigue interfere with your 




To what degree did your fatigue interfere with 




How often were you too tired to leave the house? 19.6 UA 
  
FATIMP26 





How often were you too tired to watch television? 14.5 UA 
FATIMP48 
 
To what degree did your fatigue interfere with 









To what degree did you have to limit your social 









To what degree did your fatigue interfere with 




To what degree did you have to limit your 





To what degree did your fatigue interfere with 




How often did you have to limit your social 









To what degree did your fatigue interfere with 




How often did you have to limit your social 





To what degree did you have to limit your social 




How often did your fatigue interfere with your 
ability to engage in recreational activities?  
14.1 UA 
3.4c (Group 3- Motivation to Do Things (Intensity), 10 Items)  










To what degree did you have trouble finishing 




To what degree did you have trouble starting 
things because of your fatigue? 
13.6 MOTV 
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 









I am frustrated by being too tired to do the things 









To what degree did your fatigue interfere with 




To what degree did you have to push yourself to 




To what degree did your fatigue make it difficult 









To what degree did you have trouble finishing 










I am frustrated by being too tired to do the things 




To what degree did you have trouble starting 










To what degree did your fatigue make it difficult 




To what degree did your fatigue interfere with 















To what degree did you have trouble starting 




To what degree did your fatigue make it difficult 









Due to your fatigue were you less effective at 




To what degree did you have to push yourself 





To what degree did you have to force yourself to 




I feel fatigued … 12.6 OTH 
  
AN4 





To what degree did your fatigue make it 





To what degree did you have trouble starting 
things because of your fatigue? 
14.8 MOTV 
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 














To what degree did your fatigue interfere with 









I feel fatigued … 9.6 OTH 
FATIMP47 
 
To what degree did you have to force yourself 






How often did you have to force yourself to get 




To what degree did you have to push yourself to 
get things done because of your fatigue?  
14.1 MOTV 




I am frustrated by being too tired to do the 










To what degree did your fatigue make it difficult 
to organize your thoughts when doing things at 









To what degree did you have trouble finishing 




To what degree did your fatigue interfere with 
your ability to engage in recreational activities?  10.7 UA 
AN16 
 






To what degree did you have to limit your social 




To what degree did your fatigue interfere with 




Due to your fatigue were you less effective at 




To what degree did your fatigue interfere with 




I am frustrated by being too tired to do the things 









Due to your fatigue were you less effective at 





I have to limit my social activity because I am 
tired … 
13.6 SOCIAL 
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 














Did fatigue make you less effective at home? - - 
3.4d. (Group 4- Items measuring frequency in the sub-domain "Motivation to Do 
Things" and their locally dependent items)  




How often did you have trouble finishing 





How often were you too tired to do errands? 22.9 ROLES 
  
FATIMP04 















How often did your fatigue make it difficult to 





How often did your fatigue interfere with your 




How often did your fatigue make it difficult to 




How often were you less effective at work due to 









How often did you have to force yourself to get 





How often were you too tired to leave the house? 18.9 UA 
  
FATIMP47 
To what degree did you have to force yourself to 




How often did you have to push yourself to get 




How often did you have trouble starting things 
because of your fatigue? 
- MOTV 
Locally dependent items of items from the sub-domain "Motivation to Do Things" 
FATIMP13 
 










How often did you have trouble finishing things 




How often did your fatigue make it difficult to 




How often were you too tired to socialize with 
your family? 
18.3 SOCIAL 
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 














How often were you less effective at home due 





How often were you less effective at work due to 




How often did you have trouble finishing things 










How often were you too tired to do errands? 25.6 ROLES 
  
FATIMP56 





How often did you have trouble finishing things 




How often did your fatigue interfere with your 















How often did you have trouble finishing things 




How often did your fatigue make it difficult to 




How often were you less effective at work due to 




How often did your fatigue make it difficult to 




How often were you too tired to do errands? 20.1 ROLES 
  
FATIMP15 
How often did your fatigue interfere with your 









How often were you less effective at work due 









How often did your fatigue make it difficult to 




How often did your fatigue make it difficult to 




How often did your fatigue limit you at work 
(include work at home)? 
- ROLES 
3.4e. (Group 5- Items from different sub-domains) 
Possibly high item difficulty 
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 















How often were you too tired to do errands? 17.5 ROLES 
  
FATIMP29 
How often were you too tired to leave the house? 16.5 UA 
  
FATIMP26 





How often did your fatigue make it difficult to 









How often did your fatigue interfere with your 




I am too tired to eat … 10.7 UA 
FATIMP26 
 











How often were you too tired to do errands? 18.3 ROLES 
  
FATIMP08 





How often was it an effort to carry on a 















How often did you have to force yourself to get 














How often were you too tired to take a short 
walk? 
13.8 PHY 















How often were you too tired to leave the house? 13.8 UA 
  
AN5 
I have energy … 11.8 VIGOR 
  
FATIMP21 











How often were you too tired to leave the house? 15.2 UA 
  
FATIMP10 
How often did your fatigue make it difficult to 
start anything new? 
14 MOTV 
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 









How often were you too tired to take a short 
walk? 
11.7 PHY 
3.4f. (Group 6- Items without similar LD-pairs ) 
FATIMP45 
 
To what degree did your fatigue interfere with 






To what degree did you have to limit your social 




To what degree did you have trouble starting 









To what degree did your fatigue interfere with 




To what degree did your fatigue interfere with 




I am frustrated by being too tired to do the things 









To what degree did your fatigue make it difficult 




To what degree did your fatigue interfere with 




To what degree did you have to push yourself to 




To what degree did your fatigue make it difficult 




How often did your fatigue interfere with your 









How often did your fatigue make it difficult to 




How often did your fatigue make it difficult to 









How often did you have to limit your social 














How often did your fatigue interfere with your 




How often did your fatigue interfere with your 
social activities? 
14.4 SOCIAL 
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Table 3.4 Item groups of items with similar LD-pairs (Impact sub-bank) 
Item No 
Item 









How often were you too tired to do errands? 13.4 ROLES 
  
FATIMP53 















I feel tired … 14.3 GFE 
  
FATIMP49 
To what degree did your fatigue interfere with 




To what degree did you have to push yourself to 




To what degree did your fatigue make it difficult 




To what degree did your fatigue interfere with 





I feel fatigued … 12.7 OTH 
  
FATIMP45 
To what degree did your fatigue interfere with 









I feel fatigued … 14.3 OTH 
  
HI12 
I feel weak all over ... 8.6 GFE 
AN12 
 










How hard was it for you to carry on a 





How often was it an effort to carry on a 




To what degree did your fatigue make it 
difficult to organize your thoughts when doing 





I am frustrated by being too tired to do the things 









I feel tired … 8.6 GFE 
α
 Item number prefixes indicate the source of items. Original item numbers are retained for 
PROMIS items and are indicated with these prefixes: FATEXP- (fatigue experience), 
FATIMP- (fatigue impact), AN- / HI- (items from two legacy instruments).  
α
 EMO: Emotional; UA: Usual Activities; MOTV: Motivation; ROLES: Ability to fulfill roles 
and responsibilities; OTH: Other; PHY: Physical; GFE: General Fatigue Experience 
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 Separately, the likelihood of surface local dependence was also evaluated. 20 
out of 102 pairs were considered for potential surface local dependence because of the 
content similarity between items. (Table 3.5)  An example of a potential surface LD 
pair is between items FATIMP42 “How often were you less effective at home due to 
your fatigue?” and FATIMP05 “How often were you less effective at work due to 
your fatigue (include work at home)?”, which are similar in wording and content. 
Item-pairs that measure the degree of the same concept had similar LD-pairs (Pairs 
No. 1 to 8). Among these eight pairs, four pairs had different item stems. Items with 
the stem “I have…” had additional LD-pairs over items with the stem “To what 
degree…” (Pairs No. 5 to 8). Similarly, item-pairs measuring the same concept in 
different dimensions (frequency vs. degree) shared LD-pairs, but one item had more 
LD pairs than the other (Pairs No. 9 to 13). Semantically similar items that measured 
slightly different concepts shared different LD-pairs (Pairs No. 14 to 17). Finally, the 
similarity in LD pairs could not be compared in Pairs No. 18 to 20 as each item had 
too few LD pairs.  
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Items 1 & 
2 




To what degree did you have trouble 
starting things because of your fatigue? 
AN3 (4) 








To what degree did your fatigue make it 
difficult to start anything new? 
FATIMP27 
(4) 
To what degree did you have trouble 





To what degree did your fatigue make it 
difficult to start anything new? 
AN3 (4) 






To what degree did your fatigue interfere 
with your social activities? 
FATIMP34 
(4) 
To what degree did you have to limit your 





To what degree did you have to limit your 
social activities because of your fatigue?  
AN16 (6) 
I have to limit my social activity because I 










To what degree did your fatigue interfere 
with your social activities? 
AN16 (6) 
I have to limit my social activity because I 





To what degree did you have trouble 
finishing things because of your fatigue?  
AN4 (8) 
I have trouble finishing things because I am 





To what degree did you have trouble 
starting things because of your fatigue? 
AN4 (8) 
I have trouble finishing things because I am 
tired … * 
Perhaps 




How often did your fatigue make you feel 
slowed down in your thinking? 
FATIMP02 
(7) 
To what degree did your fatigue make you 
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To what degree did your fatigue make you 
more forgetful?  
FATIMP11 
(7) 











To what degree did your fatigue make it 
difficult to make decisions? 
FATIMP17 
(7) 
How often did your fatigue make it difficult 





How often did your fatigue make it 
difficult to organize your thoughts when 
doing things at home? * 
FATIMP14 
(3) 
How often did your fatigue make it difficult 
to organize your thoughts when doing 





How hard was it for you to carry on a 
conversation because of your fatigue? 
FATIMP25 
(4) 
How often was it an effort to carry on a 





I have trouble finishing things because I 
am tired … * 
AN3 (4) 











How often were you less effective at home 
due to your fatigue? 
FATIMP05 
(3) 
How often were you less effective at work 








How often were you too tired to socialize 
with your friends? 
FATIMP26 
(5) 
How often were you too tired to socialize 




I feel fatigued … 
AN2 (2) 
I feel tired … Perhaps 
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Items 1 & 
2 




How often did you have to force yourself 




To what degree did you have to force 
yourself to get up and do things because of 







To what degree did you have to limit your 
social activities because of your fatigue?  
FATIMP18 
(2) 
How often did you have to limit your social 







To what degree did you have to force 
yourself to get up and do things because of 
your fatigue?  
FATIMP01 
(3) 
To what degree did you have to push 






 Item number prefixes indicate the source of items. Original item numbers are retained for PROMIS items and are indicated with these prefixes: 
FATEXP- (fatigue experience), FATIMP- (fatigue impact), AN- / HI- (items from two legacy instruments).  
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Local dependence of fatigue experience items 
 
 Local dependence observed among fatigue experience items was less 
extensive and of a smaller magnitude than fatigue impact items. (Table 3.6) The 
largest magnitude of LD-X2 observed were for item-pairs measuring the sub-domain 
of “vigor”.  The item AN5 “I have energy” had the largest LD-X2 statistic (10.1) with 
item FATEXP44 “How energetic were you on average?”. AN5 was also locally 
dependent with FATEXP42 “How much mental energy did you have on average?” 
and FATEXP54 “How often did you have physical energy?” Item pairs from other 
sub-domains had LD-X2 statistics smaller than 5.0, which are not considered to be 
large.  With the exception of FATEXP36 “How exhausted were you on average?” that 
had 3 LD pairs, remaining items also had fewer than three LD item-pairs.  
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No Locally Dependent Item 
LD-
X2  
Items measuring vigor 
AN5 
 
I have energy …   
  
FATEXP44 How energetic were you on average? 10.1 
  FATEXP42 How much mental energy did you have on average? 5.2 
  FATEXP54 How often did you have physical energy? 4.5 
FATEXP44 
 
How energetic were you on average?   
  AN5 I have energy … 10.1 
FATEXP42 
 
How much mental energy did you have on average?   
  AN5 I have energy … 5.2 
FATEXP54 
 
How often did you have physical energy?   
  FATEXP31 How often were you energetic? 4.8 
  AN5 I have energy … 4.5 
FATEXP31 
 
How often were you energetic?   
  FATEXP54 How often did you have physical energy? 4.8 
Remaining Items (in descending order of number of LD-pairs)    
FATEXP36 
 
How exhausted were you on average?  
  
AN4 
I have trouble finishing things because I am tired … 4.3 
  
FATEXP26 
How often were you too tired to enjoy life? 3.9 
  
FATEXP34 
How tired did you feel on average? 3.2 
FATEXP48 
 
How often did you find yourself getting tired easily?  
  
FATEXP20 
How often did you feel tired? 4.8 
  
FATEXP05 
How often did you experience extreme exhaustion? 3.1 
AN4 
 
I have trouble finishing things because I am tired …  
  
FATEXP36 
How exhausted were you on average? 4.3 
  
AN15 





How often were you too tired to enjoy life?  
  
AN2 
I feel tired … 3.1 
  
FATEXP36 
How exhausted were you on average? 3.9 
FATEXP34 
 
How tired did you feel on average?  
  
FATEXP36 
How exhausted were you on average? 3.2 
  
FATEXP51 
How easily did you find yourself getting tired on average? 3.8 
FATEXP20 
 
How often did you feel tired?  
  
FATEXP48 
How often did you find yourself getting tired easily? 4.8 
FATEXP51 
 
How easily did you find yourself getting tired on average?  
  
FATEXP34 
How tired did you feel on average? 3.8 
FATEXP43 
 
How physically drained were you on average?  
  
FATEXP40 
How fatigued were you on average? 3 
AN15 
 





I have trouble finishing things because I am tired … 3.5 
AN2 
 
I feel tired …  
  
FATEXP26 
How often were you too tired to enjoy life? 3.1 
FATEXP05 
 
How often did you experience extreme exhaustion?  
  
FATEXP48 
How often did you find yourself getting tired easily? 3.1 
FATEXP19 
 
How often were you physically drained?  
  
HI7 
I feel fatigued … 3.5 
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 Item number prefixes indicate the source of items. Original item numbers are retained for 
PROMIS items and are indicated with these prefixes: FATEXP- (fatigue experience), 
FATIMP- (fatigue impact), AN- / HI- (items from two legacy instruments). 
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Evaluation of generated PLUS Items   
 
Content of PLUS Items 
 
Six items measuring fatigue were identified from three existing SLE HRQoL 
questionnaires. Four items that addressed unique concepts were adapted for use as 
PLUS items. 28 new items were written by the study team based on concepts 
identified from the focus groups. Table A4 of the Appendix lists the PLUS items and 
the concepts and sub-domains that these items were intended to measure. Two 
concepts that were not specific to sub-domains were introduced with the new items. 
Six items measured the “need for more rest” and two items measured “limiting 
oneself” in work or activities due to the lack of energy. Some items were added to 
slightly modify the nature of fatigue measured.  “I feel full of energy” was intended 
to be an easier item to “I have energy”. Two items introduced a temporal dimension 
to measure whether the concept was sustained throughout the day: “I feel drained 
throughout the day”, and “On how many days did you feel that you have enough 
energy for the whole day ahead?”   
 
Some new items were also sub-domain specific and were intended to 
supplement PROMIS fatigue items in existing sub-domains when unique concepts or 
phrases were identified from focus groups. Eight items described the impact of 
fatigue on the ability to do things in order to fulfill one’s roles and responsibilities, 
such as work and household chores. Three items were written for each of  the 
following sub-domains: physical, emotional, mental impact and participation in 
activities. One item was also written to describe the feeling of “need to sleep”.  
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Psychometric properties of PLUS items 
 
 11 PLUS items were evaluated with PROMIS fatigue experience items. Two 
items with the stem “on how many days” had dissatisfactory traditional scale statistics 
and/or were poorly understood. One item (LUPQOL32) with the word  “sluggish” 
was poorly understood. (Table 3.2) An item measuring the feeling of needing to sleep 
(FATSLE22) and “I feel full of energy” (FATSLE18) were also poorly scaled. Three 
of the remaining six items that fit the scale had no LD involvements. These items 
were LUPQOL34 “How often were you exhausted in the morning?”, FATSLE08 “I 
feel frustrated by the energy level I had”, and FATSLE09 “I did not have enough 
energy to do things that interest me.” The latter two items were written for the 
“emotional” sub-domain. Three other items had one local dependent pair with 
PROMIS items. 
 
21 PLUS items were analyzed with PROMIS fatigue impact items. One item 
FATSLE24 “I have little energy for small tasks at work/home” was poorly scaled. No 
item had reported cognitive difficulty. Similar to the PROMIS fatigue Impact Items, 
PLUS items exhibited extensive local dependence. In fact, four PLUS items had more 
LD-pairs (27 pairs – 15 pairs) than any PROMIS items (maximum 13 pairs observed) 
when PROMIS and PLUS items were analyzed together. Four of the top five items 
with the most LD-pairs measured the newly introduced concepts of “need to rest” 
and “limiting oneself”.  
 
The remaining items that were sub-domain specific displayed patterns of local 
dependence similar to PROMIS fatigue impact items described earlier. In addition, 
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items that measured the new concept “need for rest” were locally dependent with one 
another. 4 items for the “mental” sub-domain had many local dependent pairs with 
items from the similar domain. In particular, 2 items that asked about “concentration” 
were also locally dependent on items from other sub-domains. Items from the sub-
domain “ability to do things in one’s roles” were locally dependent on items from the 
same sub-domain, or with “motivation”. This is a similar pattern seen for PROMIS 
items. Items from the sub-domains “activities” were locally dependent on items with 
“social” and “usual activities”, as well as other sub-domains. Two items that 
measured the concept of “need more rest” in the physical sub-domain were locally 
dependent on other items that measured rest.  




We investigated whether the generic PROMIS fatigue item bank could be used 
to measure fatigue in SLE patients as a disease-specific measure. After 14 items were 
excluded for reported cognitive difficulty and poor item statistics based on traditional 
scale analyses, unidimensionality for the remaining 81 items was supported by 
results from an exploratory factor analysis. However, the local independence 
requirement for IRT modeling was not met.  Extensive local dependence was 
observed, especially among items that measured the same sub-domains of fatigue 
impact. The two methods adopted to generate items (PLUS items) for the item pool, 
in order to increase the bank’s relevance to SLE patients yielded 32 new items. These 
items introduced the measurement of one new concept (the need for more rest), and 
items to supplement existing sub-domains of the PROMIS bank. Although most 
items had acceptable scale statistics, PLUS items that measured fatigue impact 
displayed similar patterns of local dependence when analyzed with PROMIS items.  
 
PROMIS item banks have been used in different ways for the development of 
disease-specific PRO measures. The PROMIS cancer-specific fatigue bank is a 
reduced version of the original PROMIS fatigue bank, removed of items identified to 
be irrelevant to cancer patients. (Garcia et al., 2007) Although it was planned that 
cancer-specific items would be added to the bank variant, no concepts were found 
that necessitated the writing of new items, following analysis of cancer patient focus 
groups and cognitive interviews for the fatigue domain. A different strategy was 
adopted for the creation of an orthopedic-specific item bank where item calibration of 
the complete PROMIS Physical Function bank was performed in an orthopedic 
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population. However, the authors also suggested that separate subscales might be 
needed for upper and lower extremity problems, as differential item functioning was 
observed and evidence that the scale was not truly unidimensional. (Hung et al., 
2011) In contrast, the Neuro-QOL team developed a domain framework that was 
independent of the PROMIS framework and created distinct item pools for the 
assessment of health-related quality of life (HRQoL) in populations with neurological 
disorders. (Gershon et al., 2012)  In the later phase of qualitative item review, 
PROMIS items were compared against candidate Neuro-QOL items and redundant 
candidate items were eliminated.  
 
In our study, the full PROMIS fatigue bank was administered to a SLE patient 
sample. A single-factor model fit poorly to the data with confirmatory factor analysis. 
However, a further exploratory factor analysis supported unidimensionality of the 
construct. One reason for the poor model fit is the extensive local dependence 
exhibited, which is also reflected in the high residual correlations of item-pairs from 
the single-factor CFA. Another reason may be that the sample size of our study is 
insufficient for model stability. To interpret the observed LD, we evaluated the 
content and surface characteristics of items and compared patterns of LD across item-
pairs. (Chen & Thissen, 1997)  The LD observed can be explained with a model of 
underlying local dependence (ULD), as clusters of items with similar LD pairs and 
similar sub-domain classification could be identified.  
Items that measure the mental impact of fatigue showed the most consistent 
patterns of local dependence, in that almost all its items exhibited local dependence 
within the sub-domain, and local dependence with only one item outside the sub-
domain. This pattern suggests that the mental impact of fatigue experienced in SLE is 
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distinguishable from a more general sense of fatigue, such that patients who have that 
experience in the 7-day period recognize, recall and endorse related items 
consistently. Another consistent pattern of local dependence was for items that 
measured the degree of fatigue impact on motivation. However, these items were 
independent from items measuring frequency of the same concepts. Instead, 
frequency items were locally dependent on items measuring frequency in other 
domains. Furthermore, frequency item-pairs had LD-X2 statistics of a larger 
magnitude even across sub-domains. Within the context of the ULD model, these 
results suggest that an underlying trait could be the measured dimension of frequency 
of fatigue impact.  
 
It is possible that the local independence assumption failed to hold in this 
specific disease population, even as identical items have been successful calibrated in 
the general US population. (Cella et al., 2010) The experience of fatigue in healthy 
and diseased individuals may be different, as has been reported in a comparative 
study of healthy and cancer individuals. (Glaus, Crow, & Hammond, 1996) In SLE 
patients, mental fatigue has been described to be “a misty feeling” that included 
foggy-headedness. (Pettersson et al., 2010) However, the experience commonly 
coined as “brain fog” in SLE may also be viewed conceptually as a neurological 
involvement, (Stockl, 2007) rather than within the conventional definition of fatigue. 
In particular, when the concept of concentration difficulties was measured with PLUS 
items, local dependence was shown with items both within and outside the mental 
sub-domain. Qualitative studies have conceptualized concentration difficulties as 
either separate from, (McElhone et al., 2010; Stockl, 2007) or within the concept of 
fatigue. (Pettersson et al., 2010)  
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The variability of fatigue along the temporal dimension could be another 
aspect that is unique in SLE patients. Although the timing of fatigue and the intra-day 
fluctuation has been studied, (Cleanthous, Tyagi, Isenberg, & Newman, 2012) the 
temporal patterns over one week is not known. Qualitative studies report fluctuating 
and unpredictable symptoms and fatigue in the short-term, daily and even as “sudden 
attacks”. (McElhone et al., 2010; Mendelson, 2006; Pettersson et al., 2010) As 
compared to a general population or a disease with less variability, the temporal 
dimension measured in SLE patients could be slightly different, in the sense that the 
item stem “how often” may not be a pure measure of “how much of the time”. 
Instead, the temporal variability of fatigue over a week may be captured as a 
separate, underlying trait of the SLE patient, reflected in the respondent’s choice 
between the options “never”, “seldom”, “sometimes”, “often” or “always”,  
  
This study’s attempt to increase the bank relevance to SLE patients yielded 
relatively few items. The first strategy of using extant items from SLE-specific 
questionnaires yielded only six items for consideration. Eliminating items for content 
similarity, eventually four items were adapted and tested as candidate items. This 
small yield is expected since selected instruments were disease-specific to SLE and 
not domain-specific for fatigue. Thus, instruments covered multiple domains, with a 
small number of items addressing each domain. Furthermore, a previous comparison 
with PROMIS and SLE-specific instruments found that the PROMIS bank provided 
the widest coverage of all fatigue sub-themes discussed by SLE focus groups.The 
second strategy of writing new items from concepts identified with SLE patient input 
from focus groups yielded one broad concept “need to rest” and a related concept of 
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limiting one’s own activities. Several items that addressed the latter concept were 
present in the PROMIS bank, thus new items were added as to supplement gaps. The 
need for rest was identified to be a distinct concept, as SLE patients described the 
impact of fatigue as a need to take a rest as a means of coping with fatigue as a 
disease symptom, and also because there was some expectation that fatigue is a 
trigger for a disease flare. Therefore, in writing new items for SLE patients, the 
impact of fatigue was conceptualized beyond a direct interference of the symptom, to 
also encompass the patient’s coping and disease management strategy. 
 
 A similar concept was presented in a qualitative study of fatigue in SLE 
patients.  (Pettersson et al., 2010) “Restriction” was a strategy described by patients 
to manage life despite fatigue by setting boundaries, setting restrictions on demands 
and avoidance, which was to stay away from things that consumed too much power 
or strength.  The authors proposed a complex model of the fatigue experience in SLE 
patients, comprising four broad components: the perception of fatigue, aspects 
affected by fatigue (including emotions and social interaction), striving towards 
power and control and factors influencing the perception of fatigue. Prior to this 
study in 2010, no fatigue-specific qualitative study or model had been proposed to 
explain how clinical, biologic or social factors contributed to the construct of fatigue 
in SLE patients. (Ad Hoc Committee on Systemic Lupus Erythematosus Response 
Criteria for Fatigue, 2007)  
 
In evaluating PROMIS items to measure fatigue in SLE patients, the 
quantitative psychometric analysis of items was limited by its small sample size. 
Furthermore, as items have not been calibrated in the Singapore general population, it 
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is not certain whether the local dependence observed was indeed specific to the 
disease population, or might have been observed in this geographical population as 
well. The study of PROMIS items was also limited by the lack of prior in-depth, 
qualitative item review methods laid out in the methodological guidelines by 
PROMIS (PROMIS® Validity Standards Committee, 2012) that would include a 
cross-cultural adaptation of items for use in the Singapore population.
8
 Some 
ameliorative measures were taken in this regard. First, PROMIS fatigue items were 
administered to three respondents in an earlier phase of the study (the focus group 
study of Chapter 2) and to two respondents in pilot administrations to determine the 
acceptability of these items in the local population. In total, the PROMIS fatigue 
items were administered to five respondents prior to study commencement. Second, 
qualitative feedback of items was obtained alongside the test administration via a 
standardized data collection completed by the interviewer. Third, items identified as 
difficult to understand from the pilot and initial administrations were reordered to the 
end of the questionnaire, so that the interviewer could obtain item-level feedback for 
these items.   
 
This study explored whether a PROMIS bank could be used in the 
development of a disease-specific item bank. When administered to a SLE patient 
population, the psychometric properties of these items did not meet IRT assumptions 
and could not be calibrated. Evaluating the basis of local dependence exhibited, we 
have suggested reasons why the local dependence assumptions might not have held 
                                                 
 
8
 As the current study was an exploratory study investigating the feasibility of adopting PROMIS items 
for use in disease-specific banks, in-depth qualitative item review to assess respondents’ cognitive 
understanding of the items was not performed. Cross-cultural adaptation of the items was also not 
performed as the study plan precluded modification of PROMIS items. 
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for a SLE-specific disease population. The two methods used to generate new items 
for the bank to increase its relevance to SLE patients did not yield substantially 
different concepts and were not sufficient to clarify the construct of fatigue in SLE. A 
recent model proposes that the fatigue experience in SLE is complex, influenced and 
modulated by several internal and external factors. This suggests that the fatigue 
experience and fatigue impact conceptualization of the generic PROMIS fatigue bank 
is not sufficient for the measurement of the fatigue construct in SLE patients.  To 
measure fatigue in SLE, a review of the domain definition and concepts is needed. A 
broader or narrower definition may be adopted, to include factors that modulate 
fatigue impact, or to restrict it to fatigue experience to avoid measuring additional 
traits. If deemed to be important, a multi-dimensional model or separate scales may 
be constructed, to address different sub-domains and dimensions of fatigue.  
 




The different psychometric properties observed when PROMIS fatigue items 
are administered to a SLE patient population suggest that a disease-specific item 
bank is needed to measure fatigue in this population. In such an area where the 
measured construct is not theoretically well defined and extant measures are few, the 
strategy to review and adapt from literature and extant items yielded little 
information on how the bank could be tailored for this population. Instead, what is 
required is an initial clarification of the domain concept and its definition, followed 
by generating relevant items with expert and patient input. In other words, the 
complete multi-phase methodology is required to develop a well-functioning SLE-
specific fatigue item bank. It is not known whether PROMIS banks for other domains 
would exhibit such different psychometric properties if tested in the SLE population. 
For example, differences may be limited to different estimates of item parameters, 
more pronounced floor and ceiling effects, or individual items that are irrelevant or 
fit poorly to an IRT model, rather than an extensive violation of assumptions for IRT 
modeling. Future research can evaluate PROMIS banks in other domains to 
determine how they can be used in disease-specific assessment. Within each domain, 
if most PROMIS items can be calibrated, a disease-specific bank for that domain may 
not be necessary. At best, individual items could be added or removed from banks, 
modifying it for greater relevance to the disease population. Conversely, if 
dissatisfactory psychometric properties are consistently observed when PROMIS 
banks are administered to disease-specific populations, this would suggest that 
unique item banks developed from the outset for each disease is both more valid and 
more efficient.  
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CHAPTER 4 Distilling the patient perspective from 
patient focus groups for the development of 
health-related quality of life measures – a 
qualitative study 




The patient’s view has gained importance with the shift toward patient-
centered medicine, a movement that begun in the 1980s. (Sullivan, 2003) Since then, 
patient perspectives have been increasingly sought using qualitative research methods. 
(Hansen, Draborg, & Kristensen, 2011) One method of accessing these perspectives is 
the patient focus group. The unique element of focus groups is group interaction, 
proposed to positively influence the content shared through lessened inhibition, 
collective insight, potential for synergy and serendipity. (Stevens, 1996; Willis et al., 
2009) Within the broad field of health research, there are additional unique 
advantages for specific research problems. For example, a group discussion benefits 
research problems that involve a social setting, such as community health phenomena, 
because the intersection of individual ideas with collective beliefs can be explored in 
this setting. (Stevens, 1996; Willis et al., 2009) In contrast, observing interactive 
processes between participants can also provide rich data on the areas of controversy 
and agreement between participants, (Kidd & Parshall, 2000) and individually held 
meanings and understanding of health and illness. (Wilkinson, 1998) 
 
One area of health research that uses patient focus groups is in the 
development of health-related quality of life (HRQoL) measures. HRQoL are 
commonly measured patient-reported outcome (PRO) and refers to the physical, 
psychological and social domains of health that are influenced by a person’s illness 
experiences, beliefs, expectations and perceptions. (Testa, Hollenberg, Anderson, & 
Williams, 1991)  The necessity of patient input in PRO development is recognized, 
(Patrick et al., 2011) recommended in industry guidance by the US Federal Drug 
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Administration (FDA), (Burke, 2006) and incorporated in the phases of major PRO 
development initiatives. (DeWalt et al., 2007; Perez et al., 2007) Inclusion of patient 
perspectives is important because patients have been reported to assess their HRQoL 
differently, (Sainfort, Becker, & Diamond, 1996) identified additional domains, 
(Hansel et al., 2004) and conceptualized HRQoL differently from their healthcare 
providers in some domains. (Bounthavong & Law, 2008) Thus, one main function of 
patient input is the identification of key concepts and definition constructs of 
measurement that are relevant from the patient point-of-view. (DeWalt et al., 2007; 
Patrick et al., 2011; Turner-Bowker et al., 2009)  
 
Because the purpose of such focus group studies is to access authentic patient 
perspectives, it is of interest to understand how limitations of the focus group method 
can impede expression of these perspectives. One such limitation can be attributed to 
the negative influences of group interaction, which is the unique feature of focus 
groups described earlier. The negative effects of group interaction suggested are 
suppression of  minority voices, (Kitzinger, 1994) and censoring or conformity of 
opinions. (Carey & Smith, 1994) A more subtle influence is how the social context of 
a focus group inevitably shapes the discussion and a recognition that focus group 
findings are to some extent context-specific to the discussion. (Hollander, 2004; 
Smith, 1999) Although these limitations have been recognized, evaluation of patient 
focus group findings for the effects of a social context and group evaluation in health 
research is still lacking, (Webb & Kevern, 2001; Willis et al., 2009) and few studies 
have reported the analysis of interaction effects on patient focus groups. (Moen et al., 
2010; Rothwell, 2010; Stevens, 1996; Williams & Ayres, 2007) 
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To help researchers using patient focus groups evaluate study findings for 
these effects, Lehoux, Poland and Daudelin have proposed analytic questions to 
conceptualize and analyze group interactions. (Lehoux, Poland, & Daudelin, 2006)  
Prior to developing this template of analytic questions, the authors developed a 
descriptive model of the processes that occur during a focus group. This model 
integrated knowledge about the focus group method and the nature of patient 
perspectives. Briefly, from a sociological standpoint, social dynamics shape the 
content of discussion. From an epistemological standpoint, the exact nature of 
knowledge shared by patients is unknown, as the illness experience is shaped by 
multiple factors, such as socioeconomic, cultural and phenomenological factors. 
(Stewart, Shamdasani, & Rook, 2007)  Thus, in the Lehoux, Poland and Daudelin 
(LPD) paradigm, patient focus groups are described to be "social spaces in which 
participants co-construct the "patient's view" by sharing, contesting and acquiring 
knowledge.” Focus group narratives are interpreted as views that have emerged from 
multiple patients, with omission of other views that have remained latent during 
discussions.  
 
Through this paradigm, it is not only the content of the discussions that is 
important but also “the ways in which knowledge is articulated and information 
censured”. (Kitzinger, 1994) Thus, using the above paradigm and the proposed 
analytic questions as tools, the objective of this study is to evaluate how patient focus 
group findings may be limited by the effects of the social context and group 
interaction in focus groups. Specifically, patient focus group data will be analyzed to 
account for how and why content emerges in patient focus groups, including the 
effects of group interaction. The second objective of this study is to present the 
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analysis methods developed for this analysis groups that are relevant to the specific 
research purpose of obtaining patient input for the development of HRQoL measures.  
 






As the LPD paradigm of focus groups is incompatible with a direct 
interpretation of focus group narratives, the authors provide an analytic template for 
researchers to perform a secondary analysis of patient focus group data. (Figure 4.1) 
This analytic template addresses the sociological processes that occur during focus 
groups and what these processes reflect about the research topic. Using the analytic 
questions in Figure 4.1, we designed a codebook a priori to systematically identify 
interactive features from focus group transcripts. Through an iterative process of 
analysis and codebook refinement, codes were added, removed or modified to better 
describe interactive features of our empirical data. (Hruschka, Picone-decaro, Jenkins, 
& Carey, 2004; Tuckett, 2005) 
 
 Nine out of the 15 codes applied in the final round are presented in Table 4.1, 
including the code name, how each code was applied and the analytic objective of 
each code. These nine codes were selected for presentation in Table 4.1 because their 
findings are included in the results section. Codes were applied by one of the 
researchers from our study who was the moderator for all focus group sessions, and 
independently by another research member of the group. Thematic analysis was used 
to analyze the content of transcripts segments when necessary. Themes were 
generated by the first researcher and validated by the second research group member. 
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Through analysis of empirical data, we developed a separate analytic framework 
for two reasons. First, the original analytic questions were re-framed to be directly 
applicable for health researchers. To be useful, findings from this secondary analysis 
must contribute to (1) improving the techniques in the use of patient focus groups, or 
(2) provide more information about the phenomenon studied. Second, this framework 
organized and simplified analysis. Only three dynamics of interest are analyzed to 
consider how content gets shaped in focus groups. Each dynamic corresponded to a 
“layer” of focus group data. Recognizing the multi-leveled nature of focus group data 
is not unique to this analysis. In analyses of focus group content, views articulated can 
belong to either the individual or group levels. (Carey & Smith, 1994; Duggleby, 
2005) 





  Figure 4.1 Analytical template proposed by Lehoux, Poland and Daudelin 
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Table 4.1 Codes applied to identify interactive features from transcripts 
Code Name Application to transcript Analytic objective 
General interactive features 
 
Claims Statements about facts or personal 
experiences and opinions 
 
Identify general 
interactive features in 
focus groups  
 Question for 
information / 
about others 
Question directed toward other 
participants to seek information / 
about their experiences 
 
Speculation Guessing or an expression of 
uncertainty about a claim 
 





Sidetrack Content of discussion is unrelated to 
research question   
Determine the 
participant’s purpose 




Role / group Participant identifies with a social 
role / part of larger group 
 
Perspective adopted 
by participant  
Third-person Participant presents an account of a 
third person  
 
Inter-participant co-construction of claims 
 
Agree/ disagree Participant agrees / disagrees with a 
previous member’s claim. 
 
Handling claims 
made by other 
members 
Similar/ dissimilar  Participant describes a fact (e.g. 
experience or characteristic), relating 
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The empirical study  
 
 The empirical study used in this analysis was the focus groups which were 
conducted among multi-ethnic, Asian patients with Systemic Lupus Erythematosus 
(SLE) in Singapore described in Chapter 2. SLE is an autoimmune disease with 
variable clinical manifestations and an unpredictable, fluctuating disease course. 
(D'Cruz et al., 2007) Briefly, these focus groups were conducted to identify health-
related quality of life (HRQoL) domains of importance and relevance to SLE patients. 
Patients were recruited from an outpatient clinic at the Singapore General Hospital 
(SGH) and from a patient support group, the Lupus Association (Singapore). For each 
session, participants were selected based on availability and for age and ethnicity to 
be as homogenous as possible. Participants had no prior acquaintance with each other, 
except in the group involving volunteers of the lupus support group. In total, 27 
female SLE participants aged 23 to 62 years participated in six focus groups. (Table 
4.2) The discussion was led by a moderator and facilitated by a note-taker in English. 
80% of the Singapore resident population aged 15 years and over are English literate. 
(Ministry of Trade and Industry Singapore, 2010) English is also the medium of 
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Table 4.2 Characteristics of female participants (n=27; 6 focus group 
sessions) from the empirical focus group study 
Characteristic Number (%) 
Age (year)  
Median 45 
Range 23 - 62 
Race  
   Chinese 19(70) 
   Malay 4(15) 
   Indian 3(11) 
   Other 1(4) 








Unemployed (able to work) 1(4) 
Unemployed (unable to work) 1(4) 
Other 2(7) 
Education  
University degree 10(37) 
Diploma 2(7) 
GCE “A” Levels 5(19) 
GCE “N” or “O” Levels  6(22) 
Incomplete secondary schooling and below 4(15) 
Years since diagnosis  
Under 5 years 2(7) 
5 years to under 10 years 9(33) 
10 years to under 20 years 8(30) 
20 years and more 8(30) 
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A new analytic framework for health researchers  
 
 Three levels of focus group data were considered: the individual, inter-
participant and group levels. (Figure 4.2) At the individual level, the dynamic of 
interest was how participants approached the discussion. This was evaluated against 
the assumed approach of research participant. The adopted paradigm of focus groups 
recognizes that participants do not always approach the discussion from the role of a 
research participant, as ascribed to them. Thus, we analyzed alternative purposes and 
perspectives of participants.  
 
At the inter-participant level, the dynamic of interest is how participants built 
narratives on a topic together. Because the illness experience is shaped by many 
factors, these factors should account for content discussed about an illness experience. 
Through this sociological paradigm, however, it becomes possible that claims based 
on some factors are more readily articulated by participants. Thus, discussion content 
emerging from a social space is distorted. We evaluated which factors were used as 
the basis of participants’ claims, comparing these factors against a theoretical model 
of HRQoL. The Wilson & Cleary model specifies causal relationships between health 
concepts, from both the biomedical and social science models. (I. B. Wilson & 
Cleary, 1995) 
 
At the focus group level, collective dynamics underlying focus groups were 
assumed to influence the content of discussion. We used interactive features from 
transcripts to identify the presence of four social contexts known to exist within focus 
groups. We related these contexts to the characteristics of associated participants and 
Chapter 4. Evaluating interaction effects in patient focus groups  Ow, YL Mandy 
135 
focus groups. We then hypothesized how each context influenced the discussion 
content. 
 
 Only interactive features at the individual and inter-participant levels of our 
framework could be facilitated by content analysis with the codebook (Table 4.1). At 
the focus group level, codes cannot be applied directly on the transcript. Instead, 
selective coding and generation of comparative tables across sessions, with a 
consideration of participant and focus group characteristics, was necessary. Analysis 
of interaction features or concepts not included in the codebook was performed by the 
same two researchers as previously described. 
 
Figure 4.2 A framework proposed for health researchers to analyze three 










Inter-participant co-construction of 
narratives on a discussion topic 




* Shaded ovals represent focus group participants 




(A) Individual approach to the discussion  
 
Alternative participant purposes  
 
 The archetypal response addressing the research question was a “personal 
claim” about one’s experience, opinion or attitude. Other interactive features were 
also identifiable from our transcripts. (Figure 4.3) These were questions for 
information, questions about others’ experiences, speculation about uncertainties, and 
displays of support, such as encouragement, empathy or reassurance. We analyzed the 
content of (1) “non-claim” features and (2) “personal claims” coded with “sidetrack” 
(applied to claims that did not address the research question) (Table 4.1).  
 
Five themes were distilled: (a) speculation of SLE disease cause and triggers 
of flare, (b) speculation of symptom attribution (SLE, side effects, or other) (c) 
identifying common personality traits of lupus patients, (d) describing suffering 
unrelated to SLE and (e) sharing coping strategies. These interactive features and 
themes are features of everyday interaction and topics of concern to SLE patients.  
 
 However, theme (b) highlighted a challenge to research assumptions. An 
assumption was that patients could attribute experiences to SLE and its treatment, 
thereby discussing only relevant impact. ‘Speculation’ highlighted both uncertain and 
inaccurate patient knowledge about symptom attribution, illustrated with the example 
in Transcript Segment 1 (Table 4.3, TS1). As patients questioned one another and 
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speculated about symptom attribution, their alternative approach to the discussion as 
“knowledge-seekers” was revealed. Also, rather than making personal claims, patients 
sometimes spoke about "someone I know", or spoke for a larger group, most 
commonly taking the perspective of “as a lupus patient”.  

















are the side 



















* Personal claims were the archetypal response addressing the research question  
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Table 4.3 Examples of focus group interactive features and content illustrated 
with transcript segments* 
 
TS1 – Speculation, questions, uncertainty and inaccuracy about symptom 
attribution to SLE   
 
R1: Can I also ask - I don’t know how long the rest of you have got your lupus -  
but I’m wondering whether it affects your menses?  
R2: Yeah, it does, for quite long already. 
R1: Oh is it? Is it because of menopause? Oh, I’m sorry, I’m going to have to ask 
that.  
R2: No, because of taking too many medications. 
R3: Well, I don’t think it’s because of the sickness (lupus), for me it’s as per 
normal. 
(R4 agrees)  
(The discussion continues for a while longer and someone suggests a hormonal 
imbalance.) 
 
TS 2 – Relational positioning of claims (in bold) and information introduced 
(underlined) to support differentiated claims  
 
R1: For my case is, I am a very active person. I love to swim, dance and be under 
the sun. But after lupus, everything changed. I chose not to swim because 
if I swim too early or too late, I feel cold and we’re allergic to the sun, so 
I don’t swim at all…  
R2: For me, I think it affects my family too. Because when I had lupus, my 
youngest daughter is only 4 years old. So every time they want to go out, 
[I say] “Mummy is sick, cannot go out”. Because I’m sick, I cannot go 
under the sun. It also affects my own life because I like sports, running 
and everything but because of this disease I cannot go under the sun or 
exercise. Then, in the first two years, I was always admitted to the 
hospital… so nobody looked after them. Actually, it affects them also, can 
say that they are very independent but I also think that they have some 
problems in their heart but they don’t tell me… so I feel a bit guilty and a 
bit sad.   
R3: Okay, for me, I think I’m a very sedate person, I lead a sedate life. I can just 
sit down and do my bead work. I think the only thing that affects me is the 
sun – I can’t go fishing with my son, he likes fishing. Other than that, I 
don’t think it’s too bad because I had lupus when my kids were teenagers, 
so it’s not too bad… I don’t have outdoor hobbies, I’m a very sedate 
person. My gardening I can do in the evening, so in that aspect, I’m okay.  
 
TS 3 – A view expressing non-adherence to medical advice was challenged 
 
R1: Occasionally I still do go out under the sun… I was on the boat for 12 hours. 
So I don’t know, I’m disobedient. 
R2: Don’t tell Dr X that, seriously, he’ll be very upset.  
R3: You see, the thing is… (interrupted) 
R1: Yeah, I mean, I’m fortunate, that’s why… (interrupted) 
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Table 4.3 Examples of focus group interactive features and content illustrated 
with transcript segments* 
R3: Yeah, you’ve very blessed. You see, the thing is, sometimes you think of your 
family and people around you. Why must I take this risk just because of 
myself, then in the end, I suffer, the people around me suffer, the whole 
family suffer. It is not fair to the doctor, that he’s such a nice man, you 
know… 
R2: He is such a sweet man…  
R3: You know, sometimes you feel that you.. 
R2: disappoint him…  (continued) 
 
TS 4 –  The associative context created in a focus group of SLE patients 
facilitates sharing of experiences 
 
R: I had some old friends, primary and secondary school friends. Since I was 
sick, I didn’t like to contact them again because I feel that I didn’t want to 
mention the same sickness, the same experiences and bad memories I 
had… I have to repeat the same story, how I go through all this, it makes 
me feel very sad, so I don’t want to relive it. 
M: I hope I’m not making you feel sad by asking you to relive it here. 
R: No, because here everybody is the same, so I don’t feel it. Unlike my friends, 
they are normal. So when you start to say, they are like “Huh?!” 
(exclamation), like you seem very fragile and very weak, or they will gasp. 
I don’t know about you, but I feel bad, so I don’t want to mention. 
 
*
 TS: Transcript Segment; R: Respondent; M: Moderator 
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(B) Inter-participant co-construction of narratives  
 
Participants position their claims in relation to others’ claims 
 
 When contributing to an ongoing topic, participants positioned their claims in 
relation to existing claims. An example of verbal features that show relational 
positioning of claims is the extensive use of phrases, such as “for me”, or “in my 
case”, when a claim is differentiated. We marked out units of analysis by defining a 
dialogue segment on the same topic as “a thread”. A “thread” grouped individual 
contributions by topic, analogous to the grouping of electronic mail messages by 
identical subject headings.  Within a thread, interactive features that displayed relation 
to previous claims were coded with “agree” / “disagree” and “similar” / “dissimilar” 
(Table 4.1). In the absence of any interactive feature within a thread, this lack was 
also noted. 
  
 When validating others’ claims, or differentiating their own claims, members 
introduced new information to the group. An example illustrates verbal features 
showing relational positioning of claims and the new pieces of information introduced 
(underlined) (Table 4.3, TS2). In this example, members differentiated claims on how 
having to avoid the sun affects HRQoL. New information introduced was a 
description of one’s traits, preferences, hobbies and family roles.    
 
Knowledge types were shared differently  
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 Analyzing all threads, we summarized the types of information introduced as 
members co-constructed narratives (Table 4.4). These were clinical knowledge about 
the disease, personal experiences (with symptoms and social experiences), personal 
preferences (values, preferences) strategies for coping with the disease and personal 
information (character traits, demographic characteristics, social roles, hobbies). As 
expected, personal experience of symptoms was the knowledge type most commonly 
shared. Regardless whether members validated or differentiated claims, expressing an 
experience of similar symptoms was often the basis for adding to the discussion.  
 
 Not all co-construction required the introduction of new information. Four 
such instances are listed in Table 4.4. These were topics about the strategies taken to 
manage a life with SLE and its impact on HRQoL (e.g. minimizing sun exposure, 
handling public stigma). Though implicit, these differences can be inferred as 
underlying differences in personality, motivation and values and preferences. Even 
though some claims could be made without supporting information, there was one 
instance a claim was challenged by other members. (Table 4.3, TS 3) A participant 
who described non-adherence to medical advice was promptly and persistently 
interrupted by other members, even as she tried to clarify herself.  
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Table 4.4 Summary of knowledge articulated when participants co-constructed 
claims 
Topic Validation / differentiation of 
claims on topic 
Knowledge articulated by 
participants  
Theme: Direct impact of SLE  
General impact 
of SLE on 
HRQoL 
Differentiation of the impact of 
SLE on HRQoL on individuals 
Clinical knowledge that SLE 
manifests differently in 
individual patients 
 
Impact of pain Validation of the overwhelming 
and debilitating effects of severe 
pain  
 
Experiences of similar pain 
Impact of 
fatigue  
Validation of the need for 
shortened working hours 
 




Validation of the negative impact 
on one’s self image and mood  
Experiences of similar 
appearance changes, e.g. 
weight gain, hair loss, rashes, 
puffy face 
Similar value / preference for 
beauty, described as “being 
vain” 
 Differentiation of the negative 
impact as being less troubling  
 
Dissimilar value / preference for 
beauty (less important due to 
older age and married status) 
 
Impact of 
public stigma  
Validation of the negative impact 
on one’s self-image and mood 
Experiences of similar public 
stigma  
Differentiation of one’s response 
to stigma (experiencing stigma 






Validation of the negative impact 
on one’s emotional health and 
withdrawal from family activities 
 
Experiences of similar stigma 
from family members 




Validation of worries about side 
effects of long-term medication 
Experiences of similar long-term 
medication use 
 
Differentiation of one’s amount of 
worry experienced over possible 
SLE flares  
More experience of symptoms 
and its predictability  (due to 
longer disease duration) 
Theme: Managing a life with SLE 
Managing 
stress levels   
Validation of the impact of 
reduced amount of daily work 
and activities  
Similar strategies used to 
prevent a disease flare 
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Table 4.4 Summary of knowledge articulated when participants co-constructed 
claims 
Topic Validation / differentiation of 
claims on topic 








Validation of the limitations in  
outdoor and physical activities 
Similar strategy used to prevent 
a disease flare  
Differentiation of the impact due 
to limitations in outdoor and 
physical activities  
Dissimilar traits, such as being 
active or sedentary. 
Dissimilar preferences, such as 
hobbies. 
Dissimilar family roles 
Differentiation of the impact 
because one does not adhere to 
medical advice to minimize sun 
exposure 
None 
Differentiation of the extent of 
strategies used to minimize sun 
exposure e.g. avoiding the sun 







Differentiation of the extent of 
relevance of child-bearing  
Dissimilar preference for having 
a child (due to marital status, 
parity status, or individual 
values/preference)  
 
Taking risks Validation of the need to take a 
certain amount of risks to be able 
to live a normal life, rather than 
as chronically ill   
None 
Differentiation of one’s opinion 
about the optimal level risk to be 
taken 
 
Dissimilar family roles (and 
responsibilities) 
Theme: SLE and family 
Fulfilling family 
roles 
Validation of worries about 
ability to fulfill family roles, 
especially to children  
Similar family roles to fulfill 
Differentiation of one’s worry 
about ability to fulfill family 
roles  
 
Dissimilar age of children 
Being a burden  Validate concerns about not 
wanting to be a burden to family 
members  
Similar values / preferences 
*Agreements/disagreements and similarities/dissimilarities identified were interactive 
features of participant engagement during a discussion, not an analysis and comparison 
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Table 4.4 Summary of knowledge articulated when participants co-constructed 
claims 
Topic Validation / differentiation of 
claims on topic 
Knowledge articulated by 
participants  
of cases within a topic by researchers across session transcripts. 
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Evaluating knowledge types against a theoretical model of HRQoL 
 
How patients position their claims in relation to others’ claims incorporates (1) 
the patient’s interpretation of what determines one’s HRQoL and (2) what is believed 
as acceptable supporting information, because the claim is made in a social context. In 
spite of a reasonable assumption that patients are unaware of theoretical determinants 
of HRQoL, similarities were seen in the way knowledge was constructed. Symptom 
experience was the most common basis of articulated claims. This corresponded to 
“Symptom Status” defined in the Wilson & Cleary conceptual model of HRQoL. 
Participants also mobilized knowledge types that corresponded to individual and 
environmental characteristics, postulated to influence the patient’s overall quality of 
life in the model. Patients introduced various types of information regarding personal 
characteristics that corresponded to the model’s ‘personality’, ‘motivation’, ‘values’ 
and ‘preferences’ factors. They also described stigma experienced from the public and 
family members, corresponding to the lack of social support, an environmental factor 
in the model. However, we noted that discussion based on the environmental factor of 
economic support was lacking. Knowledge types were also mobilized differently. 
Individual values and preferences were sometimes implicit in the discussions. A view 
of intentional non-adherence to medical advice was also resisted. Thus, it is possible 
that claims based on these knowledge types, especially when incompatible with 
previous claims, may be avoided.  
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(C) Collective dynamics of focus groups - multiple social contexts  
 
The status context - a hierarchy within the focus group   
 
Hollander described the “status context” in focus groups when participants 
with “higher status… talk more and assume more leadership roles in the group”. 
(Hollander, 2004). The concern is that these participants create dominant narratives 
while other views remain unheard. Such a context is based on “the relative positions 
of the participants in local or societal status hierarchies”. Societal status hierarchies 
typically include gender, age, race or social class. In our empiric groups, one to two 
members from each session could be identified as dominant, based on how much they 
contributed to the discussion. We found that dominance was not based on race or 
class (all our members were female). Instead, these participants tended to have more 
experiential knowledge, characterized by longer disease duration or more severe 
disease manifestations. Older age appeared to be a social characteristic but it was 
correlated with disease duration and disease severity.   
 
The associative context – how commonality influences dynamics and content 
 
 The associative context is “the common characteristics that brings the 
participants together [and] influences the group conversation and dynamics.” 
(Hollander, 2004) Once articulated, associative contexts based on newly introduced 
characteristics can be established. As identified previously, experiencing similar 
disease symptoms was the pre-dominant basis for co-constructing narratives on a 
topic.  More generally, the associative context established because of a shared identity 
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as lupus patients influenced both the conversation and group dynamics positively. A 
poignant reminder of how this context facilitates access to the patient view, justifying 
the use of patient focus groups, is illustrated in Table 4.3, TS 4. The shared identity, 
combined with clinical knowledge that SLE manifests differently in people (Table 
4.4), was likely the basis of the open, unchallenging discussions. 
 
Similar age was another likely associative context influencing group 
dynamics. The interaction between young women in one session was extensive and 
warm, and some topics discussed at length were fairly age-specific. They devoted 
time to discussing appearance change, self-esteem and public stigma. The need to 
avoid the sun was discussed in the context of being unable to attend outdoor parties 
and holidays.  
 
The conversational context – the conversation flow  
 
 The conversational context influences what participants share or withhold, 
depending on whether that experience is believed to be suitable for the discussion at 
hand. (Hollander, 2004) Determined by what has been shared and cultural 
conversational norms, we found that a lack of similarity impedes the conversation 
flow to topics that are unique yet important to individual participants. In four sessions, 
participants revealed significant HRQoL impact just before the session closed and 
only when urged by the moderator. These topics were the guilt of miscarrying and 
inability to conceive, severe physical limitations, decrease in sex drive and 
depression. The empathetic response of members, listening closely but with nothing 
to add, supports the hypothesis that these are unique topics. Although the general 
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climate of these sessions was open and non-challenging, as participants interacted 
with one another through questions and responses, speculation, and supportive 
comments (Figure 4.2), cultural conversational norms could have inhibited discussion 
based on economic factors and individual values and preferences.  
 
The relational context – influences type of knowledge mobilized 
 
 The relational context is “the degree of prior acquaintance among the 
participants”, reflecting how comfortable participants are with each other. (Hollander, 
2004) Only members of one session were acquainted prior to the session. These were 
volunteers of a lupus patient support group who met regularly. The content and 
dynamics of this group were distinct. The content shared was personal and topics 
discussed invoked strong emotions. It was also the only instance when a claim based 
on negative “environmental supports” (impact of family stigma) when co-constructing 
claims was shared. (Table 4.4) 
 
Improving the Use of Focus Groups   
 
Depending on specific research objectives, analysis findings can be used in 
various ways to inform focus group stratification strategies. Stratifying by severity 
and duration can support narratives of members whose views could have remained 
latent. These participants might have felt less comfortable expressing views among 
members with greater experiential knowledge. In addition to avoiding the potential 
correlation with disease duration, stratifying by age creates an associative context. 
This commonality supports in-depth exploration of topics, especially useful when an 
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impact is anticipated to vary across age groups. The limitation of focus groups to 
access certain topics and knowledge types are acknowledged. Rare, personal and 
sensitive topics are difficult to elicit because of the conversation flow and possibly the 
absence of prior acquaintance. Furthermore, certain knowledge types are not as 
readily mobilized, such as the effect of negative environmental supports and 
normative issues of managing the disease based on individual values and preferences.  





We adopted the Lehoux, Poland and Daudelin paradigm of patient focus 
groups as a tool to evaluate how focus group findings may be limited by intrinsic 
limitations of the focus group method. Rather than a straightforward interpretation of 
the emergent view as the patient perspective, we have used this paradigm to generate 
plausible, alternative explanations about how content was actually shaped because of 
the social context and group interaction in an empirical patient focus group study. We 
now summarize and discuss how results from this additional analysis are useful in 
patient focus groups conducted for the purpose of developing HRQoL measures. 
Subsequently, we discuss the usefulness and limitations of the chosen paradigm and 
analysis methods used in this study.  
 
Exploring the approaches adopted by participants clarified whether 
participants fulfilled the expectations or assumptions that researchers held of 
participants in the focus groups. One particular approach that was not in line with 
research assumptions was revealed, which was the uncertain stance regarding which 
experiences could be attributed to SLE. This indicated a possibility that there are 
symptoms which patients cannot attribute or mistakenly attribute to SLE. Difficulty in 
disease attribution can be expected in SLE owing to its variable manifestations, multi-
organ involvement and co-morbidities that are commonly present in SLE patients. In 
view of this, it would be especially beneficial to engage a moderator or facilitator with 
clinical knowledge in SLE patient focus groups, as a clinician may use appropriate 
probes to rule out areas unlikely to be an impact of SLE. A prepared list of co-
morbidities and medical history of each participant will further enable potential 
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ambiguities to be addressed during the discussion, rather than in subsequent transcript 
analysis. However, a broader implication in HRQoL measurement would be to 
consider how patients respond to questionnaire items that require disease attribution 
when they have insufficient knowledge about a disease. Developing PRO measures 
that do not ask patients to attribute symptoms to a cause would be in line with PRO 
development guidelines for ensuring content validity of measures, published by an 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task 
Force in 2011. (Patrick et al., 2011)   
  
Next, we compared the way participants described the impact of SLE on 
HRQoL against a theoretical model of how various factors are known to affect 
HRQoL. This comparison enabled us to identify views that could have remained 
latent because of the types of knowledge they were based on. Our findings suggest 
that economic factors were not discussed and factors recognized to be a matter of 
individual values and preference remained implicit and could have been avoided. On 
these issues, alternative or modified approaches such as individual interviews or more 
active moderator probing can be adopted. Finally, exploring the social contexts in 
focus groups and their influence on content provided ideas for future focus group 
stratification strategies, so that optimal environments for specific research objectives 
can be created. As the empirical study was conducted for HRQoL instrument 
development, issues that are relevant to a broad range of SLE patients should be 
considered. Understanding the social context of these focus groups suggested that 
groups stratified by disease duration can support views from more recently diagnosed 
patients, which would have otherwise been under-represented among other 
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participants. We also acknowledged that some content types are unlikely to be 
accessed via focus groups.  
 
The ideas of Lehoux, Poland and Daudelin are among a few other suggestions 
and demonstrations of how group interaction analysis can be conducted. (Duggleby, 
2005; Halkier, 2010; Rothwell, 2010; Stevens, 1996) The LPD paradigm chosen for 
this analysis was appropriate for two reasons. First, the conceptualization of the focus 
group paradigm was based on an understanding of both the illness experience and the 
focus group method. A paradigm that incorporates the nature of the illness experience 
is relevant to the research topic. It also considered social processes ongoing in focus 
groups, thereby blending a sociological understanding of human interaction in focus 
groups. The second advantage was that this knowledge is clearly described and 
formalized in a model. In contrast, while other authors have suggested more specific 
analyses relevant to health research problems, (Duggleby, 2005; Rothwell, 2010; 
Stevens, 1996) these were not fully supported by an explication of theory behind the 
analyses. Other recommendations provide greater detail on the methodology of 
analysis and report, (Duggleby, 2005) such as conversation analysis, but were not 
specific to patient focus groups and therefore less relevant to the research topic. 
(Halkier, 2010) For these reasons, we found the LPD paradigm and template to be 
balanced and appropriate, flexible for developing methods suited to the research topic 
with a well-defined theoretical basis to allow evaluation of methods and interpretation 
of results.  
 
Although we adopted the LPD paradigm, we also developed a separate 
framework and a set of methods for this analysis. At the heart of a separate framework 
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developed was the recognition that focus groups in health research are used for 
purposes dissimilar to social science research. (Morgan, 2010; Thorne, 2011) Unlike 
the social science’s investigation into the human experience, health research pursues 
content of the experience specific to a patient population, and for a defined research 
problem. Thus, the benefit of being without pre-conceptions to understand the human 
experience is inefficient for the applied researcher. (Thorne, 2011) Instead of this 
“blank slate” approach, the current framework and methods used are based on 
evaluating focus group findings against existing, theoretical knowledge of HRQoL (I. 
B. Wilson & Cleary, 1995) and social contexts existing in focus groups,(Hollander, 
2004) so that areas that were potentially omitted from discussion can be identified. 
The ISPOR Task Force has also recognized the need to adapt inductive methods, such 
as ground theory, by incorporating clinical knowledge based on expert opinion and 
scientific literature. (Patrick et al., 2011) For the health researcher, understanding 
social dynamics is valuable insofar as it helps to achieve the research objective. Thus, 
compared to the original template, this analysis minimizes a qualitative description of 
interaction and group processes. Instead, it emphasizes directly identifying content 
and participant characteristics alongside interactive features.   
 
The blending of analysis of interactive features and content has also been 
suggested by users of patient focus groups in health research. (Duggleby, 2005; 
Rothwell, 2010)  Unlike a previous study that applied the LPD template to evaluate its 
adequacy and utility in focus groups, (Moen et al., 2010) a deductive approach was 
adopted in the current study. As such, the paradigm was first assumed to be true, then 
methods and results were developed and analyzed accordingly. Thus, the deductive 
approach adopted is a limitation of this study. Although the previous study by Moen 
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et al. found that the LPD template was useful in understanding the soundness of 
content analyses, little further data is currently available that supports validity of this 
paradigm and template. However, if more studies adopt this paradigm, a larger body 
of evidence on this paradigm can be generated.  
 
A second limitation of this analysis is that despite a systematic guide to 
identifying group processes and content provided by the LPD template, analysis 
results are still a product of substantial interpretation by the study analysts. 
Nevertheless, failing to interpret qualitative data is also a cited misapplication of 
qualitative health research. (Thorne, 2011)  Hence, we strived for transparency by 
describing which and how codes were jointly used to identify interactive features and 
content, integrating discrete findings into a single or few major findings that address 
the dynamic of interest. Results at each level were presented methodologically from 
the methods, findings, interpretation to applications. We believe this provides readers 
an opportunity to evaluate the logic process and arrive at other conclusions, where 
appropriate.  
 





We have illustrated and discussed potential benefits of conducting an analysis 
for the effects of the social context and group interaction in patient focus groups.  
Views emerging from patient focus groups do not directly represent the patient 
perspective. The patient view emerging from these discussions is better understood 
through a lens that considers what the focus group method and the patient perspective 
actually are. Because of the nature of these groups, alternative explanations to the 
shaping of discussion must be considered when interpreting narratives to represent the 
patient perspective. While the social science disciplines provide a perspective on what 
patient focus groups are, health researchers use these methods for specific and unique 
research objectives. This work directly contributes to the methodology of using 
patient focus groups in the development of HRQoL measures.  
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CHAPTER 5 The health-related quality of life among 
patients with Systemic Lupus Erythematosus 
(SLE) in Singapore  
  
Chapter 5. HRQoL of SLE patients in Singapore  Ow, YL Mandy 
159 
 
5.1 Introduction  
 
Health-related quality of life (HRQoL) is the patient’s evaluation of the impact 
of a health condition on daily life in the domains of physical, psychological and social 
domains of health. (Acquadro et al., 2003; Testa & Simonson, 1996) Both objective 
factors, such as functioning and health status, and subjective factors, including 
experiences, beliefs, expectations and perceptions are incorporated in the assessment 
of HRQoL. (Testa & Simonson, 1996) As such, HRQoL is an indicator of the 
humanistic and social burden of disease. (Preedy et al., 2010)  
 
HRQoL is a particularly important indicator of burden in SLE because it is a 
chronic illness with an early onset and improving survival rates. (D'Cruz et al., 2007; 
Urowitz et al., 2008) Therefore, measuring premature morbidity does not adequately 
describe the burden of disease. HRQoL is also an important outcome to assess when 
evaluating health care interventions for SLE, as HRQoL represents a different 
dimension from the clinical outcomes of SLE disease activity and severity. (Jolly & 
Utset, 2004; McElhone et al., 2006; V Strand et al., 2000)  
 
SLE patients have poorer overall HRQoL than the general population and 
reduced HRQoL that is comparable to other chronic illnesses, including AIDS and 
rheumatoid arthritis. (McElhone et al., 2006) However, the specific domains that are 
negatively affected have varied across studies. Using the Medical Outcomes Study 
(MOS) 36-Item Short-Form Health Survey (SF-36), some studies have reported 
reductions in all eight health domains, (Thumboo et al., 1997; Wang et al., 2001) 
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whereas only selected domains were affected in other studies. (Alarcón et al., 2004; 
Vu & Escalante, 1999) In Singapore, poorer physical functioning, role-physical , 
general health and greater bodily pain have been reported in a pilot study of SLE 
patients compared with healthy controls. (Thumboo et al., 1997)  
 
Although SLE disease factors, namely activity and severity, do not correlate 
well with HRQoL, associations with other factors have been reported. (McElhone et 
al., 2006) Overall, older age has been associated with a poorer HRQoL whereas the 
association of disease duration is unclear. (McElhone et al., 2006) Associations with 
fatigue and psychosocial factors, such as helplessness and social support have been 
reported and suggested to be mediatory factors of SLE on HRQoL. (McElhone et al., 
2006; Seawell & Danoff-Burg, 2004) Socioeconomic factors are strongly associated 
with HRQoL and also with other important health outcomes in SLE. (Alarcón et al., 
2004; Bae, Hashimoto, Karlson, Liang, & Daltroy, 2001; Karlson et al., 1997)  SLE 
patients of lower socioeconomic status have been associated with greater disease 
severity and mortality. (Demas & Costenbader, 2009)  
 
A variety of HRQoL measures have been used in SLE patient populations. (C.-
S. Yee et al., 2009) The generic instrument recommended and most commonly used 
among SLE patients is the MOS SF-36. (V. Strand & Chu, 2011; Ware Jr & 
Sherbourne, 1992) As a profile instrument, its advantage is that health is described in 
several dimensions. Therefore, the impact of interventions on each aspect of health 
may be fully described. In contrast, preference-based measures generate single indices 
of utilities which are convenient for economic evaluations. However, a single index 
does not indicate if gains in some dimensions of health may be offset by reductions in 
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other dimensions of health. (M. Bullinger, 1993) One such instrument is the EuroQol 
(EQ-5D), (Rabin & De Charro, 2001) which has seldom been used in SLE 
populations. (Wolfe, Michaud, Li, & Katz, 2010) In a comparative study, the EQ-5D 
had a stronger correlation with the physical component score (PCS-12) of the SF-36 
than with the overall rating of health provided by the EQ-5D Visual Analogue Scale 
(VAS). (Wolfe et al., 2010) A new generic tool has also been developed by the 
patient-reported outcomes measurement information system (PROMIS). The 
PROMIS Global Health Short-Form was developed by reviewing numerous PROMIS 
item banks that measure key symptoms and health concepts applicable to a range of 
chronic conditions. (Cella et al., 2007)  Although the questionnaire is a health status 
measure, prediction equations can be used to convert these scores into health-
preference scores based on the EQ-5D index. (Revicki et al., 2009)  
 
As generic measures, a shared limitation of the SF-36, EQ-5D and PROMIS 
Global Health is that the full range of issues that are relevant to SLE, such as sleep 
disturbances, intimate and family relationships, body image, and stigma and 
discrimination is not captured. (McElhone et al., 2010) As such, SLE-specific 
measures have been recommended for use alongside generic measures. (V. Strand & 
Chu, 2011) As of 2012, five SLE-specific instruments have been developed and one 
instrument, the Systemic Lupus Erythematosus Quality of Life (SLEQOL) 
Questionnaire, has been developed and validated in a SLE patient sample in 
Singapore. (Leong et al., 2005) Both the SF-36 and the EQ-5D measures have also 
been validated in a SLE patient sample in Singapore. (Luo et al., 2003; Thumboo et 
al., 1999)  
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The main objectives of the current study are to describe the humanistic burden 
of SLE in Singapore, as measured with extant generic instruments and the SLE-
specific SLEQOL, and to identify the demographic and socioeconomic factors 
associated with HRQoL. This will identify the areas of disease burden in terms of 
HRQoL, as well as characteristics of patients who likely to experience a greater 
HRQoL impact. The secondary objective of the study is to compare the sensitivity of 
related instruments in their ability to discriminate between patients with different 
levels of HRQoL in a cross-sectional setting. Given that there are two alternative 
profile-based instruments (SF-12v2 versus PROMIS Global Health Short Form), two 
alternative approaches to obtain EQ-5D index scores (directly with EQ-5D descriptive 
system versus mapping from PROMIS Global Health Short Form) and the choice 
between generic and disease-specific measures, we would like to provide guidance on 












Subjects and Study Design 
 
In this Institutional Review Board (IRB)-approved study, SLE patients 
recruited were either outpatients at a rheumatology clinic or inpatients warded under 
the care of a rheumatologist at the Singapore General Hospital (SGH). Inclusion 
criteria for the study were (1) a diagnosis of SLE made by a rheumatologist, (2) aged 
21 to 69 years, (3) able to read and understand English, and (4) able to provide written 
informed consent. Outpatients completed the test items at the clinic and inpatients 
completed the items in the wards. Besides the test items, respondents also completed a 
background questionnaire, providing demographic, socioeconomic information, 




1. Short Form 12 Health Survey version 2 (SF-12v2) 
 
The SF-12v2 is a subset of items the SF-36v2, and published in both standard 
(4-week) and acute (1-week) recall versions for self-administration. The generic 
questionnaire consists of 12 items that are used to calculate scores on eight health 
domains: general health, physical functioning, role limitation due to physical health 
problems, role limitation due to emotional health problems, bodily pain, mental 
health, vitality and social functioning, yielding two summary measures of physical 
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and mental health referred to as PCS-12 and MCS-12, respectively. The acute form 
was chosen in this study so that the recall period could be standardized with the 
PROMIS Global Health Short Form. In addition, the advantage of a 1-week recall 
period is increased sensitivity to recent changes in health status. The US English SF-
12v2 acute version was used as the Singapore English version was not available at the 
time of the study. US norms were used to calculate norm-based scores in this study 
since the Singapore norms are not available. 
 
2. EuroQol (EQ-5D)  
 
The EQ-5D self-reported questionnaire is a standardized instrument to present 
a simple, generic measure of health for clinical and economic appraisal. In this study, 
we used the EQ-5D 3 level version (EQ-5D-3L) which consists of the EQ-5D 
descriptive system and the EQ visual analogue scale (EQ-VAS). The EQ-5D-3L 
descriptive system comprises the following 5 dimensions: mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no 
problems, some problems, and extreme problems. A unique EQ-5D health state is 
defined by combining one level from each of the five dimensions. Consistent with the 
SF-12v2, we used the United States scoring algorithm, (Agency for Healthcare 
Research and Quality, 2005) where EQ-5D utility scores ranged from -0.109 to 1.0, 




 Global Health Short Form 
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The PROMIS is a system of highly reliable precise measures of patient-
reported health status for physical, mental and social well-being. The PROMIS v1.0 
Global Health Short Form questionnaire is a 10-item instrument representing items 
from six domains: pain, fatigue, physical function, depression, anxiety and social 
function.  It is scored as a Global Physical Health (GPH) component and a Global 
Mental Health (GMH) component using the scoring algorithm available online from 
the PROMIS Assessment Centre. (Patient Reported Outcomes Measurement 
Information System (PROMIS), 2010). In the provided algorithm, response to items 
in this short form can also be used to calculate EQ-5D index scores using a prediction 
equation. Consistent with the SF-12v2 and EQ-5D, t-scores based on item calibrations 
derived from the US population are used in study for internal validity. The t-score 
ranges for the GPH and the GMH components are 16.2 to 67.7 and 21.2 to 67.6 
respectively.  
  
4. Systemic Lupus Erythematosus Quality of Life (SLEQOL) Questionnaire 
 
Leong et al. developed and validated a 40-item SLE-specific QoL instrument, 
the SLEQOL. The disease-specific questionnaire consists of the following six 
subsections: physical functioning, activities, symptoms, treatment, mood and self-
image. Scores were computed by summing up all the items and possible total scores 
range from 40 to 280, with a lower score representing better HRQoL. This instrument 
was selected as it was developed and validated in the Singapore SLE population. 
Unlike the SF-12v2, EQ-5D, GPH and GMH, normative data were not used in the 
computation of SLEQOL scores.   
 





Descriptive statistics (mean and standard deviation) are reported for each 
summary measure of HRQoL and its constituent sub-sections and scales for the 
overall sample and in sub-groups of gender, age and ethnicity. Univariate analyses 
were performed for summary scores and constituent scale, sub-section or dimension 
scores to compare scores among the sub-groups. Multiple linear regression was 
performed with each HRQoL summary score as the dependent variable measure in 
order to identify the demographic, socioeconomic and disease factors associated with 
each HRQoL measure. The demographic factors included were age, gender and 
ethnicity. Socioeonomic factors were education level, employment status, living 
arrangement and any health insurance coverage. Disease factors were the years 
diagnosed with SLE and the presence of co-morbidities. 
 
 Correlations between the following instrument pairs/group were analyzed 
using Spearman’s correlation: (1) PCS-12 and PROMIS GPH, (2) MCS-12 and 
PROMIS GMH, (3) EQ-5D-3L index scores and PROMIS EQ-5D index scores, as 
well as (4) PCS-12, MCS-12, PROMIS GPH, PROMIS GMH and SLEQOL. We 
hypothesized that correlation among similar measures would be strong (i.e. pairs (1) 
to (3)). 
9
 We hypothesized that the correlation between generic and disease-specific 
instruments (i.e. group (4)) will be moderate, reflecting that the measures overlap but 
do not replace each other as each serves a unique purpose. Correlation coefficients of 
                                                 
 
9
 Pair (1) measures physical health, Pair 2 measures mental health, and Pair 3 calculates utility scores 
based on the EQ-5D. 
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>0.50, 0.35 - 0.50, and <0.35 are considered to be strong, moderate, and weak, 
respectively. (Juniper, Guyatt, & Jaeschke, 1996) To compare the sensitivity of the 
instruments, the relative effect size was computed. First, patients were dichotomized 
into high or low overall HRQoL using median EQ-VAS scores. Next, the mean 
difference between the two groups was divided by the pooled standard deviation. 
Relative effect sizes (RES) were computed as ratios of the effect sizes of an 
instrument relative to its comparator. (Peter M. Fayers & Hays, 2007)  As the SF-
12v2 is a more widely used instrument, it was selected as the comparator for pairs (1) 
and (2) and group (4). In pair (3), as EQ-5D index is the more widely used instrument, 
it was selected as the comparator.   
 
  







 119 outpatients and 8 inpatients aged 21 to 69 years under the care of a 
rheumatologist were recruited for this study. The mean respondent age was 41 years 
(SD: 10.44) and the mean SLE duration was 11 years (SD: 7.30). (Table 5.1) 90% of 
respondents were female and 72% were Chinese. All except eight respondents (6.3%) 
had at minimum completed secondary school education, 17% had a post-secondary 
education and 43% had a degree qualification or higher. 69% of the sample was 
employed full-time or part-time and 11% was self-reported to be unemployed. 66.9% 
reported SLE as their sole medical condition.  
  




Table 5.1 Participant characteristics (n=127) 
Characteristic     Number (%)*  
Age (year) 








































































   
 






































   
 








Alone / not specified 
 
4 (3.1) 






















 Not insured   24 (18.9) 
* Unless otherwise stated 
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Overall HRQoL and HRQoL by sex, age and ethnicity 
  
 The HRQoL scores of the overall sample and sub-groups according to sex, age 
and ethnicity for the various instruments administered are presented in Table 5.2. As 
scores from the PROMIS Global Health and SF-12v2 instrument are norm-based 
scores, a score of 50 indicates a health status level equivalent to the reference average 
(US population). For estimated group mean scores, scores of less than 47 are 
interpreted to be below average. (J.E. Ware, 2007)  With the SF-12v2, physical 
health (mean PCS-12 score (SD): 46.35(7.87)) but not mental health (mean MCS-12 
score (SD): 49.82(8.46)) was poorer in the study sample. With the PROMIS 
instrument, both physical health (mean GPH score (SD): 45.43 (7.11)) and mental 
health (mean GMH score (SD): 45.93 (6.88)) were poorer among SLE patients. The 
overall sample scores for the EQ-5D index, EQ-VAS, and the SLEQOL were 0.89 
(SD: 0.83), 77.04 (SD: 16.30), and 74.89 (SD: 33.67), respectively.    
 
Across the summary scores and scales or dimensions of all instruments, two 
trends were observed of the HRQoL scores by patient sub-groups. First, patients aged 
40-49 years consistently reported the best HRQoL. The only exception was on the 
sub-section of “Self-Image” of the SLEQOL, on which patients of the 50 – 69 years 
sub-group reported the best HRQoL (21-39 vs. 40-49 vs. 50-69 years mean SLEQOL 
Self-Image score (SD): 20.27(11.18) vs. 18.13(11.74) vs. 16.89(6.58); p-value: 
0.037). The second observed trend was that non-Chinese patients reported worse 
HRQoL than Chinese patients with the EQ-5D index (Chinese vs. non-Chinese mean 
score (SD): 0.9(0.1) vs. 0.8(0.2); p-value: 0.008), PCS-12 (Chinese vs. non-Chinese 
mean score (SD): 47.3(7.1) vs. 43.6(9.2); p-value: 0.025) and MCS-12(Chinese vs. 
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non-Chinese mean score (SD): 50.8(8.0) vs. 46.9(9.2); p-value: 0.023). Also, non-
Chinese patients reported poorer scores on six of the eight SF-12v2 scales (p-values 
< 0.05). Only scores on the General Health and Social Functioning scales were not 
significantly different between Chinese and non-Chinese in univariate analyses. 
These observed ethnicity differences are similar to findings from a Singapore 
population based-survey. (Thumboo et al., 2001) Chinese patients were previously 
found to score better than Malay and Indian patients on several SF-36 scales, 
whereas Indian patients had higher scores on General Health, and Malay patients had 
higher scores on Vitality.   
 
A mixed trend for the gender sub-groups was observed. However, the small 
number of male respondents in this sample (9.45%) should be noted. This percentage 
is reflective of the 9:1 female-to-male prevalence ratio of SLE. Summary scores of 
physical health and mental health, measured by either the PROMIS or SF-12v2 
instruments, were similar between the gender sub-groups. With the EQ-5D VAS, a 
10-point difference was observed, with males reporting poorer HRQoL (males vs. 
females mean score (SD): 67.83 (19.05) vs. 77.92 (15.63); p-value: 0.041). EQ-5D 
index scores and SLEQOL total scores were also worse with male patients (males vs. 
females mean EQ-5D index score (SD): 0.83 (0.27) vs. 0.90 (0.11); p-value: 0.077 );  
(males vs. females mean total SLEQOL total score (SD): 93.75(28.22) vs. 
73.30(33.79); p-value of 0.103), though these differences did not reach statistical 
significance.   
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Domains of HRQoL affected in SLE patients 
 
 For the overall sample, only the General Health scale score was reduced 
(mean GH score (SD): 41.99(10.14)) out of the eight SF-12v2 scales. This reduction 
was observed across all sub-groups of age, sex and ethnicity, and ranged from a 6.24 
to 9.05 point reduction in these sub-groups. Only the sub-groups of non-Chinese 
patients and patients aged 50-69 years reported poorer health in several other scales. 
Non-Chinese patients reported poorer health in all scales except Vitality, and patients 
aged 50-69 years reported poorer health in all scales except Vitality and Mental 
Health. Among other patient sub-groups, poorer scores were observed only on the 
Role Emotional (RE) scale among male patients (mean RE score (SD): 46.30(8.22)) 
and patients aged 21-39 years (mean RE score (SD): 46.60(9.16)). For the five 
dimensions rated in the EQ-5D measure, the dimensions with the highest percentage 
of respondents with problems was pain/discomfort (39%), followed by 
anxiety/depression (26%), self-care (13%), mobility (8%) and usual activities (3%). 
(Table 5.3)
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Table 5.2 EQ-5D, PROMIS Global Health, SF-12v2 and SLEQOL scores (overall and by gender, age and ethnicity sub-groups) α 
      Gender Age groups Ethnicity 
     Overall Male Female 
 






















EQ-5D    
 EQ-VAS 77.0 (16.3) 67.8 (19.1) 77.9 (15.6) 0.041* 75.3 (16.7) 81.6 (13.8) 74.8 (17.1) 0.449 76.7 (16.1) 77.2 (16.7) 0.880 
 EQ-5D index 0.9 (0.1) 0.8 (0.3) 0.9 (0.1) 0.077 0.9 (0.2) 0.9 (0.1) 0.9 (0.1) 0.074 0.9 (0.1) 0.8 (0.2) 0.008* 
PROMIS Global Health 
 GPH 45.4 (7.1) 47.1 (8.7) 45.1 (6.8) 0.348 44.5 (7.2) 46.8 (6.7) 45.1 (6.5) 0.831 46.0 (6.9) 43.4 (7.0) 0.066 
 GMH 45.9 (6.9) 45.7 (8.8) 45.9 (6.7) 0.932 44.5 (6.6) 47.8 (7.3) 46.3 (6.0) 0.545 46.0 (6.9) 45.6 (6.9) 0.786 
 PROMIS predicted EQ-5D index 
score# 
0.7 (0.1) 0.7 (0.1) 0.7 (0.1) 0.596 0.7 (0.1) 0.7 (0.1) 0.7 (0.1) 0.328 0.7 (0.1) 0.7 (0.1) 0.084 
SF-12v2 
 Physical functioning 48.0 (9.3) 48.1 (11.4) 48.0 (9.2) 0.959 48.4 (9.4) 50.5 (8.1) 43.7 (9.8) 0.526 49.2 (7.9) 44.6 (11.9) 0.014* 
 Role physical 48.5 (7.8) 47.2 (8.7) 48.5 (7.8) 0.594 48.3 (7.3) 50.8 (7.7) 45.8 (8.7) 0.590 49.7 (7.1) 45.0 (8.7) 0.002* 
 Bodily pain 47.4 (10.7) 49.3 (13.1) 47.1 (10.5) 0.508 46.5 (11.7) 49.6 (8.6) 45.7 (11.1) 0.149 49.3 (9.4) 41.9 (12.3) 0.001* 
 General health 42.0 (10.1) 43.8 (11.2) 41.7 (10.0) 0.522 41.0 (11.0) 43.2 (8.5) 42.7 (9.8) 0.277 41.6 (10.0) 42.7 (10.6) 0.598 
 Vitality 51.2 (7.7) 52.1 (8.8) 51.6 (7.6) 0.852 50.4 (7.6) 53.7 (6.8) 52.3 (8.5) 0.524 52.7 (7.4) 48.9 (7.9) 0.015* 
 Social functioning 49.0 (9.2) 48.9 (12.6) 48.9 (8.9) 0.998 48.2 (9.4) 51.3 (7.7) 46.6 (10.5) 0.254 49.8 (9.2) 46.5 (9.0) 0.074 
 Role emotional 47.2 (9.3) 46.3 (8.2) 47.3 (9.4) 0.746 46.6 (9.2) 49.5 (8.3) 45.3 (10.7) 0.414 48.3 (9.0) 44.1 (9.5) 0.025* 
 Mental health 49.9 (9.1) 50.8 (10.0) 49.8 (9.0) 0.725 48.7 (9.3) 51.4 (8.9) 50.3 (9.0) 0.938 51.2 (7.8) 46.1 (11.2) 0.005* 
 PCS-12 46.4 (7.9) 47.4 (8.6) 46.2 (7.8) 0.649 46.4 (8.2) 48.9 (6.0) 43.1 (7.8) 0.174 47.3 (7.1) 43.6 (9.2) 0.025* 
 MCS-12 49.8 (8.5) 50.7 (7.2) 49.7 (8.6) 0.719 48.6 (8.6) 51.3 (8.7) 50.1 (8.3) 0.967 50.8 (8.0) 46.9 (9.2) 0.023* 
SLEQOL  
 Subsection 1: Physical functioning 9.3 (5.6) 9.2 (5.0) 9.4 (5.6) 0.920 9.0 (5.6) 8.5 (4.9) 11.0 (6.1) 0.532 8.4 (4.8) 12.0 (6.5) 0.001* 
 Subsection 2: Activities 17.4 (9.6) 21.4 (8.9) 17.1 (9.6) 0.234 18.6 (9.9) 14.3 (8.4) 19.6 (8.6) 0.583 17.1 (9.1) 18.7 (10.8) 0.475 
 Subsection 3: Symptoms 16.6 (9.0) 19.0 (13.2) 16.4 (8.5) 0.368 17.6 (9.6) 14.6 (7.7) 17.2 (9.4) 0.409 16.1 (9.0) 18.3 (9.0) 0.248 
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 Subsection 4: Treatment 7.3 (4.1) 8.3 (4.6) 7.2 (4.0) 0.419 7.6 (4.3) 6.4 (3.9) 7.6 (3.8) 0.771 7.1 (4.1) 7.8 (4.1) 0.421 
 Subsection 5: Mood 7.9 (5.0) 7.6 (3.3) 8.0 (5.2) 0.820 8.3 (4.9) 7.2 (4.5) 8.3 (6.2) 0.197 7.3 (4.2) 9.9 (6.5) 0.001* 
 Subsection 6: Self-image 19.0 (10.5) 24.1 (10.0) 18.5 (10.5) 0.111 20.3 (11.2) 18.1 (11.7) 16.9 (6.6) 0.037* 18.0 (10.3) 22.1 (10.9) 0.076 
  Total score 74.9 (33.7) 93.8 (28.2) 73.3 (33.8) 0.103 78.0 (35.3) 64.9 (32.1) 84.1 (22.9) 0.391 73.4 (34.2) 80.5 (32.3) 0.398 
α Higher scores indicate better HRQoL with all instruments except the SLEQOL. EQ-VAS score range: 0-100; EQ-5D index score range: -0.109-1.0; PROMIS Global Health and SF-
12v2: norm-based scores; SLEQOL total score range: 40-280. Higher SLEQOL scores indicate a worse HRQoL. 
#Scores are calculated from a prediction equation provided with the PROMIS Global Health scoring algorithms 
 
 
Table 5.3 No. of patients reporting any problem in each EQ-5D dimensions (overall and by gender, age and ethnicity sub-groups) α 
 





    
Overall Male Female 
P value 



























Mobility 92 (8) 67 (33) 95 (5) 0.001* 92 (8) 100 (0) 84 (16) 0.063 96 (4) 82 (18) 0.012* 
 
Self-Care 87 (13) 75 (25) 89 (11) 0.178 85 (15) 94 (6) 84 (16) 0.367 90 (10) 80 (20) 0.106 
 
Usual Activities 97 (3) 83 (17) 98 (2) 0.005* 95 (5) 100 (0) 100 (0) 0.226 98 (2) 94 (6) 0.292 
 
Pain/Discomfort 61 (39) 92 (8) 57 (43) 0.020 65 (35) 63 (37) 52 (48) 0.544 67 (33) 43 (57) 0.008* 
  Anxiety/Depression 74 (26) 75 (25) 74 (26) 0.921 71 (29) 74 (26) 84 (16) 0.450 78 (22) 63 (37) 0.062 
α Values are in percentages 
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Multiple linear regression 
 
 Different factors were found to be associated with HRQoL scores across the 
instruments in multivariate models that included demographic, socioeconomics and 
clinical factors. (Table 5.4) Neither age nor gender was statistically significant in any 
instrument. Ethnicity was significant with the EQ-5D index (Chinese coefficient, SE, 
p-value: 0.060, 0.030, 0.048) and the MCS-12 (Chinese coefficient, SE, p-value: 3.99, 
1.96, 0.045), and was the only variable found to be statistically significant in more 
than one instrument. These ethnic differences observed in adjusted SF-12v2 scores 
were different from the previous population-based study, whereby adjusted PCS-36 
scores were different among Chinese (best), Indians (worst) and Malays, and adjusted 
MCS-36 scores were different only with Malays (better than Chinese and Indians). 
(Thumboo et al., 2003) Poorer EQ-VAS ratings were associated with a higher 
education level and a living arrangement with extended family. Poorer PCS-12 scores 
were associated with the presence of co-morbidities. Disease duration was not found 
to be significant in any measure. Higher SLEQOL scores (worse HRQoL) were 
associated with respondents who didn’t know or preferred not disclose household 
income levels, and the absence of any health insurance coverage. This could be due to 
the presence of items in this questionnaire that directly query about the financial 
burden due to the disease.  
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EQ-5D EQ-VAS PCS-12 MCS-12 
(adjusted R
2
 = 0.17) (adjusted R
2
 = 0.23) (adjusted R
2
 = 0.16) (adjusted R
2
 = 0.17) 
Co-
efficient SE P value 
Co-
efficient SE P value 
Co-
efficient SE P value 
Co-
efficient SE P value 
Constant 0.73 0.091 0.000 87.96 12.08 0.000 43.84 5.36 0.000 49.10 5.86 0.000 
Age 0.0015 0.0017 0.382 0.13 0.21 0.530 0.080 0.10 0.432 0.14 0.11 0.194 
Gender 
            
 
Male 
    
 
Female 0.072 0.044 0.105 6.99 4.98 0.164 -4.02 2.79 0.153 -2.25 3.05 0.463 
Ethnicity 
            
 
Non-Chinese 
    
 
Chinese 0.060 0.030 0.048* -1.31 3.43 0.703 2.40 1.80 0.184 3.99 1.96 0.045* 
Education  
            
 
< Secondary 
    
 
Secondary -0.014 0.055 0.793 -10.79 7.00 0.127 3.50 3.27 0.287 -4.68 3.57 0.193 
 
Tertiary 0.025 0.058 0.660 -16.84 7.60 0.029* 5.18 3.43 0.134 -4.23 3.74 0.262 
Employment status 
            
 
Employed 
          
 
Unemployed -0.11 0.044 0.011* -9.53 5.18 0.069 -1.02 2.77 0.713 -3.89 3.02 0.202 
 
Others 0.0032 0.035 0.928 -2.73 4.14 0.511 -0.17 2.10 0.936 -2.30 2.29 0.318 
Household income 
            
 
SGD 0-5999 
          
 
SGD 6000 and above -0.029 0.031 0.340 3.33 3.76 0.378 -0.34 1.84 0.854 -0.70 2.01 0.728 
 
Don't know / prefer not to 
say 
-0.030 0.055 0.584 -7.51 6.31 0.237 -4.48 3.15 0.158 1.15 3.44 0.739 
Living arrangement 
            
 
With family nucleus 
          
 
With extended family 0.020 0.043 0.636 -12.70 5.09 0.015* 2.68 2.59 0.303 -0.089 2.83 0.975 
 
Alone / not specified -0.051 0.083 0.540 -1.94 9.36 0.836 4.35 4.78 0.365 -4.19 5.22 0.424 
Disease duration -0.00003 0.0021 0.988 0.0011 0.25 0.996 -0.20 0.12 0.107 -0.11 0.14 0.416 
Presence of co-morbidities 
            





    
 
With co-morbidities -0.020 0.030 0.509 -6.39 3.47 0.069 -3.60 1.74 0.041* -2.96 1.90 0.122 
Insurance 
            
 
Not insured 
    
 Insured 0.011 0.037 0.765 -3.79 4.35 0.386 0.99 2.17 0.649 1.99 2.37 0.405 
#
Higher scores indicate better HRQoL with all instruments except the SLEQOL. EQ-VAS score range: 0-100; EQ-5D index score range: -0.109-1.0; PROMIS Global Health 
and SF-12v2: norm-based scores; SLEQOL total score range: 40-280. Higher SLEQOL scores indicate a worse HRQoL. 
 
 




PROMIS EQ-5D GPH GMH SLEQOL 
(adjusted R
2
 = 0.13) (adjusted R
2
 = 0.14) (adjusted R
2
 = 0.074) (adjusted R
2
 = 0.37) 
Co-
efficient SE P value 
Co-
efficient SE P value 
Co-
efficient SE P value 
Co-
efficient SE P value 
Constant 0.68 0.056 0.000 44.03 4.58 0.000 42.92 4.54 0.000 114.13 27.01 0.000 
Age 0.0012 0.0011 0.268 0.12 0.087 0.184 0.12 0.087 0.186 0.16 0.57 0.784 
Gender 
            
 
Male 
            
 
Female -0.031 0.027 0.261 -3.60 2.23 0.109 1.12 2.21 0.613 -9.75 12.08 0.423 
Ethnicity 
            
 
Non-Chinese 
            
 
Chinese 0.019 0.019 0.306 2.07 1.52 0.176 -1.27 1.51 0.402 2.20 9.23 0.813 
Education  
            
 
< Secondary 
            
 
Secondary -0.048 0.034 0.154 -3.02 2.76 0.277 -3.31 2.73 0.229 -15.85 14.59 0.281 
 
Tertiary -0.026 0.036 0.473 -1.43 2.93 0.627 -2.54 2.90 0.384 -18.70 15.78 0.240 
Employment status 
            
 
Employed 
            
 
Unemployed -0.015 0.027 0.566 -2.08 2.21 0.349 0.55 2.19 0.803 9.75 13.12 0.460 




Others 0.0025 0.022 0.909 0.68 1.79 0.707 -0.97 1.78 0.587 -5.35 11.28 0.637 
Household income 
            
 
SGD 0-5999 
            
 
SGD 6000 and above -0.0025 0.019 0.894 0.13 1.55 0.935 2.00 1.54 0.198 -5.41 8.71 0.537 
 
Don't know / prefer 
not to say 
0.0017 0.034 0.960 -6.06 2.78 0.828 1.85 2.75 0.502 73.57 19.29 0.000* 
Living arrangement 
            
 
With family nucleus 
            
 
With extended family 0.0062 0.027 0.817 1.82 2.19 0.407 -0.87 2.17 0.687 3.08 11.88 0.796 
 
Alone / not specified 0.019 0.051 0.709 1.13 4.23 0.790 1.54 4.19 0.713 19.86 23.23 0.396 
Disease duration -0.0013 0.0013 0.326 -0.14 0.11 0.191 -0.034 0.11 0.751 0.18 0.60 0.759 
Presence of co-morbidities 
            
 
Without co-
morbidities             
 
With co-morbidities -0.028 0.018 0.124 -1.31 1.50 0.385 -1.60 1.49 0.285 10.10 8.42 0.235 
Insurance 
            
 
Not insured 
            
 Insured 0.041 0.023 0.070 2.52 1.85 0.177 0.83 1.83 0.651 -32.30 12.00 0.009* 
#
Higher scores indicate better HRQoL with all instruments except the SLEQOL. EQ-VAS score range: 0-100; EQ-5D index score range: -0.109-1.0; PROMIS Global Health 
and SF-12v2: norm-based scores; SLEQOL total score range: 40-280. Higher SLEQOL scores indicate a worse HRQoL. 
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Spearman’s correlation  
 
 As hypothesized, the correlation between PCS-12 and PROMIS GPH was 
strong (0.73) while the correlation between MCS-12 and PROMIS GMH was 
borderline strong (0.48). (Table 5.5) The correlation between EQ-5D index and 
PROMIS EQ-5D index were similarly strong (0.61). Interestingly, the correlation of 
SLEQOL with other generic measures of HRQoL were strong for all instruments 
(range: -0.50 to -0.59) except MCS-12 where the correlation was borderline strong 
(0.46).  One possible reason for this observation is that the SLEQOL was the most 
comprehensive questionnaire among the instruments, comprising 40 questions over 6 
sub sections. Another interesting observation was that both the SLEQOL and EQ-5D 
index scores correlated more strongly with physical health scores than mental health 
scores of the PROMIS and SF-12v2 instruments.  
 













SLEQOL -0.54 -0.54 -0.50 -0.51 -0.59 -0.46 -0.53 
PCS-12 - - 0.73 - - - - 
MCS-12 - - - 0.48 - - - 




- - 0.92 0.74 0.64 0.52 0.49 
EQ-VAS 0.38 0.49 0.51 0.50 0.46 0.19 - 
*
All p-values < 0.00 
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Relative effect size 
 
 The effect sizes for the SLEQOL, EQ-5D, PROMIS-predicted EQ-5D, 
PROMIS GPH, PROMIS GMH, PCS-12, MCS-12 were determined to be 0.60, 0.59, 
0.54, 0.56, 0.68, 0.50, 0.26 respectively. The relative effect size ratios are presented in 
Table 5.6. A ratio greater than 1 indicates that an instrument (listed in the row header) 
is more sensitive that its comparator (column). The SLEQOL was used as a 
comparator against all generic instruments and was found to be more sensitive than 
the MCS-12 (0.43),  PCS-12 (0.83), and GPH (0.93), almost equal to the EQ-5D 
(0.99), and less sensitive than the GMH (1.13). The generic instruments were also 
compared across comparable summary measures. The effect size of PROMIS GMH 
was much larger than the MCS-12 (2.63). PROMIS GPH was also slightly more 
sensitive than the PROMIS PMH (1.12). Therefore, the PROMIS Global Health 
instrument had a larger effect sizes in both the physical and mental components. Two 
interesting observations were noted in the computation and comparison of effect sizes. 
First, the PROMIS GMH had the largest calculated effect size despite being a 
summary measure of only mental health. Second, the effect size of EQ-5D was very 
similar to the SLEQOL (SLEQOL vs. EQ-5D effect size: 0.60 vs. 0.59), suggesting 
that the EQ-5D is highly efficient despite being a generic and brief instrument.  
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SLEQOL* 0.99 0.91 0.93 1.13 0.83 0.43 
PCS-12 - - 1.12 - - - 
MCS-12 - - - 2.63 - - 
EQ-5D index  - 0.92 - - - - 
α
 A value exceeding 1 suggests that the instrument in the row header is more sensitive 
than its comparator.  
*SLEQOL as the denominator across all generic instruments. 
**EQ-5D index as the denominator 
***PCS-12 as the denominator 




Comparison of EQ-5D scores and PROMIS-predicted EQ-5D scores  
 
PROMIS-predicted scores were significantly lower than EQ-5D index scores 
in the overall sample (0.69 vs. 0.89; paired t-test p- value: 0.000) and across sub-
groups. Nonetheless, the correlation between the two scores were strong (r=0.61). 
The calculated effect sizes were also fairly similar between the two scores (PROMIS-
predicted vs. EQ-5D index scores: 0.59 vs. 0.54) 
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5.4 Discussion  
 
This study has described the HRQoL burden among SLE patients in 
Singapore. Compared to the general US population, poorer physical health and 
possibly poorer mental health was reported by the study sample. Only the scale of 
General Health was impaired in the overall sample when measured with the SF-12v2. 
Non-Chinese patients are likely to suffer worse HRQoL as assessed with the generic 
EQ-5D and SF-12v2 instruments, as well as on several individual scales of the SF-
12v2. These findings are consistent with a previous population-based study in 
Singapore using the SF-36, indicating that ethnic differences of HRQoL among the 
general population were also observed among SLE patients. The study has also 
highlighted the possibility that male patients provided worse ratings of HRQoL with 
selected instruments, namely the EQ-5D and SLEQOL. A further indication that the 
instruments produced different assessments of HRQoL was that different factors 
were found to be significant in multivariate analyses of each instrument.  
 
Although poorer health was reported by respondents, HRQoL scores were 
comparatively higher than previous estimates from SLE populations. EQ-5D VAS 
scores (mean (SD): 77.04 (16.30); median (interquartile range): 80.0 (70.0 – 90.0)) 
was higher than in four previous studies of SLE patients (mean score range: 64 - 68) 
and in a study of four rheumatic diseases in Singapore (median, interquartile range: 
70.0 (50.0-79.3). (Aggarwal et al., 2009; Clarke et al., 2008; Luo et al., 2003; 
Panopalis et al., 2005; Wolfe et al., 2010)  EQ-5D index scores were also higher 
(mean (SD): 0.89 (0.13) ) than two previous estimates of 0.72 (0.21) and 0.7 2(0.19) 
in SLE populations. (Aggarwal et al., 2009; Wolfe et al., 2010)  The ethnic trends 
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observed on the SF-12v2 scales were consistent with previous Singapore population-
based findings with univariate analyses but differences were observed in multivariate 
analyses. (Thumboo et al., 2003) Specifically, ethnicity was no longer associated with 
PCS-12 after adjustment in our study.  However, the different co-variates included in 
the regression models in both studies limits such comparisons.  
 
As the instruments investigated in this study were varied in nature, their 
differences need to be noted when comparing effect sizes. Unlike the PROMIS and 
SF-12v2 instruments, which report scores of physical and mental health separately, 
the SLEQOL total score and the EQ-5D index are single indices of HRQoL that 
incorporate both physical and mental domains. Thus, when the EQ-VAS, an overall 
indicator of health, was used as an anchor to compute relative effect size, the larger 
effect sizes observed with the SLEQOL and EQ-index relative to the PCS-12, MCS-
12, GMH and GPH measures may be expected. Between the SLEQOL and the EQ-
5D index scores, however, the effect sizes were similar. The EQ-VAS was chosen as 
an anchor in this study as it represented an overall or global rating of health. (Peter M 
Fayers & Machin, 2007) Selecting a clinical variable as an external anchor to 
examine validity of HRQoL questionnaires is particularly challenging in SLE, as 
HRQoL is not well correlated with clinical indices of SLE.  
 
The EQ-VAS, EQ-5D index scores and SLEQOL appear to measure the 
physical component more since these scores are more strongly correlated with the 
physical rather than mental health measures. Interestingly, the PROMIS GMH 
demonstrated the largest effect size among all instruments. Hence, it may be prudent 
to incorporate a measure of mental health to more accurately capture the impact of 
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interventions in SLE on mental and possibly overall health. Additionally, it is 
worthwhile to note that the EQ-5D index score is as efficient as the SLEQOL total 
score as a single index of HRQoL. However, a known limitation of the SLEQOL is 
that it was developed with minimal patient input. Thus, the instrument may not 
address the full range of issues that are important and relevant to the patient’s 
HRQoL, resulting in a lower sensitivity of the instrument.  
 
Overall, the PROMIS Global Health instrument shows potential for use in a 
SLE population and is attractive because it is free for academic use compared to the 
SF-12v2. First, GPH correlated strongly with the PCS-12 and the GMH correlated 
moderately with the MCS-12. Furthermore, correlations of the GMH with the 
SLEQOL, the EQ-VAS and EQ-5D index were stronger than the correlations of the 
MCS-12 with the same instruments. Second, both the GPH and GMH had higher 
effect sizes than the PCS-12 and MCS-12 respectively. Third, the PROMIS short-
form has a lower respondent burden, comprising ten questions instead of 12 questions 
from the SF-12v2. In addition, a prediction equation for converting PROMIS Global 
Health scores to EQ-5D index scores exists, though it should be further evaluated 
before use due to the differences in predicted scores.  
 
  One limitation in interpreting study findings is that US norms and scoring 
algorithm was used in all the instruments except SLEQOL. Therefore, score 
differences may represent both true differences between the disease population and 
the general population, as well as systematic difference in HRQoL scores across 
different language and cultural groups. (Peter M. Fayers & Hays, 2007) Thus, one 
reason for the higher HRQoL scores observed in the current study sample relative to 
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other SLE patient cohorts is the use of norms and scoring algorithm that were not 
derived from the target population. A second difference is that the SF-36 standard 
form has been used in past SLE studies, rather than the current SF-12v2 acute form 
used in this study. Nonetheless, these scores would have been standardized with the 
norm-based scoring algorithm. (John E. Ware, 2002) Comparing with SF-36 scores 
among other SLE populations, the mean PCS-12 (46.35) and MCS-12 (49.8) scores 
in our study sample were also relatively higher (PCS-36 score range: 35 to 40; MCS-
36 score range: 43 to 47). (Wolfe et al., 2010)  A third potential reason for the better 
HRQoL observed is that the current sample could have comprised patients who were 
relatively well. Majority of patients who completed the study were outpatients. In 
addition, as HRQoL scores were not collected routinely, it is possible that patients 
who consented and completed the study were in a better health condition than 
patients who declined participation.  As information about SLE disease 
characteristics, namely SLE activity and SLE severity were not collected in this 
study, we also could not compare disease status of the current study sample with 
other SLE studies.  
 
A second limitation is the relatively small numbers in selected patient sub-
groups, namely the non-Chinese patients and male patients. This reduces the 
statistical power of multivariate analysis to detect true differences in HRQoL scores 
across age and ethnicity sub-groups. Another limitation is that as this was a 
descriptive, cross-sectional study, the measurement properties of responsiveness and 
test-retest reliability could not be compared across the instruments. Previously, the 
SLEQOL has been found to be more responsive than the SF-36. (Leong et al., 2005) 
The responsiveness of SF-36 and EQ-5D have not been directly compared in SLE 
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patients but the EQ-5D and SF-6D (calculated from the SF-36) have demonstrated 
similar responsiveness in SLE patients. In this study, both instruments were 
responsive to improvement but not decline in ratings with the EQ-VAS. (Aggarwal et 
al., 2009) Apart from these studies, there is no further indication about the relative 
performance of the SLEQOL and EQ-5D in terms of responsiveness. Findings from 
this study based on correlations and sensitivity in discriminating between patients 
with different HRQoL represents only one aspect in the guidance of instrument 
selection. Nonetheless, the guidance is valid for cross-sectional studies and needs to 
be confirmed for longitudinal studies.  
  





Similar to the general Singapore population, this study has found that non-
Chinese SLE patients have poorer HRQoL than Chinese SLE patients. Furthermore, 
ethnic differences are likely to be independent of demographic and socioeconomic 
factors. The importance of selecting an appropriate HRQoL instrument is highlighted 
in this study, as assessments based on each instrument appear to be affected by 
different factors. As a single index of HRQoL, the EQ-5D was as efficient as the 
SLE-specific SLEQOL in discriminating patients with different HRQoL levels. 
However, other measurement properties such as responsiveness need to be evaluated 
to guide instrument selection in intervention trials. Two other opportunities to 
improve HRQoL assessment in SLE patients have also been identified, namely to 
incorporate additional measures of mental health and the potential of using the 
PROMIS Global Health instrument for assessment.  
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CHAPTER 6 The economic burden of Systemic Lupus 
Erythematosus (SLE) in Singapore   
 
  





Systemic lupus erythematosus (SLE) is an autoimmune disease that involves 
multiple organ systems and has potential serious health outcomes. The disease 
usually develops early in life and has an unpredictable relapsing-remitting course. 
(D'Cruz et al., 2007) To both society and individual sufferers, SLE is associated with 
a substantial socioeconomic burden that is multi-faceted, including economic costs 
and a poor health-related quality of life (HRQoL). (Lau & Mak, 2009) Economic 
costs arise from health care expenditure to treat disease symptoms and lifelong 
monitoring, (D. Gladman, Urowitz, Esdaile, & Hahn, 1999; Petri, 2007) and in the 
form of productivity losses accentuated by an early disease onset. (Baker & Pope, 
2009)  The magnitude of these costs have been estimated in several countries, namely 
the USA, (Brunner et al., 2006; Carls et al., 2009; Clarke et al., 2004; Gironimi et al., 
1996; Li et al., 2009; Nichol et al., 2004; Panopalis et al., 2007; Panopalis et al., 
2008) UK, (Clarke et al., 2004; Panopalis et al., 2007; Sutcliffe et al., 2001) 
Germany, (Huscher et al., 2006) Canada, (Clarke et al., 1993; Clarke et al., 2004; 
Gironimi et al., 1996; Panopalis et al., 2007) and Hong Kong. (Zhu et al., 2009)  
 
Although several SLE cost studies have been conducted, costs in SLE are still 
not well-characterized. (Lau & Mak, 2009; K. a. Slawsky, A. Fernandes, L. Fusfeld, 
S. Manzi, & T. F. Goss, 2011a; Zhu et al., 2011) This is due to the large variations in 
cost estimates reported across studies, attributed in part to methodological 
differences. Even when the magnitude of cost estimates is disregarded, the relative 
contribution from each type of healthcare service used (e.g. outpatient, inpatient or 
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pharmacy services) differed across studies. However, in the majority of studies, a 
general observed trend was that inpatient costs exceeded outpatient costs. (Slawsky et 
al., 2011a; Zhu et al., 2011) Another observation among the studies was the large 
inter-individual differences within studies, reflected by large standard deviations 
reported with direct cost estimates. This has been attributed to the variable 
manifestation of SLE in its patients. (Slawsky et al., 2011b)  
 
Across geographic regions, unique epidemiologic patterns, patient needs, 
available resources and healthcare systems can further accentuate healthcare 
utilization and cost differences. (Lau & Mak, 2009; Mak, 2010) For example, 
ambulatory facilities of Singapore and other developed East Asian nations generally 
provide a wider range of services than a typical ambulatory facility in the West. 
(Wagstaff, 2007) Broader economic factors can also influence indirect cost estimates. 
For example, overall unemployment rates are lower in Singapore (2.0%) and  Hong 
Kong (3.4%) and higher in the US (9.1%). (Central Intelligence Agency United 
States) Such rates may influence the rates of employment losses in a disease 
population. Currently, the only published cost estimate of an Asian SLE population 
has been derived from SLE patients in Hong Kong. (Zhu et al., 2009) Although both 
are industrialized East Asian economies with a majority ethnic Chinese population 
and a colonial history, the healthcare systems of Hong Kong and Singapore differ 
primarily in their financing mechanisms. Over half of Hong Kong’s healthcare is 
financed publicly with taxes, whereas two-thirds of Singapore’s healthcare is 
privately financed. (Wagstaff, 2007) 
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Thus, the objective of the current study is to present a country-specific cost of 
illness (COI) estimate that describes the economic burden of SLE among SLE 
patients in Singapore. The unique economic factors, healthcare system, disease 
management patterns, variability of disease and variability of previous cost estimates 
suggest that a country-specific cost of illness estimate is required to understand the 
economic burden of SLE in this country. These estimates would be useful to 
healthcare administrators and providers to identify healthcare utilization patterns and 
the areas which pose considerable economic burden on the individual patient and 
society. Presenteeism costs and caregiver productivity losses will also be included in 
the estimation of indirect costs in this study. Existing SLE COI studies have focused 
on measuring losses from employment disability and work absenteeism. On the other 
hand, presenteeism costs of SLE patients have not been estimated, and patient 
caregiver productivity losses have seldom been quantified. (Aghdassi et al., 2011; 
Zhu et al., 2011; T. Y. Zhu, L. S. Tam, & E. K. Li, 2012)  Thus, this study also 










Overall Study Plan 
 
Two data sources were used to estimate the total annual cost of illness 
among SLE patients in Singapore. Patient reported direct medical, direct non-
medical and indirect costs were collected from a cross-sectional survey of prevalent 
SLE patients under the care of a rheumatologist at the Singapore General Hospital 
(SGH). SGH is the largest tertiary acute hospital in Singapore (1,559 beds) and a 
tertiary referral centre for the treatment of SLE. The second data source was hospital 
finance records, which were analyzed to estimate direct medical costs incurred at the 
institution for the surveyed patients. As these costs are a sub-component of direct 
costs and expected to be more accurate than available through patient recall, 
database estimates were combined with patient reported data to calculate total costs. 
Separately, to provide more robust direct medical cost estimates, a database analysis 
of hospital finance records for a larger SLE sample over an extended five-year 
period was conducted. Both the survey study and database analysis were approved 





Database sample  
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Medical records of patients from a SLE patient database maintained by the 
Department of Rheumatology and Immunology at SGH were reviewed for the earliest 
documentation of an established SLE diagnosis. Data were retrieved without direct 
contact with patients in this part of the study.  Patients were included in the analysis if 
their diagnosis of SLE was established before July 2010, fulfilling at least four 1982 
Revised American College of Rheumatology (ACR) criteria for the diagnosis of SLE. 
(E. M. Tan et al., 1982) There was no age limits for inclusion in the study. Written 
informed consent was waived as this is a retrospective database analysis. Hospital 
finance records for services utilized between July 2006 and June 2011 were included 
in the analysis. Patients diagnosed with SLE before 2006 would provide the complete 
data for five years, while for patients diagnosed from 2006 to 2010, only data in the 
years subsequent to diagnosis were included in the analysis.  Therefore, each patient 
would provide 12 months’ data at minimum. A patient who died or was known to be 
lost to follow-up before July 2010 was removed from analysis in the year(s) 
subsequent to reported death or lost to follow-up.  Also, a patient who satisfied all the 
above criteria but incurred no charges throughout the eligible follow-up period was 
removed from the analysis. Removing these patients and follow up periods from 
analysis was expected to yield a higher but more accurate annual cost estimate. As the 
cost estimate was calculated as an annualized average cost over five years, it was 
necessary to remove data periods subsequent to a known death or loss to follow up. 
Patients who incurred no charges throughout the eligible follow-up period were also 
deemed to be lost to follow up. As eligible patients were identified through database 
records, this criterion excluded patients who are no longer actively followed-up at the 
institution but not documented as lost to follow-up. As SLE is a chronic illness that 
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requires regular follow-up even during stable disease, it was assumed that patients 
who did not make at least one visit were lost to follow up.  
 
 
Survey sample  
 
The sample recruited for the survey was a sub-set of prevalent SLE patients 
included in the SLE database described above. SLE patients from the database who 
were attending an outpatient rheumatology clinic, or inpatients warded under the care 
of a rheumatologist at SGH were invited to participate if they were (i) 21 years old 
and above, (ii) fulfilled a minimum of four 1982 Revised ACR criteria for the 
diagnosis of SLE and (iii) were diagnosed for a minimum of 12 months. Recruited 
patients completed the study from October 2010 to June 2011. Informed consent was 
obtained before commencing the survey and the survey was administered by an 
interviewer in either English or Chinese.  
 
Data Sources  
 
Hospital Finance Databases  
 
Hospital finance databases recorded administrative detail of healthcare 
services utilized and the associated costs. Four types of healthcare visits were 
distinguished in these databases: outpatient, inpatient, day surgery and emergency 
room visits. Outpatient visits could involve or exclude a physician consultation, such 
as visits that were solely for laboratory or investigative procedures. Administrative 
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detail of visits, including visit date, visit type (physician consultation or ancillary 
services), and length of stay (for inpatient stays) were available. Basic demographic 
information of patients was also available from the databases.  
 
The true costs of hospital services were estimated from hospital charges 
available from the finance databases. As the hospital adopted a 1.0 cost-to-charge 
ratio for billing of hospital services, charges before taxes and subsidies were 
assumed to represent the true cost of services. Charges were decomposed into 
individual service categories. Item-level descriptions of each service or item charged 
was also available for outpatient services. The service categories for outpatient costs 
were professional fees (physician and other healthcare professionals), laboratory 
investigations, imaging (magnetic resonance imaging (MRI) and X-Ray), 
specialized investigations, procedures, drugs, consumables, medical supplies and 
miscellaneous services and non-treatment charges.  The service categories for 
inpatient costs were similar, with the following additional cost categories: daily fee, 
ward fee, facility fee, implants and ward procedures. In this study, all hospital 
charges and reported costs were included in the analyses without specific attribution 
to SLE. The challenge in disease-specific attribution of health resource use and 
productivity losses in studies among SLE patients has been recognized, due to the 
wide spectrum of health problems that occur due to the disease. It has therefore been 
recommended that studies conducted among SLE patients do not estimate SLE-
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Overview of economic questionnaire 
 
An economic questionnaire was developed for this study to collect patient 
reported healthcare utilization, expenditures, productivity changes and other 
information used for the calculation of total cost. A copy of this questionnaire, 
which has not been validated in the local population, can be found in the Appendix. 
Part One of the questionnaire recorded sub-categories of direct costs. Direct costs 
are expenditures on healthcare and non-healthcare expenditures due to illness or 
disease. (Hodgson & Meiners, 1982; Mittendorf et al., 2003) Examples of healthcare 
expenditures are for hospitalizations, outpatient clinical care and care by other health 
professionals. Healthcare expenditures also include rehabilitation services, aids or 
devices to prevent or overcome illness-related impairments, and household help. 
Non-healthcare but disease-related expenditures include costs of transportation to 
health care providers and modifications of property. Compared to the database 
analysis, the patient survey would include health services utilized outside of SGH 
and would thus be more comprehensive albeit subject to recall bias.  
 
Part Two of the questionnaire recorded information on indirect costs. 
Indirect costs are the loss in output from productivity losses due to morbidity and 
mortality, usually valued monetarily as lost market wages for labor market work, 
and imputed market value of lost housekeeping services. (Hodgson & Meiners, 
1982) Two main components of indirect costs, absenteeism and presenteeism, were 
measured in this study. Absenteeism is productivity lost due to absence from work 
in terms of lost work-days or lost work hours. Presenteeism is productivity loss due 
to reduced capacity at work. (Mattke, Balakrishnan, Bergamo, & Newberry, 2007; 
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Prasad, Wahlqvist, Shikiar, & Shih, 2004) In this questionnaire, patient and patient 
caregiver loss of productivity in labor market and non-market work were recorded.  
In addition, background information of survey respondents was collected. These 
included demographic, socioeconomic, health insurance status and disease 
information (year diagnosed with SLE and presence of co-morbid conditions).  
 
Direct cost components 
 
The utilization (i.e. number of units) of medical services (outpatient clinical 
visits, inpatient hospitalizations and visits to the emergency room) was recorded 
separately from expenditure (i.e. unit cost) on these services. The recall period for 
all direct cost components was 6 months, as it was expected that SLE patients 
frequently utilized healthcare services for routine monitoring and follow-up of the 
disease. Thus, a shorter period had the advantage of a more accurate recall of the 
number of visits made. The number of visits and average expenditure per visit were 
recorded for outpatient medical services (SGH clinics, general practitioner clinics, 
polyclinics and other clinics, emergency room services and visits to healthcare 
professionals). The number of visits, length of stay and expenditure were recorded 
for inpatient hospitalizations. Utilization of services at SGH was recorded separately 
from services at other medical institutions to allow database cost estimates to be 
substituted. Other non-medical, healthcare-related direct costs were expenditures on 
ancillary healthcare services (health supplements and complementary and alternative 
medicines (CAM)), expenditures for nursing home care, home health care, day care 
facilities and aids and devices. The direct non-medical costs recorded were 
transportation to obtain health care services and home remodeling expenditures.  




Productivity losses and indirect costs 
  
 Respondents reported their employment status, i.e. whether they were 
engaged in full-time work, part-time work, retired, student, housewife or 
unemployed. Employed respondents provided further information on their 
occupation type and salary. Respondents who were not employed reported whether 
this was voluntary, involuntary due to health reasons, or involuntary due to health 
and/or other reasons combined.  
 
Absenteeism from paid, labor market work was recorded in four categories: 
days of no pay leave, days of medical leave, time off for feeling unwell and time off 
to visit the doctor. Absenteeism from housework was recorded in two categories:  
time off for feeling unwell (including the whole day off) and time off to visit the 
doctor. Presenteeism was recorded for both paid work and housework separately 
using a 10-point Visual Analogue Scale (VAS). Respondents reported how effective 
they were at work or when doing housework when their health condition affected 
their work/housework, with zero being least effective and ten being most effective. 
Respondents also reported any help received from caregivers, employment status of 
caregivers, and productivity losses of caregivers due to care provision for one’s 
health condition.   
 
Data Analysis  
 
Direct costs 




Patient reported data on utilization and expenditure were used to calculate 
annual costs for all components of direct costs, except for costs incurred at SGH. As 
the recall period was six months, costs were multiplied by two to derive annual 
estimates. For the sub-components of direct medical costs incurred at SGH, hospital 
finance data records were used instead of patient-report data. To synchronize with 
the survey recall period, database records on the survey date and up to one year 
preceding this date were extracted and analyzed for each respondent.  
 
To calculate average annualized estimates from the larger database sample 
based on five years of cost data, the total cost per patient was divided by the number 
of years of follow-up for each patient. The estimates for each cost component and 
the total cost were expressed as means with standard deviations.  Although medians 
are appropriate to describe healthcare costs which is usually skewed, mean costs are 
often reported because decision-makers are interested in total costs. (Douglasrizzo & 
Powe, 1999)  As database costs spanned a five-year period, these costs were 
adjusted for inflation using the Singapore Health Care Consumer Price Index (CPI) 
and are expressed in constant 2011 Singapore dollars. (Department of Statistics 




Three broad categories of indirect costs were quantified: (i) reduced paid 
production (of employed persons and persons unemployed due to health reasons), 
(ii) reduced unpaid production (of persons unemployed due to non-health reasons) 
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and (iii) productivity losses of patient caregivers. To calculate indirect costs, 
productivity losses due to absenteeism were monetized using the human capital 
approach (HCA). The human capital approach views human beings as assets and 
values life and health as lost production to the economy. (Zhang, Bansback, & Anis, 
2011) Thus, productivity losses are valued as the lost time multiplied by income or 
the market wage. (Prasad et al., 2004) . Productivity losses were valued according to 
self-reported employment status, and whether the respondent was involuntarily 
unemployed due to health reasons. 
 
For full-time and part-time employed respondents, reduced paid production 
was calculated in a two-step process. First, individual-reported wage rates were 
multiplied with the number of absenteeism hours to calculate absenteeism losses. 
Next, presenteeism losses were calculated by multiplying the reduction in work 
effectiveness (rated with the presenteeism VAS) with annual wages after 
absenteeism losses were accounted for.
10
  For respondents involuntarily unemployed 
due to health reasons, indirect costs were valued as reduced paid production, 
estimated using patient-reported last-drawn salaries. Finally, for respondents who 
were voluntarily not employed, or involuntarily unemployed for non-health reasons, 
reduced unpaid production (housework) was valuated as absenteeism losses and 
presenteeism losses in the same two-step process used for employed respondents. 
Instead of individual-reported wage rates, the wage rate was calculated by 
multiplying the number of housework hours reported by respondents with an  hourly 
                                                 
 
10
 Using an example of an employed respondent with an annual wage of $72,000, calculated annual 
productivity loss due to absenteeism of $8,000 , and a self-rated presenteeism score of 8 (on a scale of 
10), presenteeism losses will be calculated as follows: ($72,000 - $8,000) * [(10-8)/10]. 
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wage rate estimate for housekeeping in Singapore. This hourly rate of $12 was 
estimated from a previous COI study of rheumatoid arthritis patients recruited from 
a hospital outpatient clinic in Singapore.
11
 (Wong, Koh, Leong, Group, & Wee, 
2011) To avoid double-counting, unpaid productivity loss in persons involuntarily 
unemployed for health reasons was excluded, as this their last drawn salary had been 
included in paid production valuation. Depending on the employment status of 
caregivers reported, indirect caregiver costs were calculated in a similar manner.  
 
  
                                                 
 
11
 The wage rate was estimated by multiplying activity-specific replacement costs by the number of 
hours spent per day on five types of activities, namely household chores, cooking, childcare, caregiving 
and leisure time (included but valued at $0).  





Database Sample  
 
 Hospital records of 407 SLE patients who met study inclusion criteria for the 
database analysis were used to estimate direct medical costs at SGH. Of these, 33 
patients incurred no hospital charges in the eligible follow-up period and were hence 
removed from further analysis. The mean age of the remaining 374 patients was 45.6 
years (range: 16 – 90, median: 45 years) and the mean SLE duration was 11.0 years 
(range: 1 – 42, median: 9 years), calculated as of January 2011 (Table 6.1). Majority 
of the sample were female (88.5%) and Chinese (74.6%). 15.8% were Malay, 1.1% 
were Indian and 8.6% were of other races. Complete five-year data were available 
from 281 patients (75.1%) who were diagnosed with SLE prior to 2006 and not 
deceased or known to be lost to follow-up by 2011. Another 93 patients contributed 
between 1 to 4 years of data for this analysis (Table 6.1). In total, 1667 patient-years 
of data were analyzed from the database sample. 
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Table 6.1 Database sample characteristics (n=374) 
Characteristic Number (%)* 
Age (year)  
Median 45 
Range 16 - 90 
SLE duration (year)  
Median  9 
Range 1 - 42 
Sex  
Female 331 (88.5) 
Male 43 (11.5) 
Race  
Chinese 279 (74.6) 
Malay 59 (15.8) 
Indian 4 (1.1) 
Other 32 (8.6) 
Years of data analyzed  
1 10 (2.7) 
2 23 (6.1) 
3 34 (9.1) 
4 26 (7.0) 
5 281 (75.1) 
* Unless otherwise stated. 
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Survey Sample   
 
 127 SLE outpatients were recruited from the rheumatology clinic and 7 
inpatients were recruited from hospital wards for this study. The mean (SD) 
respondent age was 41.7 (10.6) years (range: 21 – 67, median: 40 years) and the mean 
(SD) SLE duration was 12.2 (7.2) years (range: 1 – 38, median: 10 years). (Table 6.2) 
91.0% of respondents were female, 72.4% were Chinese, 16.4% were Malay and 
7.5% were Indian. 64.2% of respondents were married and 30.6% were single.  38.8% 
of respondents had a university qualification at the bachelor level and above, 50.0% 
had a secondary or post-secondary education, and 11.2% had an incomplete 
secondary education or less.  68.7% of respondents were employed full-time or part-
time, 14.9% were homemakers and 10.4% reported themselves as unemployed. Most 
respondents were living with family members, with only four respondents reported to 
be living alone.  
 
33.5% of respondents reported their monthly household income to be $6,000 
or more, which was above the Singapore resident population median monthly 
household income of $5,600 reported for 2010. (Department of Statistics Singapore, 
2011a) 59.7% reported a household income of $6,000 or less, and 6.7% did not know 
or preferred not to disclose household income. About half of respondents (49.3%) 
lived in a public 4 bedroom flat or smaller. As a reference, 63.9% of the Singapore 
resident population live in public 4 bedroom flats or smaller. (Ministry of Trade & 
Industry Singapore, 2010) 29.1% lived in a public 5 bedroom or larger flat and 
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18.6% lived in private property.
12
 Respondents reported all the different types of 
health insurance owned. Medical expense insurance was the most common type of 
health insurance reported. 46.2% reported owning Medishield (a government-
administered, low cost catastrophic illness insurance scheme that operates on a co-
pay, deductible system) and 28.0% reported other types of private and integrated 
medical expense insurance plans (see footnote for more details on these insurance 
plans).
13
 28 respondents reported having no medical expense insurance (13.4%) and 
remaining patients did not know details or reported other types of medical expense 
insurance.   
 
Many conditions reported as co-morbidities were potentially SLE-related or 
related to SLE treatment complications. Comparing the prevalence rates of diseases 
that are also common in the general population, the rates of hypertension (18.7%), 
hyperlipidemia (10.4%) and diabetes (2.2%) observed in this sample was lower than 
the Singapore population aged 18 to 69 years.
14
 Among the reported conditions that 
were likely related to SLE or its treatment, 11 patients (8.2%)  reported renal 
dysfunction, among which 3 were on dialysis. 8 patients (6.0%) reported existing 
                                                 
 
12
 Public housing in Singapore refers to flats that are built by the government and sold to Singaporeans 
or Permanent Residents at subsidized rates, subject to a 99-year lease term. As the Housing and 
Development Board (HDB) is the government agency that develops these flats, public housing also 
refers to “HDB flats” in Singapore.  
13
 Medishield is an affordable medical insurance scheme to insure Singaporeans and Permanent 
Residents (PR) against large hospitalization costs incurred at lower class wards. The premiums for 
Medishield can be paid using funds from Medisave, the compulsory individual national medical 
savings account for citizens and PR.  In addition to Medishield, there is an option to purchase private 
Integrated Shield Plans that function as an add-on to basic Medishield coverage in order to use higher 
ward classes during hospitalizations.  
14
 The prevalence rates of hypertension, high total cholesterol and diabetes in 2010 were 23.5%, 17.4% 
and 11.3% respectively. (Ministry of Health Singapore, 2012)   
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heart disease or a history of stroke, and 7 patients (5.2%)  reported eye-related 
problems, including cataracts and glaucoma.  
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Table 6.2 Survey Sample Characteristics (n=134) 
Characteristic Number (%)* 
Age (year)  
Median 40 
Range 21 - 67 
SLE duration (year)  
Median  10 
Range 1 - 38 
Sex   
Female 122 (91.0) 
Male 12 (9.0) 
Race   
Chinese 97 (72.4) 
Malay  22 (16.4) 
Indian 10 (7.5) 
Other 5 (3.7) 
Marital status   
Single 41 (30.61) 
Married 86 (64.2) 
Separated / prefer not to say 7 (5.2) 
Education level   
None or incomplete primary 4 (3.0) 
Primary or incomplete secondary 11 (8.2) 
Secondary 36 (26.9) 
Post-secondary 31 (23.1) 
Degree and above 52 (38.8) 
Employment status   
Working, full-time 80 (59.7) 
Working, part-time 12 (9.0) 
Unemployed 14 (10.4) 
Homemaker or housewife 20 (14.9) 
Retired 5 (3.7) 




Alone 4 (3.0) 
With spouse 81 (60.4) 
With children 60 (44.8) 
With parents 57 (42.5) 
With siblings 30 (22.4) 
With extended family members 13 (9.7) 
Monthly household income   
SGD 0 - 1999 22 (16.4) 
SGD 2000 - 3999 36 (26.9) 
SGD 4000 - 5999 22 (16.4) 
SGD 6000 - 7999 14 (10.4) 
SGD 8000 and above 31 (23.1) 
Don’t know / prefer not to say 9 (6.7) 
Housing Type   
Public 1 or 2 bedroom flat  2 (1.5) 
Public 3 or 4 room flat 64 (47.8) 
Public 5 room flat 31 (23.1) 
Public executive apartment 8 (6.0) 
Private apartment 20 (14.9) 
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Table 6.2 Survey Sample Characteristics (n=134) 
Characteristic Number (%)* 
Private landed property 5 (3.7) 
Other / not specified 4 (3.0) 
Type of health insurance owned 
# α
  
Medical expense (Medishield) 66 (46.2) 
Medical expense (Integrated or Private) 40 (28.0) 
Critical illness insurance 45 (31.5) 
Disability income insurance 15 (10.5) 
Hospital cash insurance 15 (10.5) 
Long-term care insurance 8 (5.6) 
Do not know details 11 (7.7) 
Others 8 (5.6) 
Self-reported co-morbidities   
Hypertension 25 (18.7) 
Hyperlipidemia 14 (10.4) 
Renal disorderˆ 8 (6.0) 
Renal disorder (requiring dialysis)ˆ 3 (2.2) 
Heart disease / stroke history 8 (6.0) 
Eye-related problemsˆ 7 (5.2) 
Asthma & other allergy conditionsˆ 5 (3.7) 
Other cardiovascular conditionsˆ 5 (3.7) 
Thyroid disorders 4 (3.0) 
Autoimmune diseases (other than SLE)ˆ 4 (3.0) 
Diabetes 3 (2.2) 
Cancer 3 (2.2) 
Hip-Replacement 3 (2.2) 
Other conditions 10 (7.5) 
* Unless otherwise stated. 
#  
Percentage sum for these categories are not 100% as questions allow respondents to select all 
options that apply. 
α 
 The benefits of each type of insurance is described briefly: - Medical expense: covers medical 
expenses that result from accident or illness, usually including inpatient treatment and some 
outpatient charges; Critical illness: pays a lump sum after diagnosis of a critical illness or first 
surgery performed for the illness; Disability income: provides income replacement in the event 
of total or partial disability; Hospital cash: pays a fixed amount for each day warded in hospital 
regardless of actual expenses; Long-term care: pays a fixed monthly amount for long-term 
nursing treatment in the event of inability to perform a stated number of activities of daily 
living 
ˆ Indicates categories that condense one or more patient-report conditions. Renal disorder: 
kidney problems (unspecified), nephrotic syndrome, lupus nephritis; Eye-related problems: 
cataract, glaucoma, eye-problem (unspecified); Asthma & other allergic disorders: asthma, 
anaphylactic allergies, sinusitis; Other cardiovascular disorders: idiopathic thrombocytopenic 
purpura, deep-vein thrombosis, on warfarin therapy, anti-phospholipid syndrome; Autoimmune 
diseases: psoriasis, rheumatoid arthritis, chronic inflammatory demyelinating polyneuropathy 
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Direct costs  
 
Database sample  
 
 Annually, each patient made an average of 6.80 (SD: 4.23) physician 
consultation visits to the hospital’s outpatient clinics. (Table 6.3) During the eligible 
follow-up period, 27.0% of patients used emergency services at least once. 36 patients 
(9.6%) were admitted into inpatient wards and 10 patients (2.7%) were admitted for 
day surgery at least once during the follow-up period. On average across all patients, 
the annual mean visit rates (SD) to the emergency room, inpatient stays and day 
surgery were 0.29 (0.74), 0.07 (0.25), and 0.01 (0.09) respectively.  
 
 The total direct medical cost at SGH, annualized over 5 years, was estimated 
to be $2,005.36 (SD: 4563.84) per patient. (Table 6.4 ) Outpatient services 
contributed to 60.9% of costs (mean:  $1,220.62; SD: 1388.48). The two largest 
components, laboratory investigations (44.4% of outpatient costs) and professional 
fees (29.6% of outpatient costs) together comprised three-quarters of outpatient costs. 
In contrast, drug costs accounted for only 3.5% of outpatient costs. Inpatient services 
amounted to 35.6% of total medical costs at SGH (mean: $714.31, SD: 4349.75) and 
were more evenly spread across cost components as listed in Table 6.4. Ward and 
facility fees comprised the largest component (24.8% of inpatient costs), followed by 
laboratory investigations (19.4%) and drug costs (12.2%).   
  
Chapter 6. Economic burden of SLE in Singapore  Ow, YL Mandy 
211 
 
Table 6.3 Number of visits to a tertiary medical institution per patient annually, 
unless stated otherwise* (n=374) 




Mean, SD Range 
Outpatient physician consultation 372 (99.5) 6.80 (4.23) 0-28.33 
Emergency room 101 (27.0) 0.29 (0.74) 0-7.33 
Inpatient 36 (9.6) 0.07 (0.25) 0-2.0 
Day surgery 10 (2.7) 0.01 (0.09) 0-1.0 
* Annual mean visits are calculated by averaging the number of visits per year over 
the number of years of data used for each patient.  
#  
Number of patients who utilized the specified health service at least once during 
the entire follow-up period  
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Table 6.4 Annual medical costs per patient at a tertiary medical institution 
(n=374) 







Emergency Room 60.52 (158.47) 3.0 0 - 1506.86 
Day Surgery 9.91 (82.72) 0.5 0 - 992.74 
Outpatient Services 1220.62 (1388.48) 60.9 0 - 18166.68 
Laboratory investigations 542.56 (389.35) 44.4 0 - 2768.57 
Professional fees 360.79 (209.87) 29.6 0 - 1397.95 
Imaging (MRI & Xray) 106.26 (174.27) 8.7 0 - 1260.81 
Procedures  51.92 (449.98) 4.3 0 - 8108.17 
Specialized investigations 49.63 (112.81) 4.1 0 - 1842.08 
Drugs 43.26 (259.68) 3.5 0 - 3399.63 
Miscellaneous services 41.95 (481.11) 3.4 0 - 9227.53 
Consumables & medical 
supplies  
24.24 (306.42) 2.0 0 - 5604.04 
Inpatient Services 714.31 (4349.75) 35.6 0 - 58690.73 
Ward & facility fees 176.94 (910.80) 24.8 0 - 10158.47 
Laboratory investigations 138.85 (943.93) 19.4 0 - 14749.92 
Drugs 87.38 (777.72) 12.2 0 - 13121.34 
Specialized investigations 67.77 (724.10) 9.5 0 - 13367.81 
Consumables, medical 
supplies  and implants 
55.01 (391.34) 7.7 0 - 6337.22 
Daily fee 45.30 (237.68) 6.3 0 - 2297.04 
Imaging (MRI & Xray) 44.03 (283.71) 6.2 0 - 3691.61 
Procedures (ward & other) 37.81 (305.90) 5.3 0 - 4513.25 
Professional fees 27.52 (134.03) 3.9 0 - 1426.09 
Others 26.78 (383.78) 3.7 0 - 7346.15 
Miscellaneous services 6.92 (55.13) 1.0 0 - 822.10 
Total medical costs at SGH 
2005.36 (4563.84) 100.0 
12.86 - 
60170.07 
* Mean costs are calculated by averaging costs per year over the number of years of 
data used for each patient.  
# 
Percentages of sub-total costs are expressed in italics beneath each sub-total.   
  





 The utilization of medical services at SGH among surveyed patients were 
generally higher than the database sample. The mean one year utilization rates (SD) of 
outpatient clinic visits, emergency room and inpatient stays at SGH were 7.31 (4.73), 
0.62 (1.97) and 0.27 (0.97) visits, respectively. (Table 6.5) However, the total one-
year treatment costs at SGH for the 134 surveyed patients was very similar to the 
database sample at SGD $2,084.57, with $1,276.36 (SD: 1516.55) as outpatient costs 
and $736.99 (SD: 2509.40) as inpatient costs. The percentage contributions of 
outpatient costs and inpatient costs were also very similar between the survey and 
database samples (61.2% vs. 60.9% and 35.4% vs. 35.6%, respectively). 
 
Medical costs at SGH amounted to 85% of costs reported for medical services 
obtained at all institutions reported by survey respondents. Among the additional 15% 
spent on medical care at other institutions, majority of the expenditure was for 
outpatient clinic visits, such as for regular eye check-ups at a specialist eye clinic 
(mean: $258.16, SD: 1191.01). Including reported visits to other medical institutions, 
the average number of visits to any outpatient clinic in one year was 11.9 visits. 18 
patients reported one or more inpatient hospitalizations at any hospital in the 
preceding 12 months (hospitalization rate: 13.4%, range: 1 to 6 hospitalizations). 
These expenditures and medical services utilization constitute the 15% of medical 
care costs incurred at other institutions that would have be under-estimated without 
the use of patient survey. Summing up costs incurred at all medical institutions, 
outpatient costs were more than double of inpatient costs (42.0% v. 19.1% of direct 
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costs). The total cost for medical services was $2458.84, accounting for 63.6% of 
total direct costs.  
 
The second largest component of direct cost, after direct medical costs, was 
ancillary healthcare services (30.7% of direct costs). This category comprised visits to 
non-medical health care professionals (19.5%), which included physiotherapists, 
occupational therapists, pharmacists, podiatrists, etc., the use of health supplements 
(6.3%), and the use of complementary and alternative medicine (4.9%). Other 
healthcare-related expenditures were home health care (paid help) (3.5%), and nursing 
home care and aids or devices, which together contributed minimally (0.05%) to 
direct costs. Finally, non-healthcare expenditures amounted to 2.1% of total direct 
costs.  In this category, most expenditures were transport costs, whereas expenditures 
for home re-modeling were minimal (0.03%) and reported by only one patient. 
Among the components that contributed minimally to direct costs, low expenditures 
for aids and devices (0.27% and 0.76%), (Sutcliffe et al., 2001; Zhu et al., 2009) and 
home remodeling (0.16%) (Zhu et al., 2009) were also reported in previous SLE COI 
studies that recorded these cost components. 







Table 6.5 Annual direct costs and utilization of healthcares services of survey sample* (n=134) 






Mean Visits, SD 







Range of costs 
Medical services    (63.6)   
Outpatient services    (42.0)   
   SGH 134 (100.0) 7.31 (4.73) 1276.36 (1516.55) 33.0 169.80-15230.85 
   General practitioner 59 (44.0) 2.37 (3.06) 71.62 (120.97) 1.9 0-600.00 
   Polyclinic 21 (15.7) 0.81 (3.40) 22.67 (102.29) 0.6 0 - 810.00 
   Other clinics 43 (32.1) 1.40 (3.31) 258.16 (1191.01) 6.7 0 - 10000.00 
Emergency room    (2.4)   
   SGH 26 (19.4) 0.62 (1.87) 71.22 (200.37) 1.8 0-1179.50 
   Non-SGH institutions 6 (4.5) 0.53 (1.72) 20.60 (147.69) 0.5 0 - 1600.00 
Inpatient   (0.0)   (19.1)   
   SGH 22 (16.4) 0.27 (0.97) 736.99 (2509.40) 19.1 0-15977.42 
   Non-SGH institutions 4 (3.0) 0.06 (0.34) 1.22 (13.82) 0.0 0 - 160.00 
Ancillary healthcare services    (30.7)   
   Healthcare professionals 10 (7.5) 0.84 (3.84) 754.39 (8291.75) 19.5 0 - 96000.00 
   Health supplements 46 (34.3) - 244.21 (552.70) 6.3 0 - 4200.00 
   Complementary and alternative 
medicines 27 (20.1) 
- 
189.00 (687.55) 4.9 0 - 4200.00 
Other healthcare expenditures    (3.55)   
Home health care (paid help) 3 (2.2) - 133.43 (894.33) 3.5 0 - 6840.00 
Day care facilities 0 (0.0) -  - -  - 
Nursing home care 0 (0.0) -  - -  - 
Aids or devices 2 (1.5) - 1.84 (19.91) 0.05 0 - 230.00 
Non-healthcare expenditures     (2.1)   







Table 6.5 Annual direct costs and utilization of healthcares services of survey sample* (n=134) 






Mean Visits, SD 







Range of costs 
Transport costs to healthcare services 127 (94.8) - 80.03 (134.32) 2.1 0 - 1283.40 
Home re-modeling  1 (0.7) - 1.12 (13.0) 0.0 0 – 150.00 
Total direct costs   3862.86 (9037.68) (100) 422.01-96871.48 
* Utilization and costs are estimated from patient self-report for all cost categories except for services at SGH. Utilization and costs of 
SGH services are determined from hospital databases. SGH: Singapore General Hospital. 
#  
Number of patients reporting any utilization / expenditure.  
^ 
All percentages are expressed as percentages of total costs.  Sub-totals are expressed in parentheses.  
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Valuing productivity losses – indirect cost  
 
Among the 134 surveyed SLE patients, 92 respondents (68.7%) were 
employed at the time of the interview. 23 of the 42 unemployed respondents reported 
that they were involuntarily unemployed for health reasons. Among them, ten 
respondents reported their employment status to be unemployed (seeking 
employment but unable to find work), nine respondents were housewives and four 
respondents were retirees.   
 
 Using the HCA to value productivity losses, most indirect costs (95.3%) were 
valuated as losses from paid production of the patient, 4.4% were losses from unpaid 
production of the patient, and only 0.2% of losses were due to reduced caregiver 
productivity. (Table 6.6) As Table 6.6 presents mean indirect costs averaged over the 
patient sample, the percentage contribution by each indirect cost component is 
influenced by the number of respondents contributing to that category. Therefore, 
relative contribution ratios are also calculated to describe how costs are distributed 
across patients. For example, the relative contribution ratio (2.7) was largest for 
involuntarily unemployed respondents, as 17.3% of the sample contributed 
approximately 45.8% of the indirect costs. 
 
In the remaining respondents, indirect costs were valued as productivity losses 
due either to absenteeism or presenteeism. Overall, presenteeism costs were 
approximately double absenteeism costs (presenteeism vs. absenteeism: 36.7% vs. 
16.9% of indirect costs). Presenteeism costs exceeded absenteeism losses among the 
full-time employed and those engaged in unpaid production. However, among the 
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part-time employed, absenteeism and presenteeism losses were approximately equal. 
In terms of the 10-point presenteeism VAS ratings, the mean scores for full-time 
employed, part-time employed and those valuated for unpaid production were not 
significantly different (full-time paid production vs. part-time paid production vs. 
unpaid production mean VAS rating: 8.14 vs. 7.42 vs. 7.06; one-way ANOVA: 
p=0.099).   
 
Reported productivity losses of caregivers was also very low, with only five 
patients reporting having caregivers taking time off paid work to provide care, 
estimated to contribute 0.2% of total indirect costs. Caregiver productivity losses are 
rarely included in SLE COI studies, (Zhu et al., 2011) but in one study, it was 
reported that one-third of the study sample required caregiver assistance. (Aghdassi 
et al., 2011) However, this study cohort could have represented a more severely ill 
population, with 56% fulfilling the criteria for lupus nephritis, as the study objective 
was to compare between SLE patients with and without lupus nephritis. In the 
current study, the total indirect costs was estimated to be $12, 859.72 (SD: 












Table 6.6 Mean annual indirect costs of survey sample (n=134) 
Indirect cost component n (%)* 
Mean Indirect Cost 
(SGD), SD 









n to Indirect 
Cost
^ 
Reduced paid production       
Full-time employed 80 (59.7)  (38.8)  0.6 
Medical leave  832.29 (2583.68) 6.5 0 – 19503  
No-pay leave  276.80 (2596.33) 2.2 0 – 29700  
Time-off  304.22 (515.96) 2.4 0 - 1950.30  
     Presenteeism  3573.39 (6261.18) 27.8 0-34875  
Part-time employed 12 (9.0)  (10.7)  1.2 
Medical leave  302.80 (1780.40) 2.4 0-17550  
No-pay leave  248.45 (2060.12) 1.9 0-22750  
Time-off  135.70 (599.02) 1.1 0-4260.60  
     Presenteeism  692.63 (3348.39) 5.4 0-10401.60  
Involuntarily unemployed due to health 
reasons 
23 (17.2) 5893.76 (13088.90) 
(45.8) 0-35134.74 2.7 
Reduced unpaid production 17 (12.7)   (4.4)   0.3 
Whole day off  43.58 (382.64) 0.3 0 - 4320  
Time off  75.76 (786.06) 0.6 0 - 9072  
         Presenteeism  449.96 (2013.69) 3.5 0-13140  
Caregiver productivity loss   (0.2)   
Full-time employed 4     
No-pay leave  0.56 (6.48) 0.0 0 - 75  
Paid leave  26.57 (263.28) 0.2 0 - 3000  
Time-off  0  0  







Table 6.6 Mean annual indirect costs of survey sample (n=134) 
Indirect cost component n (%)* 
Mean Indirect Cost 
(SGD), SD 









n to Indirect 
Cost
^ 
Part-time employed 1     
No-pay leave  3.23 (37.44) 0.0 433.40 - 433.40  
Paid leave  0 0.0 -  
Time-off  0 0.0 -  
Currently unemployed due to 
respondent’s health condition 
0 0 0.0 -   
Total indirect costs  12,859.72 (13,469.12) 100.0 0 - 69498  
* Indicates number of respondents included in each indirect cost component calculation 
#  
Percentages of sub-totals and total estimates are indicated in parentheses 
^ 
Calculated as the ratio of (% of total indirect cost) to (n % contributing to this cost component)   





This cost-of-illness study provided the first estimate of the economic burden 
of a multi-ethnic Asian SLE patient population followed up in a tertiary medical 
institution in Singapore. Cost components relevant to a societal perspective and their 
relative contributions to total costs were estimated. The annual total cost of SLE 
determined from this sample of SLE patients was estimated to be S$16,722.58 (95% 
CI: $13,813.82 to $19,635.01), with indirect costs (76.9%) exceeding direct costs 
(23.1%). From the estimated SLE prevalence rate of 40 per 100,000 in Singapore, 
and a resident population size of 3.79 million in 2011, the economic burden of SLE 
to Singapore society is calculated to be approximately $25 million annually. 
(Department of Statistics Singapore, 2011b; Edwards, 2001) Although per-patient 
annual costs were higher in SLE patients than in patients with rheumatoid arthritis 
(S$3,770) and Parkinson’s disease (S$11,345), the overall economic burden in 
Singapore due to SLE was lower than both diseases because of a lower SLE 
prevalence rate (annual economic burden estimated to be S$49.8 million in 
rheumatoid arthritis and $26-$46 million in Parkinson’s disease). (Xie et al., 2007; 
Zhao et al., 2011) The prevalence rate, per-patient costs and overall societal burden 
of chronic hepatitis B also exceeded that of SLE (annual economic burden of $418.5 
million). (Ong, Lim, & Li, 2009)  Medical costs were the bulk of direct costs (63.3%) 
and outpatient costs were double of inpatient costs. Losses due to involuntary 
unemployment for health reasons was the largest proportion of indirect costs 
(45.8%), followed by presenteeism losses (36.7%)  and absenteeism losses (16.9%)  
This study was also the first in SLE patients to include presenteeism losses in 
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valuating indirect costs. Overall, presenteeism losses accounted for about twice the 
amount of indirect costs as did absenteeism losses.  
 
Up to three-quarters of direct costs ($3862.86) are potentially borne by SLE 
patients as the following cost categories are likely to be out-of-pocket expenses: 
outpatient medical costs (42.0% of direct costs), ancillary healthcare services (30.7% 
of direct costs) and other healthcare and non-healthcare expenditures (3.6% of direct 
costs). Although 74.2% of the study sample reported medical expense insurance 
coverage, the Medishield insurance owned by the majority covers inpatient charges 
but not outpatient charges. Only 28.0% of patients reported additional private 
coverage, which may cover outpatient charges. Therefore, outpatient charges are 
likely to be out-of-pocket expenses for this study sample. Using the median wage of 
$3,249 for full-time employed residents in Singapore as a reference, the estimated 





Although all indirect cost components valuated with the HCA are relevant 
from a societal perspective as economic losses in production, some components are 
not relevant from the patient or the company perspective. (Zhang et al., 2011) In 
general, involuntary unemployment and no-pay leave are relevant costs to patients 
because they represent lost income, whereas presenteeism costs and medical leave 
absences are relevant costs to companies, and not to patients in the short-term. In the 
                                                 
 
15
 The SGD3,249 Median Gross Monthly Income From Work of Full-Time Employed  Residents 
($)(Ministry of Manpower Singapore, 2012) 
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long-term, however, other penalties to the patients may arise, such as fewer 
opportunities for promotion and advancement, but such costs are not valuated with 
the HCA. (Zhang et al., 2011) Therefore, in this study, the largest indirect cost 
component of lost wages due to unemployment is relevant from both the societal and 
patient perspective. In a study of SLE patients in Hong Kong, it was also reported 
that from the patient perspective, most indirect costs in SLE stem from permanent 
work disability. (Zhu et al., 2009)  
 
Considering only absenteeism and presenteeism costs, presenteeism costs amounted 
to 68% of these costs. This percentage is close to the 70% estimated in a study among 
rheumatoid arthritis (RA) that measured presenteeism with three different measures. 
(Braakman-Jansen, Taal, Kuper, & van de Laar, 2011) However, this study also 
highlighted a risk of over-estimating presenteeism costs by between 23% to 50%, as 
matched controls without RA did not report optimal productivity as well. Therefore, 
presenteeism costs in this study are also likely to be upper-bound estimates. Other 
sources of bias are also possible with the approach of measuring presenteeism used in 
this study. First, as patients were asked to report their effectiveness in the past 12 
months, there is a recall bias that favors recall of more recent experiences than distant 
experiences. Serious episodes are also more easily recalled than mild episodes, which 
presents a bias when patients are asked to report average effectiveness over a time. 
This self-report measure is also subjective and has also not been validated against 
objective measures of productivity, such as call centre output or supervisor ratings. A 
subjective, self-rated measure may be biased because patients with chronic illness 
could have adapted to perceive lower levels of productivity as normal.  
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Compared to previous COI estimates of SLE populations, the direct medical 
cost estimated in our study when converted to US currency (US$1,956.66) (see 
footnote for exchange rate used in conversion) was about half of lowest published 
estimates, which range from US$3,735 to US$14,410.
16
  The relative contributions of 
medical cost components were also different when compared to large database cost 
studies in the US. In this review, the contributions were 14 – 50% from outpatient 
costs, 24 – 56% from inpatient costs, and 19 – 30% from pharmaceuticals costs. 
(Slawsky et al., 2011a) Re-categorizing current database estimates, the relative 
contributions were 59.4% (outpatient), 30.6% (inpatient) and 6.5% 
(pharmaceuticals). Therefore, SLE patients in this study incurred comparatively more 
outpatient costs, and less inpatient and drug costs. To enable comparison of indirect 
costs with previous estimates, presenteeism costs were excluded as previous studies 
did not include such costs. The indirect cost estimate of US$6,483.11 is within the 
range of previous estimates calculated with the HCA (US$4,188 to US$14,614), 
(Zhu et al., 2011) Also, the finding that indirect costs exceed direct costs was in line 
with majority of previous studies. (Zhu et al., 2009)  
  
This study has several limitations. First, a small survey sample was used to 
estimate total cost, which is known to be skewed and variable. (Briggs & Gray, 1998) 
The large inter-individual variation reported in previous SLE cost studies is also 
observed with the large standard deviations observed in current cost estimates. 
                                                 
 
16
 The average 2011 exchange rate of Singapore Dollar (SGD) 1.2556 = US Dollar (USD) 1.000 was 
used for conversion, obtained from Annual Average Rates of Exchange [2011] published by the Inland 
Revenue Authority of Singapore (IRAS).      
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Second, SLE patients recruited for the survey were mostly outpatients from the 
rheumatology clinic. Thus, these patients are not representative of all SLE patients 
seen at the hospital or in Singapore. Comparing medical costs estimated from the 
database and survey samples, the magnitude of these estimates were similar 
(database vs. survey sample mean cost (SD):  $2005.36 (4563.84) vs. $2,084.58 
(3523.44) ). However, the standard deviations from the database sample were higher, 
indicating more variability in costs. Also, the survey sample utilized more services in 
terms of visits to the outpatient clinics, emergency rooms and hospitalizations in spite 
of similar overall costs. Therefore, the survey sample was likely to be more 
homogenous in terms of their healthcare resource utilization and costs.  
 
The third limitation was that cost estimates presented in this study were not 
specifically attributable to SLE. Although specific attribution of costs to SLE is not 
recommended, (Gordon & Clarke, 1999; Panopalis & Clarke, 2006) two previous 
studies adopted an alternative approach of computing incremental costs by 
comparing SLE patients to a general population, (Clarke et al., 1993) or with 
matched samples without SLE. (Carls et al., 2009) These are feasible approaches to 
consider for future studies if more refined estimates are needed. Finally, as clinical 
indicators of disease activity and severity were not collected in this study, cost 
estimates cannot be directly compared to previous COI estimates. Standardized, 
physician-completed disease indices of SLE activity and severity, such as the  SLE 
Disease Activity Index (SLEDAI) and the SLICC-ACR damage index (SLICC-DI), 
are not collected in routine clinical practice at SGH.  Based on other available sample 
characteristics, the mean age of 41.7 years and mean disease duration of 12.2 years of 
our sample was comparable to SLE patient characteristics from previous studies, 
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estimated to be approximately 40 years and ranging from 8.6 to 13.7 years 
respectively. (T.Y. Zhu, L.S. Tam, & E.K. Li, 2012) Most of the studies including 
patient-report data were also clinic-based cohorts, (Clarke et al., 1993; Clarke et al., 
2000; Clarke et al., 2004; Clarke et al., 1999; Huscher et al., 2006; Sutcliffe et al., 
2001) and only one study recruited from community sources. (Panopalis et al., 2008) 
Clinical information was also not reported by the database studies. (Carls et al., 2009; 




The current COI study of SLE patients in Singapore has identified the 
significant contributors of illness-related costs. First, these findings suggest that 
much of direct costs are borne by SLE patients as out-of-pocket expenditures. 
Furthermore, a significant component of indirect costs, lost income due to 
involuntary unemployment, is relevant from the patient perspective. These estimates 
can draw the attention of healthcare providers to the patients who directly bear a 
significant burden of these productivity losses. Second, when compared to previous 
studies of SLE patients, a unique pattern of outpatient utilization that exceeded 
inpatient utilization of medical services was observed, with an overall lower direct 
medical cost estimate. Direct medical cost estimates and healthcare utilization 
patterns are useful to health care administrators, providing information about current 
cost drivers that may help planning of future healthcare spending. Third, this study is 
the first among SLE COI studies to incorporate presenteeism costs in valuating 
indirect costs. The finding that presenteeism costs exceeded absenteeism costs 
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suggest that these costs should be included in future measures or frameworks 
developed to measure and value productivity losses in the SLE population.  
  





The Singapore General Hospital approved requests for the use of financial and 
other administrative data in this study. Ms. Esther Poo, Infotech for Electronic 
Medical Records at Singhealth, Mr. Set Kuo Lik (Senior Systems Specialist) and Ms. 
Lau Ming Ling (Senior Systems Manager) at Integrated Health Information Systems 
Pte Ltd (iHiS) reviewed data requirements and extracted hospital finance and 
administrative data. The cost survey used in this study was adapted from existing cost 
questionnaires being used by the Singapore Pharmacoeconomics and Outcomes 
Research (SPORE) research group. Ms. Tan Yan Lin, support staff at NUS, translated 
the cost questionnaire into the Chinese language. Prof. Fong Kok Yong, Prof. Julian 
Thumboo and Dr. Chong Yong Yeow identified and introduced suitable patients to 
this study. Ms. Connie Tse (Research Nurse), Ms. Tan Yishan (Rheumatology 
Specialty Nurse), Annieta, Christine and other clinic nurses at SGH were 
indispensible in patient recruitment at the busy clinics. Study participants, both at the 
outpatient clinics and inpatient wards, completed a series of questionnaires. Ms. 
Shanti Tan and Mr. Avjeet Singh, former Management Support Officers at NUS, 
helped with patient recruitment and the administration of study surveys. Mr. Choy 
Zheng Xuan and Mr.Melyvn Kee performed data-entry for the survey responses. Ms. 
Jinny Foo, Research Assistant at the National University Hospital (NUH), assisted 
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As the main findings and study limitations were addressed in the discussion of 
each chapter, Chapter 7 discusses the significant contributions of this thesis toward 
addressing knowledge gaps and the directions it has provided for future research.  
 
First, as none of the extant HRQoL instruments were developed with input from 
SLE patients in Singapore during the item generation phase, the focus groups that 
identified relevant areas of HRQoL were essential to the development of an 
instrument with content validity in this population (Chapter 2). As it was also the first 
focus group study among SLE patients from an Asian socio-cultural context, study 
findings likely represent and add to the growing qualitative evidence on cross-cultural 
differences in HRQoL.  
 
Through the difficulties encountered in developing a SLE-specific item bank from 
the generic PROMIS bank, this thesis has identified important directions for future 
research (Chapter 3). These directions are important because the investigated 
approach of using PROMIS items as a core set of items for a disease-specific bank is 
novel and has not been employed outside of the PROMIS network. One research 
direction identified was to investigate whether fatigue is indeed conceptualized 
differently in SLE patients, thus requiring a different conceptual model from the 
general population for accurate measurement. More generally, these findings 
highlight that the feasibility of using generic banks for disease-specific assessment 
should be further evaluated before a similar bank development approach is adopted.  
 
This thesis also presented the first evaluative study of the negative effects of 
group interaction on focus groups intended to elicit concepts for HRQoL instrument 
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development (Chapter 4). This work is useful and timely, especially with the recent 
emphasis on focus groups as a method to elicit patient input in PRO instrument 
development and in the absence of recommendations for addressing this known 
limitation of focus groups.  The set of newly developed methods and framework 
presented in this thesis can be further evaluated with more empirical focus groups in 
future. Focus groups that are analyzed as they are ongoing provide particularly strong 
evidence of validity of these methods, as hypotheses about the postulated effects of 
interaction can be tested in subsequent focus groups. Furthermore, through a 
comparison of numerous extant HRQoL instruments, this thesis has also identified the 
opportunities in selected instruments that can be further evaluated to improve HRQoL 
assessment in SLE patients (Chapter 5). 
 
Finally, the current socioeconomic burden of disease among SLE patients in 
Singapore was described in this thesis. Characteristics of patients who might bear 
more of the economic and humanistic burden were identified, so that attention of 
health care providers and planners might be drawn to them. Relative to other SLE 
populations, a low overall disease burden was found in this study sample. As the 
current work is limited by the cross-sectional study designs, the lack of clinical 
information, and majority recruitment from outpatient sources, these findings can be 
used to formulate a hypothesis that can be tested in future studies with greater 
methodological rigor. This would be to prospectively evaluate costs and a spectrum of 
health outcomes to determine whether comparable clinical and humanistic outcomes 
can be achieved with a relatively lower economic burden, especially since a unique 
pattern of healthcare utilization has been identified in this thesis. 
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Thematic analysis of themes descriptive of an impact on HRQoL (Chapter 2) 
 
Physical symptoms 
Fatigue, pain and sleep disturbance were domains each comprising specific sub-
themes. Tremors, weakness, pain occurring at specific locations, decreased interest in 
sex, and changes in appearance were grouped together into the domain “Other 
symptoms”. These symptoms were described by a very small number of participants 
and did not comprise more than two sub-themes. Fatigue, pain, weakness, and 
decrease in sex drive were specifically attributed to SLE disease. Sleep disturbance, 
weight gain and tremor were identified by participants to be side effects of medication 
they were taking for SLE.  
 
Activities  
Limitations in activities of daily living (ADL) were attributed to disease 
manifestations, such as being bedridden or having unbearable joint paint. ADLs 
described included basic tasks such as climbing up stairs, dressing oneself or going to 
the bathroom.  
 
Limitations in physical and recreational activities (excluding ADLs), such as sports 
and household chores, were also affected by fatigue, weakness, pain and other disease 
manifestations. In addition, many of these limitations were described by participants 
as a means of coping with the disease, rather than the inability to perform these 
activities. The reasons why participants self-imposed these restrictions include 
adherence to doctor’s advice not to do vigorous exercise, fear of sustaining injuries, 
avoiding the sun, and to avoid placing stress on the body to prevent a disease flare.  
      
260 
 
Participants also reported a change in social activities as a result of long-term 
hospitalization, fatigue, the need to avoid the sun and simply not wanting to go out. 
Reasons cited for “not wanting to go out” were changes in appearance, feelings of 
depression, and discrimination by the public. The need to avoid the sun was cited as a 
reason for restrictions in the type (e.g. beach parties, outdoor sports) and timing of 
social activities that they could participate in. 
 
Social life 
The sub-theme “family” was recurrent and was applied as both an impact and a factor 
affecting emotional states. As an impact on family life, participants described lupus as 
affecting their specific roles in the family. These effects are difficulties in 
childbearing, inability to take care of the children and family, and inability to fulfil 
their husband’s sexual needs. Participants also reported “taking it out” out family 
members, especially their husbands, during their mood swings.  As an effect on 
emotional states, “family” played an important part as well. Participants described 
emotional states of sadness and loneliness as a result of the lack of family member’s 
lack of understanding of the disease. Similarly, the sub-theme “relationships” 
(relationships excluding family) were affected as participants reported mood swings 
and being hot-tempered as affecting their relationships with others. 
 
Emotional State 
Participants discussed feelings of anger over the effects of lupus, including not being 
able to have a child, the loss of freedom in activities and frustration of weight gain. 
Feelings of depression were recounted as participants described periods of severe 
pain, dependence on others, worsening of the disease state and keeping of disease to 
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oneself. Feelings of sadness were expressed when they felt they were a burden to 
others, the lack of understanding by others, the inability to fulfil family roles and in 
general about having the disease and the need to take medication. Participants also 
expressed worry about inability to fulfil family roles, the loss of family support, work 
prospects, disease flares and side effects of medications in the future. Other emotional 
states described by participants include feelings of loneliness, mood swings and stress 




Self-image was a common topic in all the focus group sessions. Participants identified 
both disease causes (hair loss, rash and pimples) and side effects of medication 
(bloated, puffy face, weight gain) as contributors to a poor self-image. Apart from the 
words “ugly”, “fat” or “heavy”, participants used interesting descriptors to portray 
their self-image, including “humpty-dumpty” (bloated and weight gain) ,“Shrek” 
(puffy face), and having “fat clothes and  thin clothes” (bloated and weight gain)’.  A 
poor self-image also contributed to an emotional state of sadness, withdrawal from 
social activities and a poor self-esteem.  
 
Self-esteem, as a separate theme, was also negatively affected by the need to depend 
on others for ADLs. Participants also described themselves as feeling like a burden to 
family members in terms of being a financial burden and the need to be taken care of.  
Discrimination was a recurring theme and was reported in three different contexts. 
First, respondents reported being discriminated by the general public, such as being 
gawked or stared at, as a result of an altered physical appearance due to rashes, hair 
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loss, puffiness or a bloated face. Second, the lack of understanding of the disease by 
family members resulted in discrimination as they feared that lupus was contagious. 
When coding for the theme “discrimination”, coders also differentiated between 
actual and potential discrimination (perceived by participants). In the third context, 
discrimination at work, actual discrimination included being retrenched or sacked 
because of the constant need to take medical leave. Potential discrimination at work 
was described by participants who feared that declaration of lupus in job applications 
would affect their chances of getting a job.    
 
The loss of freedom was reported by participants when performing social, physical 
and recreational activities and diet. Specifically, the loss of freedom was due to the 
need to avoid the sun and the fear of triggering a disease flare. Participants reported 
needing additional considerations before doing anything, as well as the worry causing 
less enjoyment when they did do certain activities.  
  
Patients also reported an impact having lupus on work in several ways. First, fatigue 
prevented participants from working normally long hours and also manifested as the 
lack of enthusiasm at work. Second, the fear of a relapse affected work life in two 
ways. Participants who identified stress as a disease trigger described themselves as 
knowing not to work as hard and to “go slower”. Participants whose job duties 
involved being out in the sun acknowledged that they were not able to do the full 
range of duties. Third, participants felt that the need to take medical leave and time 
off to visit the doctor would leave a bad impression on the employers and were 
worried about being sacked or retrenched. Fourth, participants were concerned about 
gaining employment. One described her reluctance to change jobs for the fear of 
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losing medical benefits and another feared having reduced chances of finding 
employment because of having lupus.
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Table A1. Items and response options of the PROMIS-based SLE fatigue item bank (PROMIS and PLUS Items) 
α
 











AN1 I feel listless ("washed out") … Not at all A little bit Somewhat Quite a bit Very much 
AN12 I am too tired to eat … Not at all A little bit Somewhat Quite a bit Very much 
AN14 I need help doing my usual activities…… Not at all A little bit Somewhat Quite a bit Very much 
AN15 I am frustrated by being too tired to do the things I want to do … Not at all A little bit Somewhat Quite a bit Very much 
AN16 I have to limit my social activity because I am tired … Not at all A little bit Somewhat Quite a bit Very much 
AN2 I feel tired … Not at all A little bit Somewhat Quite a bit Very much 
AN3 I have trouble starting things because I am tired … Not at all A little bit Somewhat Quite a bit Very much 
AN4 I have trouble finishing things because I am tired … Not at all A little bit Somewhat Quite a bit Very much 
AN5 I have energy … Not at all A little bit Somewhat Quite a bit Very much 
AN7 I am able to do my usual activities … Not at all A little bit Somewhat Quite a bit Very much 
AN8 I need to sleep during the day … Not at all A little bit Somewhat Quite a bit Very much 
FATEXP02 How often did you feel run-down? Never Rarely Sometimes Often Always 
FATEXP05 How often did you experience extreme exhaustion? Never Rarely Sometimes Often Always 
FATEXP06 How often did you feel tired even when you hadn't done anything? Never Rarely Sometimes Often Always 
FATEXP07 How often did you feel your fatigue was beyond your control? Never Rarely Sometimes Often Always 
FATEXP12 To what degree did you feel tired even when you hadn't done anything? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP13 How bushed were you on average? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP16 How often were you sluggish? Never Rarely Sometimes Often Always 
FATEXP18 How often did you run out of energy? Never Rarely Sometimes Often Always 
FATEXP19 How often were you physically drained? Never Rarely Sometimes Often Always 
FATEXP20 How often did you feel tired? Never Rarely Sometimes Often Always 
FATEXP21 How fatigued were you when your fatigue was at its worst? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP22 How often were you bothered by your fatigue? Never Rarely Sometimes Often Always 
FATEXP24 How often did you have enough energy to enjoy the things you do for fun? Never Rarely Sometimes Often Always 
FATEXP26 How often were you too tired to enjoy life? Never Rarely Sometimes Often Always 
FATEXP28 How often were you too tired to feel happy? Never Rarely Sometimes Often Always 
FATEXP29 How often did you feel totally drained? Never Rarely Sometimes Often Always 
FATEXP31 How often were you energetic? Never Rarely Sometimes Often Always 
FATEXP34 How tired did you feel on average? Not at all A little bit Somewhat Quite a bit Very much 
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FATEXP35 How much were you bothered by your fatigue on average? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP36 How exhausted were you on average? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP38 How fatigued were you on the day you felt most fatigued? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP40 How fatigued were you on average? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP41 How run-down did you feel on average? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP42 How much mental energy did you have on average? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP43 How physically drained were you on average? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP44 How energetic were you on average? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP45 How sluggish were you on average? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP46 On how many days was your fatigue worse in the morning? None 1 day 2-3 days 4-5 days 6-7 days 
FATEXP48 How often did you find yourself getting tired easily? Never Rarely Sometimes Often Always 
FATEXP49 How often did you think about your fatigue? Never Rarely Sometimes Often Always 
FATEXP50 How fatigued were you on the day you felt least fatigued? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP51 How easily did you find yourself getting tired on average? Not at all A little bit Somewhat Quite a bit Very much 
FATEXP52 How wiped out were you on average?  Not at all A little bit Somewhat Quite a bit Very much 
FATEXP54 How often did you have physical energy? Never Rarely Sometimes Often Always 




To what degree did you have to push yourself to get things done because of your 
fatigue?  
Not at all A little bit Somewhat Quite a bit Very much 
FATIMP02 To what degree did your fatigue make you feel slowed down in your thinking?  Not at all A little bit Somewhat Quite a bit Very much 
FATIMP03 How often did you have to push yourself to get things done because of your fatigue?  Never Rarely Sometimes Often Always 
FATIMP04 How often did your fatigue interfere with your social activities? Never Rarely Sometimes Often Always 
FATIMP05 
How often were you less effective at work due to your fatigue (include work at 
home)?  
Never Rarely Sometimes Often Always 
FATIMP06 How often did your fatigue make you feel slowed down in your thinking? Never Rarely Sometimes Often Always 
FATIMP08 How often were you too tired to watch television? Never Rarely Sometimes Often Always 
FATIMP09 How often did your fatigue make it difficult to plan activities ahead of time?  Never Rarely Sometimes Often Always 
FATIMP10 How often did your fatigue make it difficult to start anything new? Never Rarely Sometimes Often Always 
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FATIMP11 How often did your fatigue make you more forgetful? Never Rarely Sometimes Often Always 
FATIMP13 How often were you too tired to do errands? Never Rarely Sometimes Often Always 
FATIMP14 
How often did your fatigue make it difficult to organize your thoughts when doing 
things at work (include work at home)?  
Never Rarely Sometimes Often Always 
FATIMP15 
How often did your fatigue interfere with your ability to engage in recreational 
activities?  
Never Rarely Sometimes Often Always 
FATIMP16 How often did you have trouble finishing things because of your fatigue? Never Rarely Sometimes Often Always 
FATIMP17 How often did your fatigue make it difficult to make decisions? Never Rarely Sometimes Often Always 
FATIMP18 How often did you have to limit your social activities because of your fatigue?  Never Rarely Sometimes Often Always 
FATIMP19 How often were you too tired to do your household chores? Never Rarely Sometimes Often Always 
FATIMP20 How often did your fatigue make you feel less alert? Never Rarely Sometimes Often Always 
FATIMP21 How often were you too tired to take a bath or shower? Never Rarely Sometimes Often Always 
FATIMP22 
How often did your fatigue make it difficult to organize your thoughts when doing 
things at home?  
Never Rarely Sometimes Often Always 
FATIMP24 How often did you have trouble starting things because of your fatigue? Never Rarely Sometimes Often Always 
FATIMP25 How often was it an effort to carry on a conversation because of your fatigue?  Never Rarely Sometimes Often Always 
FATIMP26 How often were you too tired to socialize with your family? Never Rarely Sometimes Often Always 
FATIMP27 To what degree did you have trouble starting things because of your fatigue? Not at all A little bit Somewhat Quite a bit Very much 
FATIMP28 How hard was it for you to carry on a conversation because of your fatigue? Not at all A little bit Somewhat Quite a bit Very much 
FATIMP29 How often were you too tired to leave the house? Never Rarely Sometimes Often Always 
FATIMP30 How often were you too tired to think clearly? Never Rarely Sometimes Often Always 
FATIMP33 How often did your fatigue limit you at work (include work at home)? Never Rarely Sometimes Often Always 
FATIMP34 To what degree did you have to limit your social activities because of your fatigue?  Not at all A little bit Somewhat Quite a bit Very much 
FATIMP35 
To what degree did your fatigue make it difficult to organize your thoughts when 
doing things at home?  
Not at all A little bit Somewhat Quite a bit Very much 
FATIMP36 To what degree did your fatigue make it difficult to start anything new? Not at all A little bit Somewhat Quite a bit Very much 
FATIMP37 Due to your fatigue were you less effective at work (include work at home)?  Not at all A little bit Somewhat Quite a bit Very much 
FATIMP38 To what degree did your fatigue make it difficult to make decisions? Not at all A little bit Somewhat Quite a bit Very much 
FATIMP40 How often did you have enough energy to exercise strenuously?  Never Rarely Sometimes Often Always 
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FATIMP42 How often were you less effective at home due to your fatigue? Never Rarely Sometimes Often Always 
FATIMP43 
To what degree did your fatigue make it difficult to organize your thoughts when 
doing things at work (include work at home)?  
Not at all A little bit Somewhat Quite a bit Very much 
FATIMP44 To what degree did your fatigue make you more forgetful?  Not at all A little bit Somewhat Quite a bit Very much 
FATIMP45 
To what degree did your fatigue interfere with your ability to engage in recreational 
activities?  
Not at all A little bit Somewhat Quite a bit Very much 
FATIMP47 
To what degree did you have to force yourself to get up and do things because of your 
fatigue?  
Not at all A little bit Somewhat Quite a bit Very much 
FATIMP48 To what degree did your fatigue interfere with your social activities? Not at all A little bit Somewhat Quite a bit Very much 
FATIMP49 To what degree did your fatigue interfere with your physical functioning? Not at all A little bit Somewhat Quite a bit Very much 
FATIMP50 Did fatigue make you less effective at home? Not at all A little bit Somewhat Quite a bit Very much 
FATIMP51 To what degree did you have trouble finishing things because of your fatigue?  Not at all A little bit Somewhat Quite a bit Very much 
FATIMP52 To what degree did your fatigue make you feel less alert? Not at all A little bit Somewhat Quite a bit Very much 
FATIMP53 How often were you too tired to take a short walk? Never Rarely Sometimes Often Always 
FATIMP55 
How often did you have to force yourself to get up and do things because of your 
fatigue?  
Never Rarely Sometimes Often Always 
FATIMP56 How often were you too tired to socialize with your friends? Never Rarely Sometimes Often Always 
FATSLE02 On how many days did you feel the need to rest before the day was over? None 1 day 2-3 days 4-5 days 6-7 days 
FATSLE03 I feel that I needed more rest Not at all A little bit Somewhat Quite a bit Very much 
FATSLE04 I feel that my low energy level was giving me problems in my daily life Not at all A little bit Somewhat Quite a bit Very much 
FATSLE05 How often did you have to sit down for a rest during the day because you were tired? Never Rarely Sometimes Often Always 
FATSLE06 How often did you find it hard to concentrate because you felt tired? Never Rarely Sometimes Often Always 
FATSLE07 
How often were you unable to pay attention to things because of your low energy 
level? 
Never Rarely Sometimes Often Always 
FATSLE08 I feel frustrated by the energy level I had Not at all A little bit Somewhat Quite a bit Very much 
FATSLE09 I did not have enough energy to do things that interest me Not at all A little bit Somewhat Quite a bit Very much 
FATSLE10 
I feel disappointed that I did not finish doing some things because of my lack of 
energy 
Not at all A little bit Somewhat Quite a bit Very much 
FATSLE11 I worry about what other people thought of me when I was too tired to do things Not at all A little bit Somewhat Quite a bit Very much 
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FATSLE12 I needed more time to do things because of my energy level Not at all A little bit Somewhat Quite a bit Very much 
FATSLE13 I did not have enough energy to do the things I had to do Not at all A little bit Somewhat Quite a bit Very much 
FATSLE14 
How often did you have to limit your recreational activities because of your lack of 
energy? 
Never Rarely Sometimes Often Always 
FATSLE15 How often did you have to limit your work because you wanted more rest? Never Rarely Sometimes Often Always 
FATSLE16 How often did you avoid going out because you wanted some rest? Never Rarely Sometimes Often Always 
FATSLE17 How often did you go home early because you needed to get some rest? Never Rarely Sometimes Often Always 
FATSLE18 I feel full of energy Not at all A little bit Somewhat Quite a bit Very much 
FATSLE19 
On how many days did you feel that you have enough energy for the whole day 
ahead? 
None 1 day 2-3 days 4-5 days 6-7 days 
FATSLE20 I feel low in energy when walking to places Not at all A little bit Somewhat Quite a bit Very much 
FATSLE21 To what dgree did you need more time to think about things because you felt tired? Not at all A little bit Somewhat Quite a bit Very much 
FATSLE22 How often did you feel that you want to sleep throughout the day? Never Rarely Sometimes Often Always 
FATSLE23 
I took a longer time than other people to finish doing things because of my energy 
level 
Not at all A little bit Somewhat Quite a bit Very much 
FATSLE24 I have little energy for small tasks at work/home. Not at all A little bit Somewhat Quite a bit Very much 
FATSLE25 I need rest so that my body has more energy. Not at all A little bit Somewhat Quite a bit Very much 
FATSLE26 I did not have enough energy to meet friends when I want to Not at all A little bit Somewhat Quite a bit Very much 
FATSLE27 I spend less time with friends/family because of my lack of energy. Not at all A little bit Somewhat Quite a bit Very much 
FATSLE28 I spend less time doing the things that I enjoy because of my lack of energy. Not at all A little bit Somewhat Quite a bit Very much 
FATSLE29 I feel drained throughout the day.  Not at all A little bit Somewhat Quite a bit Very much 
HI12 I feel weak all over ... Not at all A little bit Somewhat Quite a bit Very much 
HI7 I feel fatigued … Not at all A little bit Somewhat Quite a bit Very much 
LUPQOL31 How often were you unable to concentrate for long periods of time? Never Rarely Sometimes Often Always 
LUPQOL32 How often did you feel worn out and sluggish? Never Rarely Sometimes Often Always 
LUPQOL33 How often did you need to have early nights? Never Rarely Sometimes Often Always 
LUPQOL34 How often were you exhausted in the morning? Never Rarely Sometimes Often Always 
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 A 7-day recall period applies to all items. The phrase “In the past 7 days…” precedes each question on the electronic test form and at the top of each page on the paper 
form.  
* Item number prefixes indicate the source of items. Original item numbers are retained for PROMIS items and are indicated with these prefixes: FATEXP- (fatigue 
experience), FATIMP- (fatigue impact), AN- / HI- (items from two legacy instruments). PLUS items are indicated with these prefixes: FATSLE- (newly written), 
LUPQOL- (adapted from LupusQoL©) 
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Responses Response Category Frequency (%) 
 Item No* 
No. of 
administrations  
Missing (%) Response Mean SD  Cat. 1 Cat. 2 Cat. 3 Cat. 4 Cat. 5 
AN3 109 0.0 1.94 1.04 47 (43.1) 35 (32.1) 14 (12.8) 12 (11.0) 1 (0.9) 
AN5 109 0.0 2.20 0.96 28 (25.7) 44 (40.4) 24 (22.0) 13 (11.9) 0 (0.0) 
AN7 109 0.0 2.10 1.36 54 (49.5) 21 (19.3) 13 (11.9) 11 (10.1) 10 (9.2) 
AN15 109 0.0 1.86 1.17 56 (51.4) 31 (28.4) 10 (9.2) 5 (4.6) 7 (6.4) 
FATEXP26 109 0.0 1.99 0.92 39 (35.8) 39 (35.8) 24 (22.0) 7 (6.4) 0 (0.0) 
FATEXP34 109 0.0 2.39 0.91 11 (10.1) 65 (59.6) 14 (12.8) 18 (16.5) 1 (0.9) 
FATIMP01 109 0.0 2.00 1.01 39 (35.8) 45 (41.3) 13 (11.9) 10 (9.2) 2 (1.8) 
FATIMP06 109 0.0 2.16 0.96 33 (30.3) 35 (32.1) 33 (30.3) 7 (6.4) 1 (0.9) 
FATIMP09 109 0.0 2.09 0.91 34 (31.2) 37 (33.9) 32 (29.4) 6 (5.5) 0 (0.0) 
FATIMP29 109 0.0 1.91 0.91 46 (42.2) 31 (28.4) 28 (25.7) 4 (3.7) 0 (0.0) 
FATIMP30 109 0.0 2.06 0.85 31 (28.4) 45 (41.3) 30 (27.5) 2 (1.8) 1 (0.9) 
FATIMP49 109 0.0 1.87 0.97 43 (39.4) 49 (45.0) 9 (8.3) 4 (3.7) 4 (3.7) 
FATSLE04 103 0.0 1.81 1.02 52 (50.5) 30 (29.1) 12 (11.7) 7 (6.8) 2 (1.9) 
FATSLE07 103 0.0 2.21 0.96 29 (28.2) 31 (30.1) 36 (35.0) 6 (5.8) 1 (1.0) 
FATSLE14 103 0.0 2.15 0.93 31 (30.1) 33 (32.0) 32 (31.1) 7 (6.8) 0 (0.0) 
FATSLE28 101 0.0 1.86 1.03 45 (44.6) 37 (36.6) 11 (10.9) 4 (4.0) 4 (4.0) 
AN14 109 0.9 1.36 0.87 87 (80.6) 11 (10.2) 4 (3.7) 4 (3.7) 2 (1.9) 
FATEXP05 109 0.9 2.08 0.98 38 (35.2) 31 (28.7) 32 (29.6) 6 (5.6) 1 (0.9) 
FATEXP35 109 0.9 2.16 1.10 33 (30.6) 46 (42.6) 12 (11.1) 13 (12.0) 4 (3.7) 
FATEXP48 109 0.9 2.56 0.92 11 (10.2) 44 (40.7) 38 (35.2) 12 (11.1) 3 (2.8) 
FATEXP56 109 0.9 2.19 0.70 15 (13.9) 60 (55.6) 30 (27.8) 3 (2.8) 0 (0.0) 
FATIMP03 109 0.9 2.27 1.05 28 (25.9) 39 (36.1) 29 (26.9) 8 (7.4) 4 (3.7) 
FATIMP08 109 0.9 1.83 0.80 44 (40.7) 39 (36.1) 24 (22.2) 1 (0.9) 0 (0.0) 
FATIMP18 109 0.9 2.12 1.05 37 (34.3) 35 (32.4) 24 (22.2) 10 (9.3) 2 (1.9) 
FATIMP24 109 0.9 1.97 0.85 36 (33.3) 43 (39.8) 25 (23.1) 4 (3.7) 0 (0.0) 
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Responses Response Category Frequency (%) 
 Item No* 
No. of 
administrations  
Missing (%) Response Mean SD  Cat. 1 Cat. 2 Cat. 3 Cat. 4 Cat. 5 
FATIMP43 109 0.9 1.72 0.96 56 (51.9) 35 (32.4) 11 (10.2) 3 (2.8) 3 (2.8) 
FATIMP47 109 0.9 2.00 0.98 36 (33.3) 50 (46.3) 9 (8.3) 12 (11.1) 1 (0.9) 
FATIMP51 109 0.9 1.86 1.05 52 (48.1) 31 (28.7) 16 (14.8) 6 (5.6) 3 (2.8) 
FATIMP56 109 0.9 1.85 0.92 51 (47.2) 25 (23.1) 29 (26.9) 3 (2.8) 0 (0.0) 
LUPQOL31 109 0.9 2.17 0.92 30 (27.8) 37 (34.3) 35 (32.4) 5 (4.6) 1 (0.9) 
LUPQOL33 109 0.9 2.68 1.08 15 (13.9) 34 (31.5) 36 (33.3) 17 (15.7) 6 (5.6) 
LUPQOL34 109 0.9 2.27 0.95 23 (21.3) 46 (42.6) 28 (25.9) 9 (8.3) 2 (1.9) 
FATSLE05 103 1.0 2.32 0.98 24 (23.5) 33 (32.4) 34 (33.3) 10 (9.8) 1 (1.0) 
FATSLE06 103 1.0 2.18 0.93 27 (26.5) 39 (38.2) 27 (26.5) 9 (8.8) 0 (0.0) 
FATSLE12 103 1.0 2.07 1.24 44 (43.1) 30 (29.4) 12 (11.8) 9 (8.8) 7 (6.9) 
FATSLE15 103 1.0 2.32 0.88 20 (19.6) 37 (36.3) 37 (36.3) 8 (7.8) 0 (0.0) 
FATSLE17 103 1.0 2.14 1.02 37 (36.3) 23 (22.5) 33 (32.4) 9 (8.8) 0 (0.0) 
FATSLE25 101 1.0 2.57 1.11 13 (13.0) 46 (46.0) 19 (19.0) 15 (15.0) 7 (7.0) 
AN2 109 1.8 2.32 0.86 11 (10.3) 65 (60.7) 20 (18.7) 8 (7.5) 3 (2.8) 
AN8 109 1.8 1.85 1.00 48 (44.9) 38 (35.5) 13 (12.1) 5 (4.7) 3 (2.8) 
AN16 109 1.8 2.03 1.19 47 (43.9) 30 (28.0) 16 (15.0) 8 (7.5) 6 (5.6) 
FATEXP19 109 1.8 2.40 0.96 19 (17.8) 41 (38.3) 34 (31.8) 11 (10.3) 2 (1.9) 
FATEXP22 109 1.8 2.32 0.99 23 (21.5) 42 (39.3) 29 (27.1) 11 (10.3) 2 (1.9) 
FATEXP24 109 1.8 2.66 1.20 19 (17.8) 34 (31.8) 28 (26.2) 16 (15.0) 10 (9.3) 
FATEXP31 109 1.8 2.42 0.85 14 (13.1) 45 (42.1) 37 (34.6) 11 (10.3) 0 (0.0) 
FATEXP54 109 1.8 2.34 0.88 19 (17.8) 43 (40.2) 35 (32.7) 10 (9.3) 0 (0.0) 
FATIMP05 109 1.8 2.12 0.84 27 (25.2) 45 (42.1) 30 (28.0) 5 (4.7) 0 (0.0) 
FATIMP11 109 1.8 2.11 0.92 32 (29.9) 39 (36.4) 28 (26.2) 8 (7.5) 0 (0.0) 
FATIMP13 109 1.8 2.18 0.84 27 (25.2) 37 (34.6) 40 (37.4) 3 (2.8) 0 (0.0) 
FATIMP15 109 1.8 2.12 0.91 32 (29.9) 36 (33.6) 33 (30.8) 6 (5.6) 0 (0.0) 
FATIMP16 109 1.8 2.01 0.90 38 (35.5) 34 (31.8) 31 (29.0) 4 (3.7) 0 (0.0) 
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Responses Response Category Frequency (%) 
 Item No* 
No. of 
administrations  
Missing (%) Response Mean SD  Cat. 1 Cat. 2 Cat. 3 Cat. 4 Cat. 5 
FATIMP20 109 1.8 2.13 0.92 29 (27.1) 43 (40.2) 29 (27.1) 4 (3.7) 2 (1.9) 
FATIMP27 109 1.8 1.92 0.99 43 (40.2) 42 (39.3) 12 (11.2) 8 (7.5) 2 (1.9) 
FATIMP34 109 1.8 1.85 1.04 50 (46.7) 36 (33.6) 11 (10.3) 7 (6.5) 3 (2.8) 
FATIMP44 109 1.8 2.07 0.95 32 (29.9) 46 (43.0) 19 (17.8) 9 (8.4) 1 (0.9) 
FATIMP45 109 1.8 2.05 1.08 39 (36.4) 41 (38.3) 14 (13.1) 9 (8.4) 4 (3.7) 
FATSLE02 103 1.9 2.07 1.00 35 (34.7) 34 (33.7) 24 (23.8) 6 (5.9) 2 (2.0) 
FATSLE03 103 1.9 2.53 1.09 16 (15.8) 41 (40.6) 23 (22.8) 16 (15.8) 5 (5.0) 
FATSLE09 103 1.9 1.69 0.96 57 (56.4) 26 (25.7) 11 (10.9) 6 (5.9) 1 (1.0) 
FATSLE11 103 1.9 1.73 1.13 62 (61.4) 19 (18.8) 9 (8.9) 7 (6.9) 4 (4.0) 
FATSLE18 103 1.9 2.94 1.26 16 (15.8) 25 (24.8) 19 (18.8) 31 (30.7) 10 (9.9) 
FATSLE21 103 1.9 1.91 0.91 37 (36.6) 44 (43.6) 13 (12.9) 6 (5.9) 1 (1.0) 
FATSLE22 103 1.9 2.06 1.08 40 (39.6) 27 (26.7) 25 (24.8) 6 (5.9) 3 (3.0) 
FATSLE27 101 2.0 1.65 0.99 61 (61.6) 21 (21.2) 10 (10.1) 5 (5.1) 2 (2.0) 
FATSLE29 101 2.0 1.87 0.95 41 (41.4) 40 (40.4) 9 (9.1) 8 (8.1) 1 (1.0) 
AN12 109 2.8 1.30 0.60 82 (77.4) 16 (15.1) 8 (7.5) 0 (0.0) 0 (0.0) 
FATEXP02 109 2.8 2.10 0.90 30 (28.3) 42 (39.6) 28 (26.4) 5 (4.7) 1 (0.9) 
FATEXP06 109 2.8 1.87 0.82 42 (39.6) 37 (34.9) 26 (24.5) 1 (0.9) 0 (0.0) 
FATEXP07 109 2.8 2.07 1.03 39 (36.8) 32 (30.2) 26 (24.5) 7 (6.6) 2 (1.9) 
FATEXP12 109 2.8 1.96 0.94 38 (35.8) 44 (41.5) 14 (13.2) 10 (9.4) 0 (0.0) 
FATEXP18 109 2.8 2.31 0.85 18 (17.0) 46 (43.4) 33 (31.1) 9 (8.5) 0 (0.0) 
FATEXP29 109 2.8 2.07 0.96 33 (31.1) 43 (40.6) 22 (20.8) 6 (5.7) 2 (1.9) 
FATEXP40 109 2.8 2.25 0.80 12 (11.3) 68 (64.2) 14 (13.2) 12 (11.3) 0 (0.0) 
FATEXP41 109 2.8 2.08 0.96 30 (28.3) 50 (47.2) 14 (13.2) 11 (10.4) 1 (0.9) 
FATEXP49 109 2.8 2.08 0.95 29 (27.4) 51 (48.1) 16 (15.1) 8 (7.5) 2 (1.9) 
FATEXP51 109 2.8 2.38 0.87 11 (10.4) 59 (55.7) 22 (20.8) 13 (12.3) 1 (0.9) 
FATIMP02 109 2.8 2.00 1.00 37 (34.9) 44 (41.5) 16 (15.1) 6 (5.7) 3 (2.8) 
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Responses Response Category Frequency (%) 
 Item No* 
No. of 
administrations  
Missing (%) Response Mean SD  Cat. 1 Cat. 2 Cat. 3 Cat. 4 Cat. 5 
FATIMP04 109 2.8 1.97 0.88 39 (36.8) 34 (32.1) 30 (28.3) 3 (2.8) 0 (0.0) 
FATIMP10 109 2.8 1.98 0.87 37 (34.9) 38 (35.8) 27 (25.5) 4 (3.8) 0 (0.0) 
FATIMP14 109 2.8 1.92 0.87 40 (37.7) 40 (37.7) 21 (19.8) 5 (4.7) 0 (0.0) 
FATIMP17 109 2.8 1.91 0.93 47 (44.3) 26 (24.5) 29 (27.4) 4 (3.8) 0 (0.0) 
FATIMP19 109 2.8 2.25 1.03 28 (26.4) 37 (34.9) 31 (29.2) 6 (5.7) 4 (3.8) 
FATIMP22 109 2.8 1.83 0.89 48 (45.3) 32 (30.2) 22 (20.8) 4 (3.8) 0 (0.0) 
FATIMP26 109 2.8 1.70 0.83 55 (51.9) 30 (28.3) 19 (17.9) 2 (1.9) 0 (0.0) 
FATIMP33 109 2.8 2.09 0.97 36 (34.0) 32 (30.2) 31 (29.2) 6 (5.7) 1 (0.9) 
FATIMP35 109 2.8 1.63 0.90 60 (56.6) 32 (30.2) 9 (8.5) 3 (2.8) 2 (1.9) 
FATIMP38 109 2.8 1.76 0.92 51 (48.1) 36 (34.0) 14 (13.2) 3 (2.8) 2 (1.9) 
FATIMP42 109 2.8 2.06 0.87 33 (31.1) 38 (35.8) 31 (29.2) 4 (3.8) 0 (0.0) 
FATIMP55 109 2.8 2.08 0.97 34 (32.1) 41 (38.7) 21 (19.8) 9 (8.5) 1 (0.9) 
HI12 109 2.8 1.75 0.95 54 (50.9) 33 (31.1) 13 (12.3) 4 (3.8) 2 (1.9) 
FATSLE13 103 2.9 1.74 0.99 53 (53.0) 30 (30.0) 9 (9.0) 6 (6.0) 2 (2.0) 
FATSLE16 103 2.9 2.42 1.02 21 (21.0) 34 (34.0) 27 (27.0) 18 (18.0) 0 (0.0) 
FATSLE20 103 2.9 1.80 1.06 50 (50.0) 33 (33.0) 9 (9.0) 3 (3.0) 5 (5.0) 
AN4 109 3.7 1.94 1.03 43 (41.0) 38 (36.2) 13 (12.4) 9 (8.6) 2 (1.9) 
FATEXP20 109 3.7 2.76 0.86 5 (4.8) 37 (35.2) 43 (41.0) 18 (17.1) 2 (1.9) 
FATEXP28 109 3.7 1.79 0.87 48 (45.7) 36 (34.3) 16 (15.2) 5 (4.8) 0 (0.0) 
FATEXP36 109 3.7 2.29 0.98 17 (16.2) 60 (57.1) 12 (11.4) 13 (12.4) 3 (2.9) 
FATEXP42 109 3.7 2.24 1.03 25 (23.8) 48 (45.7) 17 (16.2) 12 (11.4) 3 (2.9) 
FATEXP43 109 3.7 2.33 0.84 13 (12.4) 56 (53.3) 24 (22.9) 12 (11.4) 0 (0.0) 
FATEXP44 109 3.7 2.44 0.92 17 (16.2) 39 (37.1) 35 (33.3) 14 (13.3) 0 (0.0) 
FATIMP25 109 3.7 1.68 0.80 55 (52.4) 30 (28.6) 19 (18.1) 1 (1.0) 0 (0.0) 
FATIMP28 109 3.7 1.47 0.79 72 (68.6) 20 (19.0) 10 (9.5) 3 (2.9) 0 (0.0) 
FATIMP37 109 3.7 2.10 1.01 32 (30.5) 44 (41.9) 19 (18.1) 7 (6.7) 3 (2.9) 
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Responses Response Category Frequency (%) 
 Item No* 
No. of 
administrations  
Missing (%) Response Mean SD  Cat. 1 Cat. 2 Cat. 3 Cat. 4 Cat. 5 
FATIMP48 109 3.7 1.82 1.02 51 (48.6) 33 (31.4) 13 (12.4) 5 (4.8) 3 (2.9) 
FATIMP50 109 3.7 1.91 0.91 41 (39.0) 38 (36.2) 21 (20.0) 4 (3.8) 1 (1.0) 
FATIMP53 109 3.7 1.77 0.86 48 (45.7) 37 (35.2) 17 (16.2) 2 (1.9) 1 (1.0) 
HI7 109 3.7 2.27 0.90 17 (16.2) 57 (54.3) 18 (17.1) 12 (11.4) 1 (1.0) 
LUPQOL32 109 3.7 2.15 0.95 30 (28.6) 38 (36.2) 29 (27.6) 7 (6.7) 1 (1.0) 
FATSLE24 101 4.0 1.69 0.95 54 (55.7) 27 (27.8) 9 (9.3) 6 (6.2) 1 (1.0) 
FATSLE26 101 4.0 1.74 1.10 57 (58.8) 21 (21.6) 10 (10.3) 5 (5.2) 4 (4.1) 
FATEXP46 109 4.6 2.00 1.09 47 (45.2) 23 (22.1) 22 (21.2) 11 (10.6) 1 (1.0) 
FATIMP21 109 4.6 1.37 0.65 75 (72.1) 21 (20.2) 7 (6.7) 1 (1.0) 0 (0.0) 
FATIMP36 109 4.6 1.95 1.04 43 (41.3) 37 (35.6) 11 (10.6) 12 (11.5) 1 (1.0) 
FATIMP40 109 4.6 3.35 1.02 2 (1.9) 20 (19.2) 38 (36.5) 28 (26.9) 16 (15.4) 
FATIMP52 109 4.6 2.13 1.09 32 (30.8) 45 (43.3) 14 (13.5) 8 (7.7) 5 (4.8) 
FATSLE08 103 4.9 1.80 1.12 54 (55.1) 24 (24.5) 11 (11.2) 4 (4.1) 5 (5.1) 
FATSLE10 103 4.9 1.85 1.12 49 (50.0) 29 (29.6) 12 (12.2) 2 (2.0) 6 (6.1) 
FATSLE23 103 4.9 1.77 0.97 50 (51.0) 29 (29.6) 13 (13.3) 4 (4.1) 2 (2.0) 
AN1 109 5.5 1.88 0.99 46 (44.7) 33 (32.0) 15 (14.6) 8 (7.8) 1 (1.0) 
FATEXP16 109 6.4 2.04 0.86 30 (29.4) 42 (41.2) 27 (26.5) 2 (2.0) 1 (1.0) 
FATEXP38 109 6.4 2.67 1.14 11 (10.8) 46 (45.1) 20 (19.6) 16 (15.7) 9 (8.8) 
FATSLE19 103 6.8 2.65 1.33 23 (24.0) 25 (26.0) 24 (25.0) 11 (11.5) 13 (13.5) 
FATEXP21 109 7.3 2.94 1.24 12 (11.9) 31 (30.7) 22 (21.8) 23 (22.8) 13 (12.9) 
FATEXP52 109 7.3 2.05 0.82 23 (22.8) 58 (57.4) 12 (11.9) 8 (7.9) 0 (0.0) 
FATEXP45 109 8.3 1.90 0.88 38 (38.0) 40 (40.0) 16 (16.0) 6 (6.0) 0 (0.0) 
FATEXP50 109 8.3 1.76 0.89 48 (48.0) 33 (33.0) 15 (15.0) 3 (3.0) 1 (1.0) 
FATEXP13 109 27.5 1.92 0.86 28 (35.4) 33 (41.8) 14 (17.7) 4 (5.1) 0 (0.0) 
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Responses Response Category Frequency (%) 
 Item No* 
No. of 
administrations  
Missing (%) Response Mean SD  Cat. 1 Cat. 2 Cat. 3 Cat. 4 Cat. 5 
α 
Category 5 responses indicate highest levels of fatigue in all items. Items have been reverse-scored where applicable.  
* Item number prefixes indicate the source of items. Original item numbers are retained for PROMIS items and are indicated with these prefixes: FATEXP- (fatigue 
experience), FATIMP- (fatigue impact), AN- / HI- (items from two legacy instruments). PLUS items are indicated with these prefixes: FATSLE- (newly written), 
LUPQOL- (adapted from LupusQoL©)  
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I am too tired to eat … 0.53 0.9880# 11 0.48 
AN14 








I am frustrated by being too tired to do 
the things I want to do … 
0.77 0.9878 1 0.62 
AN16 
I have to limit my social activity because 
I am tired … 
0.79 0.9878 1 0.62 
AN2 
I feel tired … 0.68 0.9879 4 0.57 
AN3 
I have trouble starting things because I 
am tired … 
0.77 0.9878 1 0.61 
AN4 
I have trouble finishing things because I 
am tired … 
0.80 0.9878 1 0.62 
AN5 
I have energy … 0.61 0.9880# 4 0.49 
AN7 
I am able to do my usual activities … 0.42 0.9883# 11 0.34α 
AN8 
I need to sleep during the day … 0.50 0.9880# 13 0.41 
FATEXP05 
How often did you experience extreme 
exhaustion? 
0.70 0.9879 4 0.55 
FATEXP06 
How often did you feel tired even when 
you hadn't done anything? 
0.73 0.9879 2 0.60 
FATEXP07 
How often did you feel your fatigue was 
beyond your control? 
0.81 0.9878 1 0.64 
FATEXP12 
To what degree did you feel tired even 
when you hadn't done anything? 
0.76 0.9878 4 0.60 
FATEXP18 
How often did you run out of energy? 0.68 0.9879 4 0.56 
FATEXP19 
How often were you physically drained? 0.70 0.9879 0 0.58 
FATEXP20 
How often did you feel tired? 0.73 0.9879 1 0.60 
FATEXP22 
How often were you bothered by your 
fatigue? 
0.76 0.9878 2 0.61 
FATEXP24 
How often did you have enough energy 







How often were you too tired to enjoy 
life? 
0.78 0.9878 1 0.62 
FATEXP28 
How often were you too tired to feel 
happy? 
0.65 0.9879 3 0.52 
FATEXP29 
How often did you feel totally drained? 0.68 0.9879 1 0.54 
FATEXP31 
How often were you energetic? 0.69 0.9879 2 0.58 
FATEXP34 
How tired did you feel on average? 0.77 0.9878 2 0.64 
FATEXP35 
How much were you bothered by your 
fatigue on average? 
0.75 0.9878 5 0.59 
FATEXP36 
How exhausted were you on average? 0.77 0.9878 2 0.63 
FATEXP40 
How fatigued were you on average? 0.74 0.9879 3 0.63 
FATEXP42 




 5 0.43 
FATEXP43 




 6 0.47 
FATEXP44 
How energetic were you on average? 0.54 0.9880
#
 10 0.45 
FATEXP46 
On how many days was your fatigue 
worse in the morning? 
0.69 0.9879 2 0.55 
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How often did you find yourself getting 
tired easily? 
0.74 0.9879 2 0.60 
FATEXP49 
How often did you think about your 
fatigue? 
0.72 0.9879 1 0.58 
FATEXP51 
How easily did you find yourself getting 
tired on average? 
0.77 0.9878 0 0.63 
FATEXP54 




 5 0.49 
FATEXP56 
What was the level of your fatigue on 
most days? 
0.68 0.9879 4 0.58 
FATIMP01 
To what degree did you have to push 
yourself to get things done because of 
your fatigue?  
0.72 0.9879 1 0.57 
FATIMP02 
To what degree did your fatigue make 
you feel slowed down in your thinking?  
0.74 0.9879 2 0.58 
FATIMP03 
How often did you have to push yourself 
to get things done because of your 
fatigue?  
0.67 0.9879 2 0.53 
FATIMP04 
How often did your fatigue interfere 
with your social activities? 
0.74 0.9879 2 0.60 
FATIMP05 
How often were you less effective at 
work due to your fatigue (include work 
at home)?  
0.81 0.9878 1 0.66 
FATIMP06 
How often did your fatigue make you 
feel slowed down in your thinking? 
0.71 0.9879 2 0.57 
FATIMP08 




 14 0.42 
FATIMP09 
How often did your fatigue make it 
difficult to plan activities ahead of time?  
0.78 0.9878 1 0.63 
FATIMP10 
How often did your fatigue make it 
difficult to start anything new? 
0.77 0.9878 1 0.62 
FATIMP11 
How often did your fatigue make you 
more forgetful? 
0.66 0.9879 2 0.53 
FATIMP13 
How often were you too tired to do 
errands? 
0.72 0.9879 4 0.61 
FATIMP14 
How often did your fatigue make it 
difficult to organize your thoughts when 
doing things at work (include work at 
home)?  
0.78 0.9878 1 0.62 
FATIMP15 
How often did your fatigue interfere 
with your ability to engage in 
recreational activities?  
0.75 0.9878 1 0.61 
FATIMP16 
How often did you have trouble 
finishing things because of your fatigue? 
0.74 0.9878 2 0.60 
FATIMP17 
How often did your fatigue make it 
difficult to make decisions? 
0.76 0.9878 1 0.61 
FATIMP18 
How often did you have to limit your 
social activities because of your fatigue?  
0.77 0.9878 1 0.60 
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How often were you too tired to do your 
household chores? 
0.72 0.9879 2 0.57 
FATIMP20 
How often did your fatigue make you 
feel less alert? 
0.72 0.9879 3 0.58 
FATIMP21 
How often were you too tired to take a 
bath or shower? 
0.55 0.9880
#
 7 0.48 
FATIMP22 
How often did your fatigue make it 
difficult to organize your thoughts when 
doing things at home?  
0.78 0.9878 1 0.62 
FATIMP24 
How often did you have trouble starting 
things because of your fatigue? 
0.82 0.9878 1 0.66 
FATIMP25 
How often was it an effort to carry on a 
conversation because of your fatigue?  
0.68 0.9879 3 0.56 
FATIMP26 
How often were you too tired to 
socialize with your family? 
0.62 0.9879 1 0.50 
FATIMP27 
To what degree did you have trouble 
starting things because of your fatigue? 
0.79 0.9878 2 0.61 
FATIMP28 
How hard was it for you to carry on a 
conversation because of your fatigue? 
0.59 0.9880
#
 4 0.50 
FATIMP29 
How often were you too tired to leave 
the house? 
0.73 0.9879 2 0.58 
FATIMP30 
How often were you too tired to think 
clearly? 
0.77 0.9878 2 0.62 
FATIMP33 
How often did your fatigue limit you at 
work (include work at home)? 
0.82 0.9878 1 0.65 
FATIMP34 
To what degree did you have to limit 
your social activities because of your 
fatigue?  
0.79 0.9878 1 0.63 
FATIMP35 
To what degree did your fatigue make it 
difficult to organize your thoughts when 
doing things at home?  
0.76 0.9878 1 0.63 
FATIMP36 
To what degree did your fatigue make it 
difficult to start anything new? 
0.74 0.9878 2 0.58 
FATIMP37 
Due to your fatigue were you less 
effective at work (include work at 
home)?  
0.77 0.9878 2 0.61 
FATIMP38 
To what degree did your fatigue make it 
difficult to make decisions? 
0.71 0.9879 2 0.57 
FATIMP40 
How often did you have enough energy 







How often were you less effective at 
home due to your fatigue? 
0.82 0.9878 1 0.66 
FATIMP43 
To what degree did your fatigue make it 
difficult to organize your thoughts when 
doing things at work (include work at 
home)?  
0.73 0.9879 1 0.60 
FATIMP44 
To what degree did your fatigue make 
you more forgetful?  
0.75 0.9878 1 0.59 
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To what degree did your fatigue interfere 
with your ability to engage in 
recreational activities?  
0.76 0.9878 1 0.60 
FATIMP47 
To what degree did you have to force 
yourself to get up and do things because 
of your fatigue?  
0.81 0.9878 2 0.65 
FATIMP48 
To what degree did your fatigue interfere 
with your social activities? 
0.78 0.9878 1 0.62 
FATIMP49 
To what degree did your fatigue interfere 
with your physical functioning? 
0.75 0.9878 3 0.61 
FATIMP50 
Did fatigue make you less effective at 
home? 
0.75 0.9878 1 0.59 
FATIMP51 
To what degree did you have trouble 
finishing things because of your fatigue?  
0.78 0.9878 1 0.62 
FATIMP52 
To what degree did your fatigue make 
you feel less alert? 
0.60 0.9880
#
 4 0.47 
FATIMP53 
How often were you too tired to take a 
short walk? 
0.72 0.9879 1 0.58 
FATIMP55 
How often did you have to force 
yourself to get up and do things because 
of your fatigue?  
0.79 0.9878 1 0.63 
FATIMP56 
How often were you too tired to 
socialize with your friends? 
0.79 0.9878 1 0.64 
HI12 
I feel weak all over ... 0.67 0.9879 4 0.55 
HI7 
I feel fatigued … 0.79 0.9878 5 0.65 
δ
 Item number prefixes indicate the source of items. Original item numbers are retained for 
PROMIS items and are indicated with these prefixes: FATEXP- (fatigue experience), 
FATIMP- (fatigue impact), AN- / HI- (items from two legacy instruments).  
* Item-rest correlations less than 0.4 
#   
No reduction in alpha when item was removed from scale  
α 
 Loevinger’s H values of less than 0.4 
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domain, if any  
FATSLE29 
I feel drained throughout the day. sustained - 
FATSLE19 
On how many days did you feel that you have enough 
energy for the whole day ahead? 
sustained - 
FATSLE03 
I feel that I needed more rest need more rest - 
FATSLE17 
How often did you go home early because you needed 
to get some rest 
need more rest - 
FATSLE16 
How often did you avoid going out because you 
wanted more rest? 
need more rest - 
FATSLE02 
On how many days did you feel the need to rest before 
the day was over? 
need more rest - 
FATSLE25 
I need rest so that my body has more energy. need more rest physical  
FATSLE05 
How often did you have to sit down for a rest during 
the day because you were tired? 
need more rest physical  
FATSLE14 
How often did you have to limit your recreational 
activities because of your lack of energy?  
limit oneself activities 
FATSLE15 
How often did you have to limit your work because of 
your lack of energy?  
limit oneself roles 
FATSLE18 
I feel full of energy item difficulty  - 
FATSLE26 




I spend less time with friends/family because of my 
lack of energy. 
- activities 
FATSLE28 
I spend less time doing the things that I enjoy because 
of my lack of energy. 
- emotional 
FATSLE08 
I feel frustrated by the energy level I had  - emotional 
FATSLE09 




How often did you find it hard to concentrate because 
you felt tired? 
- mental 
FATSLE21 
To what degree did you need more time to think about 
things because you felt tired? 
- mental 
FATSLE07 
How often were you unable to pay attention to things 
because of your low energy level?  
- mental 
FATSLE20 
I feel low in energy when walking to places - physical  
FATSLE11 
I worry about what people thought of me when I was 
too tired to do things 
- roles 
FATSLE04 
I feel that my low energy level was giving me 
problems in my daily life 
- roles 
FATSLE10 
I feel disappointed that I did not finish doing some 
things because of my lack of energy 
- roles 
FATSLE23 
I took a longer time than other people to finish doing 
things because of my energy level 
- roles 
FATSLE12 








I have little energy for small tasks at work/home. 
- roles 
FATSLE22 
How often did you feel that you want to sleep 
throughout the day? 
- sleep 
LUPQOL33 
How often did you need to have early nights? (adapted item) (adapted item) 
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domain, if any  
LUPQOL31 
How often were you unable to concentrate for long 
periods of time? 
(adapted item) (adapted item) 
LUPQOL32 
How often did you feel worn out and sluggish? (adapted item) (adapted item) 
LUPQOL34 
How often were you exhausted in the morning? (adapted item) (adapted item) 
*Only concepts identified from focus groups for newly written items are listed.
 
α
 Item number prefixes indicate the source of items.: FATSLE- (newly written), LUPQOL- 
(adapted from LupusQoL©) 
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Economic Cost of SLE Self-Report Survey Questionnaire (Chapter 6) 
 
 
Index Visit Cost Survey 
SNO Study Number     
 
IID Interviewer ID  
 








TIMEE Interview end time  
 
SECTION A. SOCIODEMOGRAPHIC INFORMATION  
We would like to obtain some background information about yourself that would help us better interpret the data we obtain from 
various patients.  








What is your 
current weight? 
0  Don’t know / cannot determine 




What is your 
current height?  
0  Don’t know / cannot determine 
1 Known, specify     cm 
 
 
ETHN What is your race? 
1  Chinese 
2 Malay 
3   Indian 
4  Others, please specify: __________________________________  
 
MARRY 
What is your 
current marital 
status?  
1  Single 
2 Married 
3   Divorced or separated 










1  No formal education 
2 Incomplete Primary (did not obtain PSLE) 
3  PSLE (obtained certificate) 
4  Incomplete Secondary (did not obtain "O" Levels) 
5  GCE "N", "O" Levels or ITE 
6  GCE "A" Levels 
7  Polytechnic diploma 
8  University degree 
9  Postgraduate degree 





What type of 
house do you live 
in?  
1  HDB 1 or 2 room flat 
2 HDB 3 or 4 room flat 
3  HDB 5 room flat 
4  HDB executive maisonette, executive apartment or HUDC flat 
5  Private apartment or condominium 
6  Terrace, semi-detached or bungalow house 
7  Shophouse, attap or zinc roofed house 
8  Others, please specify: ____________________________________ 
 
CAR 
Do you currently 
own any of the 
following motor 
vehicles?  
If yes, how many?  
1  Passenger car 1600cc and below  (please specify number owned: ____ ) 
2 Passenger car 1600cc and below  (please specify number owned: ____ ) 
3  Commercial vehicle                         (please specify number owned: ____ ) 
4  Motorcycle   (please specify number owned: ____ ) 
 
HHINC 




1  <500 
2 500 to < 1000 
3  1000 to < 2000 
4  2000 to < 3000 
5  3000 to < 4000 
6  4000 to < 5000 
7  5000 to < 6000 
8  7000 to < 8000 
9  8000 and above 
10  Don’t know  





Are you the main 
or sole income 
earner (i.e. primary 
source of financial 
support) for the 
family?  




What is your 
current living 
arrangement? 
(choose all that 
apply)  
1  Staying alone 
2 Spouse 
3  Children 
4  Parents 
5  Siblings 
6  Extended family members 
7  Landlord and/or flat mate 
8  Friend 
9  Nursing home / palliative care 
10  Other, please specify: _________________________________________ 
 
A.1. HEALTH INSURANCE PRODUCTS 
Do you currently own any of the following health insurance products?  
INSUR1 
Medical expense insurance (i.e. 
insurance pays for medical 
expenses) 
1  None 
2 Medishield 
3  Integrated Shield Plan, Self-paid 
4  Integrated Shield Plan, Co-paid (Employer) 
5  Integrated Shield Plan, Employer-paid 
6  Private Insurance, Self-paid 
7  Private Insurance, Co-paid (Employer) 
8  Private Insurance, Employer-paid 
 
INSUR2 
Disability income insurance (i.e. 
insurance protects your income if 
disabled) 
1  No 
2 Yes, Self-paid 
3  Yes, Co-paid (Employer) 
4  Yes, Employer-paid 
 
INSUR3 
Hospital cash insurance (i.e. 
insurance provides a fixed 
amount of cash during 
hospitalization) 
1  No 
2 Yes, Self-paid 
3  Yes, Co-paid (Employer) 





Critical illness insurance (i.e. 
insurance reduces the financial 
impact if diagnosed with a major 
illness such as cancer)  
1  No 
2 Yes, Self-paid 
3  Yes, Co-paid (Employer) 
4  Yes, Employer-paid 
 
INSUR5 
Long-term care insurance (i.e. 
insurance pays the cost of care if 
you are weak to look after 
yourself)  
1  No 
2 Yes, Self-paid 
3  Yes, Co-paid (Employer) 
4  Yes, Employer-paid 
 
INSUR6 
I have some health insurance 
products but I do not know the 
details  
1  No 
2 Yes, Self-paid 
3  Yes, Co-paid (Employer) 
4  Yes, Employer-paid 
 




A.2. DISEASE INFORMATION 
We would like to find out more about your SLE and your other health conditions.  
DDURS 
In which year were you 
diagnosed with SLE?       (yyyy) 
 
DDURY 
(OR) How many years has it been 
since you were diagnosed with 
SLE?  
  years 
 
COMOR 
Do you have any of these co-
existing medical conditions?  
1  High blood pressure, on medication 
2 High blood pressure, not on medication 
3  Diabetes 
4  Eyes, Kidneys or Limbs complications from diabetes 
5  Heart diseases 
6  Stroke 
7  High cholesterol and other blood lipids problems 
8  Osteoarthritis 
9  Other type of arthritis 
10  Rheumatism 
11 Asthma 
12 Cancer 





SECTION B.  (MEDICAL AND NON-MEDICAL) DIRECT HEALTH CARE EXPENDITURES 
B.1. VISITS TO THE SINGAPORE GENERAL HOSPITAL (SGH)  







a) Please specify number of visits:  ___________ visits 
b) Average cost per visit: $ ______________________ 
2








a) Please specify number of visits:  ___________ visits 
b) Average cost per visit: $ ______________________ 
2







a) Please specify number of visits:  ___________ visits 
b) Length of stay for each visit: 
i. Visit 1: ______________ days 
ii. Visit 2: ______________ days 
iii. Visit 3: ______________ days 
iv. Visit 4: ______________ days 
v. Visit 5: ______________ days 
c) Total cost of all visits: $ ______________________ 
2
  No  
 
We would like to find out how much you spent on transportation to SGH on the average for the past 6 months. 
SGHTU 






Bus / MRT 
Please specify one-way trip cost: $ ____________ 
2 
Taxi 
Please specify one-way trip cost: $ ____________ 
3  
Car / Motorcycle 
a) Please specify petrol cost $ __________ OR postal code: ____________ 
b) Please specify parking cost $ _________ OR hours parked: _______ hrs 
4  
Others, please specify: ____________________________  
Please specify one-way trip cost: $ ____________ 
 
SGHTR 
In the past 6 
months, did 





1  Yes 
2 
No, I returned home by bus / MRT.  
Please specify one-way trip cost: $ ____________ 
3  
No, I returned home by taxi.  
Please specify one-way trip cost: $ ____________ 
4  
No, I returned home by other mode(s). Specify: ____________________ 





B.2. VISITS TO OTHER MEDICAL CARE INSTITUITIONS  
We would like to find out how much you spent visiting medical care institutions other than SGH in the past 6 months. 
OTHOP 
In the past 6 
months, did 











than SGH?   
1  
General practitioner  
a) Number of visits: ______________ 
b) Average cost per visit: $ _____________ 




a) Number of visits: ______________ 
b) Average cost per visit: $ _____________ 
c) Main reason(s) for visit (e.g. for a checkup or for a medical condition): 
_________________________________________ 
3  
Other, please specify: _______________________________ 
a) Number of visits: ______________ 
b) Average cost per visit: $ _____________ 





how much did 
you spend on 
transportation 
(two-way) for 
each of the 
clinic visits?   
1  None 
2 
General practitioner  
Please specify two-way trip cost: $ ____________ 
3  
Polyclinic 
Please specify two-way trip cost: $ ____________ 
4  
Other, please specify: _______________________________ 
Please specify two-way trip cost: $ ____________ 
 
OTHED 
In the past 6 
months, did 







1 Visit 1 
a) Hospital name:     ________________________ 
b) Number of visits: __________ visits 
c) Average cost per visit: $ ______________ 
d) Main reason for visit(s): _________________________________ 
2 Visit 2 
a) Hospital name:     ________________________ 
b) Number of visits: __________ visits 
c) Average cost per visit: $ ______________ 
d) Main reason for visit(s): _________________________________ 
3  Visit 3 
a) Hospital name:     ________________________ 
b) Number of visits: __________ visits 
c) Average cost per visit: $ ______________ 
d) Main reason for visit(s): _________________________________ 






how much did 
you spend on 
transportation 
(two-way) for 
each of the 
emergency 
department 
visits?   
1 Visit 1 Please specify two-way trip cost: $ ____________ 
2 Visit 2 Please specify two-way trip cost: $ ____________ 
3 Visit 3 Please specify two-way trip cost: $ ____________ 
4  N/A Not applicable 
 
OTHIP 







1 Visit 1 
a) Hospital name: ________________________ 
b) Length of stay: _____ days 
c) Cost of stay: $ ______________ 
d) Main reason for stay(s): _________________________________ 
2 Visit 2 
a) Hospital name: ________________________ 
b) Length of stay: _____ days 
c) Cost of stay: $ ______________ 
d) Main reason for stay(s): _________________________________ 
3  Visit 3 
a) Hospital name: ________________________ 
b) Length of stay: _____ days 
c) Cost of stay: $ ______________ 
d) Main reason for stay(s): _________________________________ 




how much did 
you spend on 
transportation 
(two-way) for 
each of the 
hospitalization 
stays?                                            
1 Visit 1 Please specify two-way trip cost: $ ____________ 
2 Visit 2 Please specify two-way trip cost: $ ____________ 
3 Visit 3 Please specify two-way trip cost: $ ____________ 
4  N/A Not applicable 
 
B.3. UTILIZATION OF ANCILLIARY HEALTHCARE SERVICES 
We would like to find how much you spent on non-medical healthcare in the past 6 months.  
HCP 
In the past 6 












a) Profession: ______________________________ 
b) Number of visits: ____________ visits 
c) Average cost per visit: $ _________ 




a) Profession: ______________________________ 
b) Number of visits: ____________ visits 
c) Average cost per visit: $ _________ 




a) Profession: ______________________________ 
b) Number of visits: ____________ visits 
c) Average cost per visit: $ _________ 
d) Two-way cost of transportation: $ _____________ 





In the past 6 




prescribed by a 
doctor, either for 
general health or for 





a) Specify name: ______________________________ 
b) Cost per month:$ ____________  
c) Purpose 
General Health 




a) Specify name: ______________________________ 
b) Cost per month:$ ____________  
c) Purpose 
General Health 




a) Specify name: ______________________________ 
b) Cost per month:$ ____________  
c) Purpose 
General Health 
Treatment of SLE 
4  None  
 
CAMANY 
In the past 6 
months, have you 




medicine, either for 
general health or for 
the treatment of 
SLE? 
1  Traditional Chinese Medicine 
2 Qi Gong 
3  Acupuncture 
4  Taichi 
5  Ayuvedic Medicine 
6  Music / Art Therapy 
7  Others, specify: _____________________________________ 
8  None 
 
CAMP 
If yes, did you use it 
for the 
enhancement of 
general health or for 
the treatment of 
SLE, or both?  
1  General Health 
2 Treatment of SLE 




If yes, how many 
times AND/OR for 
how long did you 
use any of the 
complementary and 
alternative 
medicines in the 
past 6 months? 
Number of times: _____________________ times in the past 6 months 





If yes, how much 




medicines in the 
past 6 months?    
$   ______________  
B.4. UTILIZATION OF LONG-TERM HEALTHCARE FACILITIES AND AIDS 
We would like to find out how much you spent on long-term healthcare facilities and aids in the past 6 months. 
NUHM 
In the past 6 
months, have you 




a) Name of nursing home:  ____________________________ 
b) Duration of stay : _________  (days / weeks / months)* 
c) Cost per month of use: $ ______________ / month  
d) Reason for stay 
General Health 






In the past 6 
months, did you 
have to buy any 
aids or devices (e.g. 
walking stick, 
wheelchair) because 




a) Name of device/aid:  ____________________________ 
b) Cost of device: $ ______________  
c) Reason for use 
General Health 





SECTION C.  NON-HEALTH CARE EXPENDITURES 
We would like to find out how much you spent on other expenses due to your health condition.  
PHELP 
In the past 6 
months, did you 
employ paid help to 
take care of you or 
take you to the 





a) Type of paid help 
Maid 
Other, specify: __________________________ 
b) Cost of employment (including levy) per month:  
$ ________  per (hour / day / week / month)* 






In the past 6 
months, have you 




a) Name of facility: ___________________________________ 
b) Frequency of use: _________ days per week 
c) Duration of use: __________  (weeks / months)* 








In the past 6 
months, did you 
have to make any 
home modification 
(e.g. installation of 
handrails or ramps, 
relocation or 
redesign of 
bathroom, toilet or 




a) Modification: ___________________________________ 














1 Yes, full-time Monthly pay: $ _____________ per month 201 
2 Yes, part-time Hourly pay: $ _____________ per hour 201 
3 No, retired Age at retirement:: ________ years old 103 
4 No, housewife  103 
5 No, student  103 
6 No, unemployed  103 
 
 








1 Yes, I am voluntarily not employed/ early retired. 301 
2 No, I am not employed/ early retired due to my health condition. 103 
3 No, I am not employed/ early retired due other reasons. 301 
4 




If you were to return to the workforce tomorrow…  
103 
REWSO 
... what is the 
salary that 
you are likely 
to be offered 
by the 
company? 




… what is the 
salary you 
will accept for 
the job? 
$      /month 
 
We would like to find out more about changes in your employment since you were diagnosed with lupus.  
107 
EMDANY 
Were you employed at the 
time when you were 
diagnosed with lupus? 
1  Yes 109 




If no, did you take up a 
new job after being 
diagnosed with lupus?  
1       Yes. I took up a new job in      (yyyy) 
 
301 






If yes, what was your 
occupation at the time 
when you are diagnosed 
with lupus? 
1  Senior Official / Manager 
2 Professional 
3  Technician / Associate Professional 
4  Clerical Worker 
5  Service / Sales Worker 
6  Production Craftsmen  
7  Machine Operators / Assemblers 




If yes, which employment 
changes have you 
experienced since you 
were diagnosed with 
lupus?  
1  Worked fewer hours per week 112 
2 Sick leave > 2 months at a time 112 
3  Required help with job tasks 112 
4  Changed duties within job 112 
5  
Quit one or more jobs  
Please specify the year(s) when you quit your job(s): 
______ , _____ , ______ , ______ , ______  
112 
6  
Took up a job 
Please specify the year(s) when you took up a job(s): 
______ , _____ , ______ , ______ , ______  
112 
7  Changed occupation type (from the time of diagnosis) 111 
8  
Other changes, specify: 
_________________________________ 
112 




If you have changed 
occupation type after 
being diagnosed with 
lupus, what was/were your 
new occupation type(s)? 
1  Senior Official / Manager 
2 Professional 
3  Technician / Associate Professional 
4  Clerical Worker 
5  Service / Sales Worker 
6  Production Craftsmen  
7  Machine Operators / Assemblers 
8  Cleaners and Laborers  




When did you quit work 
completely?  










What was your last drawn 
salary? 
$      /month 
 
 





What is your current 
occupation? 
1  Senior Official / Manager 
2 Professional 
3  Technician / Associate Professional 
4  Clerical Worker 
5  Service / Sales Worker 
6  Production Craftsmen  
7  Machine Operators / Assemblers 





changes have you 
experienced since you 
were diagnosed with 
lupus?  
1  Worked fewer hours per week 204 
2 Sick leave > 2 months at a time 204 
3  Required help with job tasks 204 
4  Changed duties within job 204 
5  
Quit one or more jobs  
Please specify the year(s) when you quit your job(s): 
______ , _____ , ______ , ______ , ______  
204 
6  
Took up a job 
Please specify the year(s) when you took up a job(s): 
______ , _____ , ______ , ______ , ______  
204 
 




Other changes, specify: 
_________________________________ 
204 




If you have changed 
occupation type after 
being diagnosed with 
lupus, what was/were your 
new occupation type(s)? 
1  Senior Official / Manager 
2 Professional 
3  Technician / Associate Professional 
4  Clerical Worker 
5  Service / Sales Worker 
6  Production Craftsmen  
7  Machine Operators / Assemblers 
8  Cleaners and Laborers  




Have you taken any no 
pay leave because of your 
medical condition in the 
past 12 months? 
1 Yes. I took     days of no pay leave. 
 
 





Have you taken any 
medical leave because of 
your medical condition in 
the past 12 months? 
1 Yes. I took     days of medical leave. 
 
 







Have you taken time-off 
from work because you 
were feeling unwell due to 
your medical condition in 
the past 12 months?  
1 Yes. I took   hours off per month on average.  
 




Have you taken time-off 
from work for visits to 
health care professionals 
due to your medical 
condition in the past 12 
months?  
1 Yes. I took   hours off per month on average.  
 






In the past 12 months, think about days you were at work, when your health condition affected 
your work…. 
 














D.3. ALL RESPONDENTS 
We would like to find out how your ability to do housework has been affected by your medical condition in the past 12 months. 
301 
HSWKC 
Do you currently do 
housework?                                        
1 Yes. I do   hours per (day / week)* of housework. 
 
303 




If no, did you stop doing 
housework because of 
your medical condition? 
1 Yes. 
a) I stopped in    /      (mm/yyyy) 
 
b) I used to  do   hours per (day / week)*. 
 
2 No, I have not been doing housework all along. 
3 No, I stopped doing housework because of other reasons. 
 
If you currently do housework…. 
303 
HSWKD 
… have you taken any 
whole day off housework 
because of your medical 
condition in the past 12 
months?  
1 Yes. I took   days off.  
 




… have you taken time-off 
from housework because 
you were feeling unwell 
due to your medical 
condition in the past 12 
months?  
1 Yes. I took   hours off per month on average.  
 




… have you taken time-off 
from housework for visits 
to health care 
professionals due to your 
medical condition in the 
past 12 months?  
1 Yes. I took   hours off per month on average.  
 






                                     
In the past 12 months, think about days you were doing housework, when your health condition 
affected your housework… 
 
















SECTION E. PRODUCTIVITY LOSSES OF CAREGIVERS 
CGHC 
In the past 12 months, did 
you require someone to 
take care of you because 
of your health condition? 
Please select all that apply.  




3  Maid 
 
4  Children 
 
5  Sibling 
 
6  Other, specify: ______________________________________ 
 




In the past 12 months, did 
you require someone to 
take you to the doctor? 
Please select all that apply. 




3  Maid 
 
4  Children 
 
5  Sibling 
 
6  Other, specify: _______________________________________ 
 
7  None 
 
 





E.1 RESPONDENTS WITH CAREGIVERS ONLY 
We would like to find out more about your caregiver.  
401 
CGWST 
What is the current 
employment status of your 
caregiver? 
1 Employed full-time 
Monthly pay:  
$ ___________ per month 
501 
2 Employed part-time 
Hourly pay:  
$ _____________ per hour 
501 
3 Retiree Age at retirement:  ________ years old 402 
4 Housewife  402 
5 Student  402 
6 Unemployed  402 
 
 
E.1.1 CAREGIVER NOT CURRENTLY EMPLOYED 
402 
CGWSV 
Is your caregiver currently 
not employed or early 
retired to provide care due 
to your health condition? 
1 
Yes, my caregiver is not employed/ early retired to provide 
care due to my health condition.  
403 
2 
Yes, my caregiver is not employed/ early retired to provide 
care due to my health condition and other reasons.  
403 
3 
No, my caregiver is not employed/ early retired to provide 





When did he/she quit work 
completely to provide care 
for you?  










What was his/her last 
drawn salary? 
$      /month 
 
If your caregiver were to return to the workforce tomorrow… 
406 
CGWSO 
... what is the salary that 
he/she is likely to be 
offered by the company? 




… what is the salary that 
he/she will accept for the 
job? 




E.1.2. CAREGIVER CURRENTLY EMPLOYED 
We would like to find out how your medical condition has affected your caregiver’s work in the past 12 months. 
501 
CGNPL 
In the past 12 months, 
has your caregiver 
taken no pay leave 
because of your medical 
condition (to take care 
of you / take you to the 
doctor)? 
1 Yes. S/he took     days of no pay leave. 
 
 







In the past 12 months, 
has your caregiver 
taken paid leave 
because of your medical 
condition (to take care 
of you / take you to the 
doctor)? 
1 Yes. S/he took     days of paid leave. 
 
 





In the past 12 months, 
has your caregiver 
taken time-off because 
of your medical 
condition (to take care 
of you / take you to the 
doctor)? 
1 Yes. S/he took    hours off per month on average. 
 
 





E.2. ALL RESPONDENTS WITH CAREGIVERS 
We would like to find out how your medical condition has affected your caregiver’s house work in the past 12 months. 
601 
CGHWC 
Does your caregiver 
currently do 
housework?                                        
1 Yes.  
 
2 No, my caregiver has completely stopped doing housework because 
of my health condition. 
 





If yes, please estimate the 
number of hours per week 
that your caregiver has 
taken off from housework 
in order to provide care for 
you due to your medical 
condition. 




If no, when did your 
caregiver stop doing 
housework to provide care 
for your medical 
condition?  




If no, how many hours of 
housework did your 
caregiver use to do before 
stopping?  
  hours per (day / week)*. 
 
--- END OF INTERVIEWER-ADMINISTERED SURVEY --- 
 
 
